













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given. 
 
Investigating the role of 
chromatin modifications in 




Eirini – Margarita Kallimasioti – Pazi 
 







Thesis presented for the degree of Doctor of Philosophy 
 
 
University of Edinburgh 
 








Precisely positioned nucleosomes and heterochromatin have been 
shown to impede CRISPR/Cas9 editing efficiency. Conversely, Cas9 can open 
previously inaccessible regions of DNA, and transcriptionally silent targets can 
usually be edited without difficulty. In order to address this paradox, we have 
developed a method that exploits the allele-specific chromatin status of 
imprinted genes to characterise the impact of chromatin modifications on 
targeted mutagenesis. Cas9 was targeted to imprinted CpG islands in F1 
hybrid mouse embryonic stem cells, and then allele-specific mutation patterns 
were characterised following high throughput amplicon sequencing. Using this 
novel system, we discovered that heterochromatin can impede mutagenesis 
with CRISPR/Cas9, but to a degree that depends on other key experimental 
parameters. Mutagenesis was impeded when Cas9 exposure was brief and 
when intracellular expression of Cas9 was low, but the consequences of 
chromatin modifications were minimal following prolonged exposure. The 
presence of mismatches between single guide RNA and genomic target 
sequence disproportionately reduced mutagenesis within heterochromatin for 
some specific combinations of mismatches. This suggests that Cas9 
proofreading activity, and hence off-target mutagenesis, may be impacted by 
chromatin state and merits further investigation. Lastly, no effects of chromatin 
modifications on the outcome of DNA repair were detected, with similar 
efficiencies of homology-directed repair (HDR) and non-homologous end 
joining (NHEJ) on maternal and paternal alleles. Upon further characterisation 
we discovered that the majority of types of insertions and deletions generated 
by NHEJ shared similar frequencies between the two alleles. Combined, my 
data show that heterochromatin imposes a permeable barrier that influences 
the kinetics, but not the endpoint, of CRISPR/Cas9 genome editing and 
suggest that therapeutic applications involving low-level Cas9 exposure will be 






One of the biggest advances in biology during the early part of the 21st 
century has been the development of methods to precisely modify DNA 
sequence in living cells. This process, termed ‘genome editing’, is achieved by 
using special tools such as CRISPR/Cas9. CRISPR/Cas9 is very efficient, 
cost-effective and can be easily adjusted to modify any desired DNA 
sequence. Editing is achieved by creating a break in the DNA through 
positioning the Cas9 protein on DNA sequence of interest. An externally 
provided DNA template can be used to incorporate any desired sequence 
change while the break is undergoing repair.  
The complete DNA sequence in every living cell is packaged with the 
aid of proteins. Consequently, DNA packaging determines which DNA 
sequences can be hidden or exposed at any time. Emerging evidence 
suggests that DNA packaging may pose a natural barrier to the action of Cas9.  
However, it is unknown whether additional factors play a role during this 
inhibition. In addition, it is currently unclear if DNA packaging affects the 
incorporation of desired modifications during genome editing with 
CRISPR/Cas9.  
During my PhD, I established a new experimental system to study how 
different modes of DNA packaging affect the ability of CRISPR/Cas9 to edit 
mammalian DNA sequences. This led to the discovery of other factors that 
influence how DNA packaging affects CRISPR/Cas9 activity. It also became 
evident that how the target DNA was packaged before it is broken by 
CRISPR/Cas9 does not affect the sequence changes that arise following 
repair. These findings help us to understand how CRISPR/Cas9 works within 
mammalian cells and could promote its safe use in the clinic for novel 
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1.1 Genome editing technology in mammalian cells 
 
1.1.1 Early approaches and gene targeting 
 
Genome editing is a valuable method for introducing desirable DNA 
sequence modifications, such as specific insertions, deletions and 
substitutions, to genomic locations of interest. By modifying the DNA sequence 
scientists can study the function of protein coding genes and non-coding 
regulatory elements, as well as develop model systems to systematically 
characterise disease phenotypes (Tan et al., 2012).  
Before the development of the currently used approaches for 
generating targeted modifications, mutagenesis was performed in a random 
manner using chemical substances, or other mutagenic sources such as 
irradiation, and screening the resulting individual phenotypes (Stanford, Cohn 
and Cordes, 2001). In particular, such random mutagenesis strategies were 
pivotal to dissect biological functions encoded within the genomes of classical 
model organisms, such as bacteria, yeast, nematode worms, the fruit fly and 
later also in mice (Muller, 1928; Brenner, 1974; Capecchi, 2001). 
This approach was succeeded by gene targeting, a method for 
generating specific modifications with the aid of homologous recombination 
(HR), which is an endogenous DNA repair mechanism (Smithies et al., 1985; 
Doetschman et al., 1987; Thomas and Capecchi, 1987). Basic gene targeting 
is achieved through the integration of an externally provided DNA template that 
contains a selectable marker gene and the desirable edit, flanked by regions 
of homology to the genomic target site (Tokunaga, Anai and Hanada, 2016). 
The advantage of gene targeting over preceding approaches is its ability to 
precisely target genomic sequences of interest, instead of a large number of 
random undesirable sites. In addition, the requirement of HR allows specific 
sequences of interest to be inserted at endogenous loci while minimising the 
chances of random integration.  
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However, gene targeting also possesses several caveats. The size of 
mammalian genomes, being larger than the genomes of other unicellular 
eukaryotic species like yeast, poses certain difficulties with obtaining desirable 
changes. Despite the fact that gene targeting was widely used to generate 
numerous mouse models to study the function of mammalian genes 
(Capecchi, 2005) the efficiency of the technique remained low (Lin, Sperle and 
Sternberg, 1985; Thomas, Folger and Capecchi, 1986). In order to obtain 
precisely engineered cells researchers would screen many clones, resulting in 
a process that requires time and creates significant technical challenges. 
Furthermore, gene targeting was only efficient within a small selection of cell 
lines, including mouse embryonic stem cells (mESCs) and few human cancer 
cell lines (Yáñez and Porter, 1998; Adachi, Nishijima and Shibahara, 2008; 
Bouabe and Okkenhaug, 2013).  
The efficiency of gene targeting was successfully increased in the 
following years, following the utilisation of endonucleases from the budding 
yeast Saccharomyces cereviciae to introduce a double-strand break (DSB) at 
the target site (Jasin, 1996). Examples include the use of the HO 
endonuclease (Rudin, Sugarman and Haber, 1989) and the I-SceI 
meganuclease (Rouet, Smih and Jasin, 1994; Choulika et al., 1995). The 
resulting DSBs promoted the occurrence of HR on the target site and thus 
increased the efficiency of gene targeting by several orders of magnitude. 
Although this work demonstrated the key underlying principle of genome 
editing, each of the above endonucleases has a specific recognition site that 
determines the site of DNA cleavage. Therefore, this approach could not 
readily be applied to other loci where the particular recognition sequence of 







1.1.2 Genome editing with programmable nucleases 
 
In order to overcome the limitation of natural yeast endonucleases for 
their DNA recognition sites, scientists opted for engineering alternative 
versions of endonucleases that could be targeted to selected genomic 
locations.  
The Zinc Finger Nuclease (ZFN) was the initial system of ‘designer 
nucleases’ that was developed (Kim, Cha and Chandrasegaran, 1996; 
Bibikova et al., 2001, 2003; Pabo, Peisach and Grant, 2001; Porteus and 
Baltimore, 2003). These ‘designer nucleases’ contain the catalytic domain of 
the FokI restriction endonuclease, which is responsible for generating DSBs, 
and a varying set of three to six zinc finger domains that can be customised to 
direct the ZFNs to any desirable site in the target genome (Fu and Voytas, 
2012). Each zinc finger consists of a Cys2 His2-type zinc finger domain of a 
transcription factor and typically recognises three nucleotides in the genome 
(Durai et al., 2005). Figure 1.1.A illustrates the ZFN genome editing strategy. 
The FokI fusion domain is capable of cleaving only one of the strands of the 
DNA double helix, therefore a pair of ZFNs positioned in proximal sites are 
required to generate a DSB at the intended target site (Urnov et al., 2005).  
Despite overcoming the need to rely on endogenous recognition sites 
for natural endonucleases, ZFNs pose additional limitations. Customised ZFNs 
are not cost-effective because they are produced commercially due to the 
demanding design process (Hermann et al., 2014). In addition, the final 
constructs may not always be functional (Ramirez et al., 2008) and are prone 
to associating with DNA sequences that resemble, but are not identical to the 
intended target site (Gupta et al., 2011).  
A second system of ‘designer nucleases’ was later developed as a more 
cost-effective alternative to ZFNs. Transcription activator-like effectors 
(TALEs) are proteins that naturally exist within bacterial plant pathogens of the 
genus Xanthomonas. In order to increase their chances of survival, 
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Xanthomonas inject TALEs into their host plant cells, where the TALE proteins 
regulate gene expression to create a favourable environment for the bacterial 
pathogens (Boch and Bonas, 2010; Bogdanove, Schornack and Lahaye, 
2010).  
Similar to ZFNs, TALEs have been fused to the catalytic domain of the 
FokI endonuclease, to generate TALENs, which are programmable nucleases 
capable of performing targeted genome editing in a genomic site of choice 
(Morbitzer et al., 2010; Li, Huang, Jiang, et al., 2011; Li, Huang, Zhao, et al., 
2011; Mahfouz et al., 2011; Miller et al., 2011). As shown in Figure 1.1.B, a 
pair of TALENs is required to generate a DSB and trigger DNA repair via HR. 
TALENs can be produced within research laboratories by individual scientists 
with the aid of several available cost-effective methods for design and 
assembly (Cermak et al., 2011; Zhang et al., 2011; Garg et al., 2012; Sanjana 
et al., 2012).  
Custom programmable nucleases have enabled scientists to create a 
plethora of specific edits in multiple model systems (Urnov et al., 2010; Joung 
and Sander, 2013). Despite the inefficiency of traditional gene targeting in 
human embryonic stem cells (hESCs), ZFNs and TALENs have been 
efficiently used to engineer a variety of human pluripotent cell lines 
(Hockemeyer et al., 2009, 2011). ‘Designer nucleases’ have evidently paved 
the way for programmable genome editing and established the potential for 
future uses of genome engineering in medicine and biotechnology. The design 
and construction of these constructs remains laborious, expensive and time-
consuming (Larson et al., 2013), which imposes limits on the scalability of their 
production. However, these issues were overcome after the development of a 
novel ‘RNA-guided’ system, derived from a naturally occurring mechanism of 
immunity in prokaryotes, which truly revolutionised all prior strategies for 







Figure 1.1 Schematic of DSB formation by different programmable nucleases.  
A: Paired ZFNs in action. Ellipses represent the four distinguishable zinc finger 
domains (as an example) while associating with a nucleotide triplet. The catalytic 
domain of the FokI restriction endonuclease is shown in pink. B: Similar to ZFNs, a 
pair of TALENs is required to generate a DSB, and the fused FokI domain is shown 
in pink. DNA binding specificity is determined by a core repetitive domain containing 
repeat-variable di-residues (RVDs). Each RVD associates with a distinct nucleotide 
of the target site. Amino acids NI (red), HD (green), NG (blue) and NN (yellow) target 
adenine, cytosine, thymine and guanine, respectively. C: Diagram of the target site 
recognition of CRISPR/Cas9. Target specificity is determined by the sgRNA molecule 
(shown in red) and the presence of a PAM sequence (highlighted in blue). A DSB is 
formed through the combined action of the two nuclease domains of Cas9, as shown 





1.1.3 Genome editing with CRISPR/Cas9 
  
CRISPR/Cas9 stands for Clustered Regulatory Interspaced Short 
Palindromic Repeats/ CRISPR-associated protein 9 and comprises an RNA-
guided endonuclease (Cas9) and a single-guide RNA (sgRNA) molecule (Mali 
et al., 2013; Cong et al., 2013; Jinek et al., 2013).  
The origin of the most popular and widely-used genome editing tool lies in 
microbial adaptive immunity mechanisms that have been discovered in 
bacteria and archaea (Makarova et al., 2011). The natural function of 
CRISPR/Cas systems is to protect the host microorganism from predatory 
viruses and invading nucleic acids of foreign origin (Horvath and Barrangou, 
2010; Bhaya, Davison and Barrangou, 2011). The CRISPR/Cas systems that 
have been characterised in detail until now have been classified into three 
distinct categories (Makarova et al., 2015).  
The common characteristics of all CRISPR/Cas defence mechanisms are 
the genes that encode RNA-guided Cas nucleases, non-coding RNAs and a 
characteristic array of repetitive elements. Short fragments of the invading 
DNA, or spacers, are integrated into this unique array in an interspaced 
manner. Following transcription of the entire array and generation of small 
guide RNA molecules, the unique short spacer sequences allow the host 
microorganism to cope with a consecutive round of infection from the same 
genetic material. In general, the guide RNA molecule leads the Cas nuclease 
to the corresponding complementary re-invading foreign nucleic acid, which is 
consecutively cleaved by the Cas nuclease (Garneau et al., 2010). In addition, 
cleavage of an invading DNA molecule requires the presence of a short 
characteristic motif that helps the microorganism determine its foreign origin 
(Mojica et al., 2009). This is called the ‘protospacer-adjacent motif’ or PAM and 




The most commonly used version of CRISPR/Cas was developed from the 
Type II immunity system from Streptococcus pyogenes and consists of the 
Cas9 endonuclease, the crRNA array of spacers and the trans-activating 
crRNA (tracrRNA). The tracrRNA molecules hybridise with the repetitive 
portions of the pre-crRNA. RNaseIII is responsible for separating the crRNA-
tracrRNA duplexes into distinct molecules. Every duplex then binds Cas9 and 
determines the specificity of the intended DSB site and positions Cas9 there 
through a 20 nucleotide-long protospacer sequence. The presence of an 
adjacent 5´ NGG PAM allows base pairing between the protospacer of the 
crRNA and its complementary target site. If sufficient complementarity is 
present in this region, Cas9 undergoes a conformational transition that allows 
the HNH and RuvC nuclease domains of Cas9 to cleave the complementary 
and non-complementary strand, respectively, and generate a targeted DSB 
between positions 3 and 4 of the protospacer sequence (Jinek et al., 2012; 
Sternberg et al., 2014; Jiang et al., 2016). A schematic is provided in Figure 
1.1.C. In addition, the domain organisation and crystal structure of Cas9 from 
Streptococcus pyogenes are shown in Figure 1.2.A and Figure 1.2.C&D, 
respectively.  
Repurposing of the Streptococcus pyogenes CRISPR/Cas9 system into 
the most potent genome editing tool was taken forward by the fusion of the 
crRNA and tracrRNA components to generate a chimeric single guide RNA 
(sgRNA) molecule, shown in Figure 1.2.B. This reduced the number of 
separate components required for editing to two, and led to the establishment 
of a novel programmable nuclease which was immediately favoured for 
generating a plethora of edits in mammalian cell lines (Cho et al., 2013; Cong 
et al., 2013; Jinek et al., 2013; Mali et al., 2013).  
The main advantage of CRISPR/Cas9 is that the target site specificity is 
determined solely from the protospacer portion of the sgRNA. The protospacer 
sequence can be easily modified by combining oligonucleotide synthesis with 
standard molecular cloning, thus rendering Cas9 reprograming easy and 
affordable for many scientists (Ran, Hsu, Wright, et al., 2013). The production 




Figure 1.2 Crystal structure of the S. pyogenes Cas9-sgRNA complex in action.  
A: Linear representation of the domains of Cas9 from S. pyogenes. B: Diagram of the 
chimeric sgRNA molecule when it associates with its complementary target DNA.  
C&D: The Cas9-sgRNA complex upon association with the target site. The crystal 
structure is shown in ribbon and surface representation, respectively. The Cas9 




Moreover, co-expression of multiple sgRNAs with the Cas9 nuclease 
allowed multiple genomic locations to be targeted simultaneously in the same 
cell. Pools consisting of thousands of sgRNAs can be introduced 
simultaneously into cell populations through lentiviral delivery (Koike-Yusa et 
al., 2014). This created ample opportunities for high-throughput screens and 
additional modifications such as rearrangements and large-scale 
chromosomal deletions (Cong et al., 2013; Choi and Meyerson, 2014; Li et al., 
2014; Shalem et al., 2014; Torres et al., 2014; Wang et al., 2014; Chen et al., 
2015; Kraft et al., 2015; Doench et al., 2016). 
One key disadvantage of CRISPR/Cas9 is the tolerance of mismatches 
during pairing of the protospacer of the sgRNA and genomic locations that 
highly resemble its intended target site. Mismatch tolerance usually leads to a 
high frequency of off-target hits and makes CRISPR/Cas9 less specific than 
other versions of programmable nucleases, most notably TALENs (Li et al., 
2014). Nonetheless, a series of adaptations have been made to increase the 
specificity and efficiency and scope of CRISPR/Cas9 as a genome editing tool 
(Cebrian-Serrano and Davies, 2017; Komor, Badran and Liu, 2017). Cas9 
nickases (Cas9n) have been generated to be used in a pairwise manner that 
resembles ZFNs and TALENs, thus the size and fidelity of the recognition site 
was doubled (Ran, Hsu, Lin, et al., 2013; Shen et al., 2014).  
Over the years, multiple algorithms and tools have emerged to predict 
the likelihood of off-target site recognition for individual sgRNAs (Tsai et al., 
2015, 2017; Kim et al., 2016; Cameron et al., 2017; Kim and Kim, 2018; 
Wienert et al., 2019). Scientists can thus minimize the chances of getting off-
target hits during the experimental design stage. Several cell-free, but also 
cell-based, off-target detection methods have been developed to predict 
putative off-target hits for CRISPR/Cas9. In general, cell-free methods produce 
large lists consisting of hundreds of possible off-target sites for every individual 
sgRNA that is examined (Kim et al., 2016; Cameron et al., 2017; Tsai et al., 
2017). Subsequent experimental validation of these predicted off-target sites 
frequently results into the realisation that many of them are false positives. By 
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contrast, cell-based off-target detection methods produce smaller lists of 
predicted off-target sites (Tsai et al., 2015).  
 A couple of more recent CRISPR/Cas9 off-target site prediction 
methods have highlighted the importance of integrating information about 
chromatin organisation relative to the target site. DIG-seq is a cell-free method, 
where chromatinised genomic DNA is incubated with purified Cas9 protein and 
sgRNAs in vitro (Kim and Kim, 2018). This method is a more recent 
development of Digenome-seq, a cell-free method that also involved purified 
genomic DNA without histones or other binding protein factors. Similar to cell-
based methods, DIG-seq produces a smaller list of putative off-target sites for 
the tested sgRNAs, but still fails to capture what happens in a real biological 
setting, where chromatin is dynamic.  
 The latest development amongst off-target detection methods is 
DISCOVER-seq, which is cell-based but also applicable to mice. This 
astonishing method allows detection of Cas9-induced DSB through MRE11 
ChIP following exposure to CRISPR/Cas9. DISCOVER-seq is widely 
applicable to mammalian species used heavily in biological research, due to 
the conservation of MRE11, and allows reliable DSB detection with minimal 
false positives (Wienert et al., 2019). This is true because MRE11 is one of the 
first factors that associate with the ends of Cas9-induced DSBs, as mentioned 
later in section 1.2.1 in this chapter, during DSB repair through HR, alt-EJ and 
SSA (Haince et al., 2008; Williams et al., 2008; Williams, Lees-Miller and 
Tainer, 2010). MRE11 association may not be relatable with repair of Cas9-
induced DSBs through c-NHEJ but is yet the best method for reporting on DSB 
recognition instead of the endpoint of CRISPR/Cas9 mutagenesis process. 
This dissertation will be focusing on genome editing with the traditional 
Cas9 endonuclease from Streptococcus pyogenes. In the context of genome 
editing in mammalian cells, Cas9 generates targeted DSBs that are sealed by 
inherent DNA repair mechanisms.  
12 
 
1.2 DNA double-strand break repair, CRISPR/Cas9 
and chromatin 
 
1.2.1 DSB repair pathways in eukaryotes in the context of genome editing 
 
After the DSB has been generated by a genome editing nuclease, 
changes to the DNA sequence occur during their repair by the native DNA 
repair machinery of the cell. The two main pathways of DNA DSB repair found 
in eukaryotes are homologous recombination (HR) and non-homologous end 
joining (NHEJ). The term Homology Directed Repair (HDR) is used to describe 
the process of DSB repair with the aid of an exogenous template donor during 
genome editing (Doudna and Charpentier, 2014), and will be discussed in 
more detail later in this section. While HR always leads to complete restoration 
of the DNA sequence in the immediate vicinity of the DSB, NHEJ is the 
mechanism favoured by multicelluar eukaryotes for DSB repair (Lieber et al., 
2003; San Filippo, Sung and Klein, 2008). 
 Fidelity during DNA DSB repair is of paramount importance. This is why 
the principle of the error-free HR mechanism is conserved from prokaryotes to 
mammals (Mladenov et al., 2016). After a DSB is identified, the MRN complex, 
cosisting of the Mre11, Rad50 and Nbs1 factors, is directed to the free DNA 
ends (Williams et al., 2008; Williams, Lees-Miller and Tainer, 2010). This event 
is called DSB sensing and triggers recruitment of the CtIP nuclease, which in 
turn begins processing of the DNA ends (Eid et al., 2010; Makharashvili and 
Paull, 2015). The 5´ to 3´ exonuclease Exo1 and Bloom helicase (BLM) are 
also recruited to unwind the DNA, complete end processing and lead to the 
formation of a 3´ end overhang on both ends (Bischof et al., 2001; 
Zakharyevich et al., 2010). The replication protein A (RPA) subsequently coats 
both 3´ overhangs and attracts the PALB2-BRCA1-BRCA2 complex 
(Moynahan, Pierce and Jasin, 2001; Xia et al., 2006; Prakash et al., 2015). As 
a result, BRCA2 mediates the exchange of RPA with Rad51, a factor that is 
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responsible for invasion of the 3´ overhang into the homologous region on the 
sister chromatid (Esashi et al., 2005). Several paralogs of Rad51 come on site 
to aid with resolution of the Holiday junction that is formed as part of HR 
(Masson et al., 2001). The most notable of them is Rad54, which is implicated 
in branch migration and Holiday juntion resolution (Bugreev, Hanaoka and 
Mazin, 2007; Mazina and Mazin, 2008; Mazin et al., 2010). Resolvases, such 
GEN1 found in human, complete the process of Holiday junction resolution, 
leading to error-free repair of the broken sister chromatid (Ip et al., 2008). Due 
to its ability to fully restore the integrity of a broken DNA molecule, HR also is 
involved in other cellular processes where DSBs are induced, such as meiotic 
recombination (Inagaki, Schoenmakers and Baarends, 2010; Schatz and 
Swanson, 2011). 
HR fundamentally relies on the presence of a homologous sequence, 
typically the sister chromatid, in order to repair a DSB occuring on a 
chromosome. HR during G1 with a homolog rather than a sister chromatid 
leads to loss of heterozygosity, with a strong potential for downstream 
complications such as development of cancer (Stark and Jasin, 2003). 
Therefore, HR is temporally restricted to the S and G2 phases of the cell cycle 
through a mechanism that involves ubiquitination of PALB2 to abrogate its 
interaction with BRCA1 during G1 (Orthwein et al., 2015). Another property of 
this high-fidelity mechanism is that HR is time consuming because it involves 
numerous steps of processing and resolution (Mladenov et al., 2013).  
On the contrary, c-NHEJ has a very short half-time of 10 to 30 minutes 
and can occur throughout the cell cycle, making it the more frequently utilised 
mechanism to repair DSBs in most animal cells (Iliakis et al., 2004). During 
classical NHEJ (c-NHEJ) the ends of a DSB are initially bound by the Ku70/80 
complex, which can excise damaged nucleotides and recruit the DNA-
dependent protein kinase (DNA-PKcs) (Downs and Jackson, 2004; Roberts et 
al., 2010; Strande et al., 2012). After DNA-PKcs associates with the Ku70/80 
complex it autophosphorylates and marks the beginning of the repair process 
(Chan et al., 2002). Autophosphorytaltion of DNA-PKcs leads to the 
recruitment of the Artemis 5´ to 3´ exonuclease, which also trims away 
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damaged nucleotides (Moshous et al., 2001; Goodarzi et al., 2006). In 
addition, the polμ and polλ polymerases are also recruited by 
autophosphorylated DNA-PKcs to fill in the small gaps that are created during 
processing by Artemis (Daley et al., 2005; Paull, 2005). These processing 
steps ensure that the DNA ends become compatible for ligation, which occurs 
via the LigaseIV DNA ligase after the ends are stably positioned in close 
proximity by the XRCC4 and XLF factors (Andres et al., 2012; Roy et al., 2015). 
These factors do not have any enzymatic activity but play a key role towards 
bridging the ligatable DNA ends. PAXX, a paralog of XRCC4, and XLF are also 
involved in bridging the processed ligatable ends by directly associating with 
the Ku7/80 complex which is still found on either end (Ochi et al., 2015). This 
mechanism can lead to error-free DSB repair, but c-NHEJ is also associated 
with small single-nucleotide insertions or deletions (InDels) that arise as a 
consequence of this type of DNA end processing (Mladenov et al., 2016).  
 Over the years, additional mechanisms that resemble c-NHEJ have 
been discovered to repair DSBs in the event of c-NHEJ inhibition. Alternative 
End Joining (alt-EJ) relies on the recruitment of PARP1 instead of the Ku70/80 
complex to initiate DSB repair (Wang et al., 2006). Histone H1 has been 
reported to enhance the activity of PARP1 during alt-EJ (Rosidi et al., 2008). 
End processing occurs with the aid of the MRN complex and CtIP nuclease, 
which are primarily part of the HR pathway (Haince et al., 2008). Polθ is 
subsequenctly recuited to prevent association of Rad51 and fill in the single-
stranded DNA overhangs generated by MRN-CtIP (Ceccaldi, Rondinelli and 
D’Andrea, 2016). During alt-EJ ligation of the processed DNA ends is achieved 
by the combined action of the DNA LigaseI and DNA LigaseIII and their 
cofactor XRCC1 (Audebert, Salles and Calsou, 2004; Arakawa and Iliakis, 
2015).  
 Extended resection facilitated by MRN-CtIP during alt-EJ may reveal 
short sequences of homology ranging from 2-25 nucleotides. Alignment of 
such microhomologies frequently leads to deletion of intermediate sequences 
through a process that is refered to as microhomology-mediated end joining 
(MMEJ), which is highly mutagenic and has even been associated with large 
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chromosomal translocations (McVey and Lee, 2008; Villarreal et al., 2012). 
Indeed, the presence of such large deletions that are reminiscent of MMEJ has 
also been observed after genome editing with CRISPR/Cas9 (Kosicki, 
Tomberg and Bradley, 2018). Evidence from a recent study comparing the 
repair kinetics of Cas9-induced and irradiation-induced DSBs in the absence 
of an externally provided repair donor concluded that repair of Cas9-induced 
DSBs requires more time on average and may last up to 15 hours (Brinkman 
et al., 2018). Furthermore, chemical inhibition of DNA-PKcs resulted primarily 
in larger deletions of up to 10 nucleotides, leading the authors to conclude that 
MMEJ works as a backup mechanism of c-NHEJ during genome editing with 
CRISPR/Cas9 (Brinkman et al., 2018). A diagram illustrating the spectrum of 
InDels that can be generated during error-prone NHEJ pathways is provided 
in Figure 1.3. 
Nevertheless, genome editing is typically used to introduce precise 
sequence changes to a genomic location of choice through HDR. This requires 
co-delivery of a single-stranded or double-stranded exogenous template 
bearing homology arms, as shown in Figure 1.3. Emerging evidence suggests 
that the nature of the repair donor determines the pathway of DSB repair, since 
single-stranded templates have been reported to stimulate DSB repair in the 
absence of the BRCA2 mediator of the traditional HR pathway (Kass et al., 






Figure 1.3 Double-strand break repair pathways during genome editing with 
programmable nucleases. 
ZFNs, TALENs and CRISPR/Cas9 generate DSBs that are repaired either by the 
error-prone NHEJ mechanism or by HDR when a homologous donor is supplied. 
Utilisation of HDR leads to the introduction of specific desirable modifications (shown 
in orange) on the target site (shown in light blue). Alternatively, c-NHEJ and MMEJ 
may lead InDel formation on the target site. Error-free repair by c-NHEJ is also highly 
possible. InDel size (indicated by brackets) is determined by the error-prone pathway 








While repair through double-stranded donors appears to utilise common 
factors in common with classical HR such as Rad51 (Bothmer et al., 2017), 
there is a general consensus that the use of single-stranded donors during 
genome editing leads to DSB repair through a mechanism that resembles 
synthesis-dependent strand annealing (SDSA). Gene conversion tract 
analysis revealed that Cas9 tracts are unidirectional, suggesting that one of 
the DNA ends associates, synthesises from and then dissociates with the 
single-stranded donor, in a manner that resembles SDSA and does not require 
on incorporation of the actual donor molecule (LaRocque and Jasin, 2010; Kan 
et al., 2017). However, HDR with  single-stranded donors during genome 
editing is Rad52-dependent and therefore associated with single-strand 
annealing (SSA), an error-prone homology-driven  DSB repair pathway that 
was originally discovered in unicellular eukaryotes and prokaryotes (Fishman-
Lobell, Rudin and Haber, 1992; Malkova et al., 2001; Cubbon, Ivancic-Bace 
and Bolt, 2018; Gallagher and Haber, 2018). During SSA Rad52 coats and 
bridges the processed DNA ends. This rough process results in flaps that are 
subsequently nicked by the ERCC1/XPF nuclease. Finally, the DNA LigaseI 
seals the nicks but leads to variable-sized deletions (Symington, 2002; 
Ceccaldi, Rondinelli and D’Andrea, 2016). 
Additional evidence has recently emerged suggesting that HDR with 
single-stranded repair donors is also linked with the Fanconi Anemia (FA) 
pathway. Depletion of FA factors during a targeted CRISPRi screen increased 
the frequency of NHEJ utilisation. Chromatin immunoprecipitation followed by 
sequencing (ChIP-Seq) revealed that the FANCD2 FA factor collocalises with 
Cas9 at DSBs during genome editing with CRISPR/Cas9 (Richardson et al., 
2018). As characterisation of the HDR mechanism used during Cas9-induced 
DSB repair with single-stranded repair templates remains incomplete, it is also 






1.2.2 Parameters that affect DSB repair within eukaryotic cells 
 
 Unlike prokaryotes, eukaryotes sequester their genome inside a nuclear 
membrane. Certain regions within the eukaryotic nucleus appear very 
compacted and dense and are historically referred to as heterochromatin 
(Brown, 1966; Straub, 2003). Heterochromatin is described in more detail in 
section 1.3.1 of this chapter.  It has recently been shown that the position 
where a DSB occurs within the nucleus determines whether HR or NHEJ will 
be utilised for repair. If a DSB occurs within a region close to the nuclear 
membrane it is more likely to be repaired by NHEJ. This is because the regions 
lining the interior of the nuclear membrane are A/T-rich, non-transcribed during 
interphase and heterochromatic (Fawcett, 1966; Meuleman et al., 2013; van 
Steensel and Belmont, 2017). On the contrary, DSBs occurring in the interior 
of the nucleus or in close proximity to the nuclear pore can be repaired either 
by HR or NHEJ (Lemaître et al., 2014).  
 Further evidence from two individual groups suggests that DNA ends 
from DSBs arising in DAPI-dense nuclear compartments migrate towards the 
periphery of these, where they are repaired by HR (Chiolo et al., 2011; Jakob 
et al., 2011). A more recent study also verified the above by generating 
targeted DSBs within chromocenters with CRISPR/Cas9. Chemical 
synchronisation of mouse NIH 3T3 cells in G2 allowed a direct comparison 
between the chances of NHEJ and HR occurrence. Monitoring of DNA end 
localisation through structured illumination microscopy (SIM) revealed that 
DSBs generated within DAPI-dense regions relocate towards the periphery of 
these regions, where they co-localise with RAD51. DNA end migration requires 
processing to have occurred, since depletion of MRE11 and CtIP results in 
stationary DSBs as assessed by immunofluorescence (IF) monitoring of the 
DNA end marker γH2Ax (Tsouroula et al., 2016). The same study showed that 
DSBs escaping relocation are repaired by SSA within heterochromatin in a 
RAD52-dependent manner in the absence of BRCA2. 
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A link between transcription and DSB repair has also emerged since it 
was observed that actively transcribed genomic regions are preferably 
repaired by HR. An engineered U2OS cell line, where targeted DSBs are 
generated in an inducible manner via the AsiSI restriction endonuclease, was 
used to study the relationship between DSBs, epigenetic modifications and 
transcription (Aymard et al., 2014). Chemical inhibition of transcription resulted 
in decreased accumulation of RAD51 near generated DSBs. The lens 
epithelium–derived growth factor (LEDGF) normally interacts with H3K36me3, 
a histone post-translational modification deposited within actively transcribed 
gene bodies, and recruits CtIP (Daugaard et al., 2012). Depletion of LEDGF 
also led to a dramatic decrease of RAD51 accumulation on DSB sites located 
in actively transcribed genes. RNAi-mediated depletion of SETD2, the 
methyltransferase responsible for H3K36me3 deposition, resulted in the same 
reduction in RAD51 accumulation at the same DSB sites. Therefore, it was 
concluded that DSBs occurring within transcriptionally active genes are 
preferentially repaired by HR (Aymard et al., 2014).  
 The idea that other factors, such as eukaryotic chromatin compaction, 
affect DNA DSB repair pathway choice is becoming increasingly popular 
(Clouaire and Legube, 2015). The term chromatin compaction is used 
frequently throughout every chapter in this thesis. This term is used to describe 
the different features of chromatin in eukaryotes, such as epigenetic 
modifications and accessibility to DNase enzymes, as well as transcription. In 
general, I use the term ‘compacted’ chromatin to describe a region that is 
transcriptionally silent, bears repressive histone modifications and methylated 
CG dinucleotides. A description for all these eukaryotic chromatin features is 
provided in the following section. Since it is unclear how Cas9-induced DSBs 
are repaired with the aid of a single-stranded donor molecule, it would be 
interesting to investigate if pre-existing chromatin compaction affects the 





1.3 Chromatin characteristics and genome editing  
 
1.3.1 Chromatin features in eukaryotes 
 
The genomes of higher eukaryotes are compacted into chromatin in 
order to fit inside the nucleus (Woodcock and Ghosh, 2010). The ‘fundamental 
subunit’ of this higher order structure is the nucleosome, which consists of 147 
base pairs that are wrapped around a core histone protein octamer, as shown 
in Figure 1.4.A (Kornberg, 1974; Kornberg and Thonmas, 1974; Luger et al., 
1997). Inter-nucleosomal interactions result in the formation of chromatin fibres 
with higher order structures, which in turn are compacted further up to mitotic 
chromosomes, as shown in Figure 1.4.B (Woodcock and Dimitrov, 2001; 
Baylin and Schuebel, 2007). It has been demonstrated that nucleosomes 
inhibit transcription initiation but may be displaced by RNA Polymerase II 
during transcriptional elongation in vitro (Knezetic and Luse, 1986; Lorch, 
LaPointe and Kornberg, 1987).  
Chromatin can bear additional layers of chemical modifications. Methyl 
groups can be added to the fifth carbon atom of cytosine residues within 
primarily CG dinucleotides in eukaryotes (Zemach et al., 2010). This 
modification is termed DNA methylation and it is the only know modification to 
be directly deposited into the genome in mammals (Robertson, 2005). 
Mammals poses two main DNA methyltransferases that deposit the mark de 
novo in any DNA sequence context, DNMT3A and DNMT3B (Okano, Xie and 
Li, 1998; Okano et al., 1999; Greenberg and Bourc’his, 2019). DNMT3L is a 
third de novo DNA methyltransferase (Bourc’his et al., 2001; Ooi et al., 2007), 
which is only catalytically active in the germline and will be mentioned later in 
section 1.4. During DNA replication the DNA methylation mark is not passed 
on to the daughter DNA strand, resulting in hemimethylated CG sites. These 







Figure 1.4 Chromatin structure representations. A: The crystal structure of a 
nucleosome, where the DNA double helix surrounds the histone octamer. Histones 
H2A, H2B, H3 and H4 are represented in orange, red, green and blue, respectively. 
Adapted from Luger et al., 1997. B: Representation of the different levels of 
chromatin organisation. From left to right there is the naked DNA double helix, the 
‘beads on a string’ nucleosome fibre, which is then condensed into a larger fibre, 
through to a highly compacted mitotic chromosome. Adapted from mitotic 
chromosomes. Adapted from Baylin and Schuebel, 2007. 
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turn attracts the maintenance DNA methyltransferase DNMT1 to deposit 
methyl groups to the relevant cytosine residues of the newly synthesised DNA 
strand (Bostick et al., 2007; Sharif et al., 2007; Ishiyama et al., 2017). Finally, 
DNA methylation is removed by TET enzymes, which facilitate oxidation of 5-
methylcytosine residues (5mC) to 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC) (Tahiliani et al., 2009; Ito 
et al., 2010, 2011; He et al., 2011). All oxidised forms of 5mC lead to loss of 
DNA methylation maintenance after DNA replication (Otani et al., 2013). 
Furthermore, 5fC and 5caC can also by removed through the base excision 
pathway since both are substrates for the thymine DNA glycosylase enzyme 
(Weber et al., 2016).  
In addition, histone proteins within nucleosomes can be post 
translationally modified to affect chromatin structure and function. Histone tails 
protrude through the nucleosome and act as substrates for a repertoire of 
modifications (Mersfelder and Parthun, 2006). The most notable ones that will 
be discussed here are histone acetylation and histone methylation.  
Histone acetylation causes chromatin relaxation by neutralising the 
positive charge of lysine residues, where an acetyl group is deposited. This 
modification is associated with transcriptionally active genomic regions 
(Allfrey, Faulkner and Mirsky, 1964; Hebbes, Thorne and Crane-Robinson, 
1988; Wang et al., 2009). Chemical inhibition of histone deacetylase enzymes 
has been shown to lead to an elevated accumulation of acetylated histones, 
resulting in chromatin decondensation at a global level (Tóth et al., 2004). 
Histone methylation is associated both with transcriptionally active and 
silent regions of the genome, depending on the residue that this small neutral 
modification is deposited. Histone tails can be methylated on arginine or lysine 
residues. More specifically, lysine residues may receive up to three distinct 
methyl groups. The most outstanding methylated histone signatures that are 
associated with actively transcribed genes are namely H3K4me3 and 
H3K36me3. These histone methylation signatures are commonly found among 
promoters of transcriptionally-active genes or within gene bodies of actively 
transcribed genes, respectively (Krogan et al., 2003; Wang et al., 2008). On 
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the contrary, H3K9me1/2/3, H4K20me3 and H3K27me3 are associated with 
chromatin compaction and are frequently referred to as the repressive histone 
modifications (Wang et al., 2008). More specifically, the Polycomb repressive 
complex 2 (PRC2) deposits H3K27me3 leading to transcriptional silencing 
(Cao et al., 2002). In general, methylation of H3K9 works as a docking site for 
other proteins that may associate with chromatin, such as the heterochromatin 
protein 1 (HP1), which leads to the formation of heterochromatin (Bannister et 
al., 2001; Fischle et al., 2005). 
DNA methylation also leads to heterochromatin formation, as the DNA 
methyltransferase enzymes mentioned earlier interact with other types of 
enzymes while depositing methyl groups on cytosine residues. For example, 
DNMT1 interacts with the G9a H3K9 methyltransferase (Estève et al., 2006; 
Epsztejn-Litman et al., 2008), the HDAC1 histone deacetylase (Fuks et al., 
2000) and the LSH chromatin remodeller (Dennis et al., 2001; Myant et al., 
2011; Tao et al., 2011). These enzymes can alter the chromatin landscape at 
methylated DNA sequences, eventually leading to transcriptional repression of 
underlying genes. Furthermore, the binding of several transcription factors is 
impaired by DNA methylation (Yin et al., 2017) and a positive correlation 
between transcriptional repression and the number of methylated CG 
dinucleotides at gene promoters has also been observed (Weber et al., 2007). 
Despite being a small, neutral with respect to charge, modification, DNA 
methylation works as a substrate for several proteins that can contribute 
further to heterochromatin formation. In mammals, these include the methyl-
CpG-binding protein 2 (MeCP2) and the four identified methyl-CpG-binding 
domain (MBD) proteins (Meehan et al., 1989; Hendrich and Bird, 1998). These 
five proteins have been shown to recruit histone deacetylases and contribute 
to transcriptional silencing of underlying genes (Nan et al., 1998; Ng et al., 
1999). Lastly, some zinc finger proteins also associate with methylated 
cytosines, such as ZFP57 (Quenneville et al., 2011) and Kaiso (Yoon et al., 
2003), which lead to DNA methylation maintenance or recruitment of histone 
deacetylases, respectively. Therefore, all the proteins mentioned above are 
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not only able to recognise and associate with methylated cytosines, but also 
mediate heterochromatin formation.  
The term heterochromatin was originally created by Emil Heitz to 
describe chromosomal regions that remained condensed after mitosis (Brown, 
1966; Straub, 2003). Further studies demonstrated that heterochromatin is an 
AT-rich, gene-poor fraction of the genome that is mostly condensed throughout 
the cell cycle and only replicated during the later stage of S-phase (Brown, 
1966; Pardue and Gall, 1970; Comings, 1978; Craig and Bickmore, 1993; 
Estandarte et al., 2016). Repetitive DNA sequences found on mammalian 
centromeres and telomeres are examples of sequences that should remain 
transcriptionally silent and are therefore persistently embedded within 
constitutive heterochromatin. This type of heterochromatin is very stable and 
is marked by H3K9me3.  
However, if the compaction of a genomic region is dynamic over time, 
for example during multicellular development, then the term facultative 
heterochromatin is used to describe the heterochromatic environment where 
this region is embedded (Dillon and Festenstein, 2002; Trojer and Reinberg, 
2007). Examples of such regions include bivalent genes, at which promoter 
sequences are simultaneously decorated with H3K4me3 and H3K27me3 and 
play a pivotal role in development and differentiation, as well as the inactive X 
chromosome in female mammals (Bernstein et al., 2006; Heard and Disteche, 
2006).  
Chromatin compaction occurs at many levels and is highly dynamic. 
Despite its natural origins CRISPR/Cas9 is very effective within mammalian 
cells and seems to perform well in the presence of chromatin. It is though 
impossible to exclude that CRISPR/Cas9 in somehow influenced by this higher 






1.3.2 CRISPR/Cas9 target search and recognition 
 
Despite its wide usage, the details on the mechanism by which 
CRISPR/Cas9 searches for and recognises its target are still emerging. A 
recent study using Förster resonance energy transfer (FRET) demonstrated 
that CRISPR/Cas9 diffuses in a lateral manner on the DNA double helix and 
refined previous findings suggesting that the complex diffuses in a three-
dimensional manner (Sternberg et al., 2014; Globyte et al., 2019). Once the 
Cas9-sgRNA complex encounters a PAM site, the Cas9 unwinds the double 
helix and the sgRNA protospacer hybridises to the complementary target 
sequence (Sternberg et al., 2014). This results in the formation of an R-loop 
between the target DNA and sgRNA, which has been proposed to be the rate 
limiting step for Cas9 cleavage (Gong et al., 2018). During R-loop formation 
the HNH nuclease domain of Cas9 constantly changes its structural 
conformation (Dagdas et al., 2017). HNH eventually settles into a permissive 
state and Cas9 undergoes a conformational change to transition to its active 
state (Jinek et al., 2014). Following this change, the HNH and RuvC nuclease 
domains of Cas9 simultaneously cleave the protospacer-bound 
complementary strand and the non-complementary PAM-containing strand, 
respectively, to generate a DSB (Jinek et al., 2012). Figure 1.5 illustrates the 
Cas9-sgRNA complex in a bound and cleavage-competent conformation with 
respect to the different levels of chromatin organisation.  
 However, the above biochemical insights into the CRISPR/Cas9 
mechanism of action have been deduced from systems that are not fully 
representative of what programmable nucleases encounter inside mammalian 
nuclei. The genomes of higher eukaryotes are compacted into chromatin, 
which may influence the target search by CRISPR/Cas9, just as it has been 
shown to influence other nuclear processes such as transcription (Li, Carey 
and Workman, 2007). In contrast to ZFNs and TALENs, CRISPR/Cas9 did not 





Figure 1.5 CRISPR/Cas9 and the barrier posed by eukaryotic chromatin 
compaction.  
The Cas9-sgRNA complex is shown during the R-loop formation stage, where the 
protospacer hybridises to the target strand (shown at the top). The pairs of scissors 
pointing upwards and downwards represent the HNH and RuvC nuclease domains of 
Cas9, respectively. Cas9 is shown in blue and the sgRNA in dark blue. The sgRNA 
protospacer and PAM are shown in green and red, respectively. On the right, the 
different levels of chromatin compaction that eukaryotic genomes undergo are shown. 
Starting from the DNA double helix at the bottom, to nucleosomes (depicted as pink 
spheres) forming a chromatin fibre and a fully compacted mitotic chromosome (shown 










1.3.3 Chromatin compaction and CRISPR/Cas9 editing efficiency 
 
Individual in vitro studies from three different research groups have 
recently assessed whether Cas9 activity is inhibited by the presence of 
nucleosomes on target DNA. In 2015 Hinz et al demonstrated that 
CRISPR/Cas9 cleavage of its target sequence is inhibited when the latter is 
wrapped around a nucleosome. Positioning of the PAM site, rather than the 
protospacer, appeared to be the main determinant of the inhibitory effect (Hinz, 
Laughery and Wyrick, 2015). A few months later Isaac et al reached the same 
conclusion using similar methods but also showed that nucleosomal inhibition 
of CRISPR/Cas9 is alleviated by adding the RSC chromatin remodelling 
enzyme from Saccharomyces cerevisiae to the reaction to resemble 
physiological intracellular conditions (Isaac et al., 2016). Similarly, the findings 
of Horlbeck et al using the Chd1 yeast chromatin remodeller also proved that 
factors promoting nucleosome dynamics increase cleavage efficiency, 
presumably by making otherwise occluded PAM sites transiently accessible 
support that the effect of nucleosome positioning in CRISPR/Cas9 activity is 
reversible (Horlbeck et al., 2016). The overall conclusion from these three 
studies is that the presence of an immobile nucleosome over a PAM site 
hinders the activity of the CRISPR/Cas9 genome editing tool in vitro. However, 
chromatin in vitro is static compared to chromatin in the context of a living cell. 
As shown more recently, the editing potency of a certain sgRNA may be 
reduced in an in vivo setting compared to an in vitro assay (Yarrington et al., 
2018; Uusi-Mäkelä et al., 2018). Therefore, it is crucial to develop more 
physiologically relevant systems to investigate further what happens in vivo. 
The first studies to report on the effect exerted by mammalian chromatin 
to CRISPR/Cas9 emerged in 2014. Genome-wide ChIP-seq binding profiles 
for catalytically dead Cas9 (dCas9) in mESCs and HEK293 cells showed that 
chromatin accessibility determines binding of the dCas9-sgRNA complex 
(Kuscu et al., 2014; Wu et al., 2014). In addition to the intended target site, 
dCas9 associated with several off-target sites with similar nucleotide 
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sequences. The likelihood of off-target binding was greater in DNase I 
hypersensitive sites (DHS), indicating that Cas9 also preferentially associates 
with open chromatin. This argument is further supported by the finding that 
CRISPR/Cas9 activity is highly correlated with H3K4me3, an epigenetic mark 
found at promoters of actively transcribed genes that is associated with open 
chromatin (Chari et al., 2015). Assay for transposase-accessible chromatin 
using sequencing (ATAC-seq) data from zebrafish embryos also verified that 
the higher the target accessibility, the higher the editing efficiency of 
CRISPR/Cas9 in vivo (Chen et al., 2017; Uusi-Mäkelä et al., 2018). 
Single-molecule tracking techniques were used to determine the 
diffusion kinetics of dCas9 near heterochromatic nuclear domains. Halo-
tagged dCas9 diffused at a significantly slower rate within nuclear domains 
occupied by the heterochromatin protein 1 (HP1) but was still able to penetrate 
heterochromatin and reach the sgRNA target site, as would also be expected 
for wt Cas9 (Knight et al., 2015). Additional evidence from editing in yeast 
suggested that the nucleosome positioning occludes the association between 
the Cas9-sgRNA complex and its target site, regardless of the chromatin 
environment where the target site is embedded (Yarrington et al., 2018). 
 Moreover, it is well established that sequence properties of the sgRNA, 
probably acting via secondary structures and effects on stability, have a major 
bearing on editing efficiency (Moreno-Mateos et al., 2015; Jensen et al., 2017). 
To assess the impact of chromatin modifications on editing efficiency, it is 
therefore desirable to assess the efficiency of editing on the same target site 
when it is embedded into different chromatin conformations.   
Notable examples of such systems include artificially-engineered cell 
lines where differential chromatin compaction of a region coding for a 
fluorescent reporter is achieved through chemical induction. Chen et al made 
use of a HEK293-based system in which a KRAB-repressor protein is recruited 
to Tet Operator repeats flanking a Cas9 target site within a fluorescent reporter 
gene. Addition of doxycycline prevented recruitment of the repressor and 
correlated with a greater number of editing events as a consequence of 
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chromatin decompaction around the reporter construct (Chen et al., 2016). A 
follow up publication from the same group demonstrated that this principle also 
applied to Cas9n (Chen et al., 2017). Similar effects have been observed by 
another group that utilised a different transgenic system in HEK293 cells, 
where compaction of the region containing the luciferase reporter gene could 
be induced upon addition of doxycycline. Surprisingly, after comparing editing 
efficiencies of multiple sgRNAs throughout the length of the luciferase reporter 
gene in open and closed chromatin, it became evident that chromatin did not 
influence all individual sgRNAs to an equal extent. Some sgRNAs showed no 
inhibition at all, whereas other sgRNAs situated at promoter-proximal positions 
among the luciferase reporter gene were profoundly inhibited (Daer et al., 
2017). Taken together, these results suggest that chromatin compaction can 
be an important factor for the efficiency of the Cas9-sgRNA complex. However, 
it also raises the possibility that additional unknown factors may influence the 
way eukaryotic chromatin regulates mutagenesis by CRISPR/Cas9. 
In 2015 Polstein et al provided the first evidence that dCas9 gained 
access to genomic regions that are protected from the transcription machinery. 
It was argued that while dCas9 associated with the target site determined by 
the sgRNA, the complex overcame the lack of accessibility by inducing 
chromatin remodelling of the region where the target site was embedded 
(Polstein et al., 2015). Soon afterwards it was also demonstrated that dCas9 
is sufficient to remodel chromatin to the extent of making it accessible for other 
Transcription Factors, whose binding motifs were previously occluded by 
nucleosomes (Barkal et al., 2016). The above findings are important points to 
consider about the behaviour of CRISPR/Cas9 in vivo. The fact that chromatin 
may interfere with CRISPR/Cas9 efficiency but Cas9 may remodel chromatin 
while searching for its target site creates a paradox. It also highlights the need 
for further investigation.  
Despite the useful insight obtained from earlier studies comparing 
CRISPR/Cas9 editing efficiency using artificial differentially compacted 
reporter constructs (Chen et al., 2016; Daer et al., 2017) it is vital to examine 
whether the same effect can be observed on endogenous gene sequences 
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when present in their natural chromatin context. A recent review summarised 
what is currently known about how chromatin influences the efficiency of 
genome editing with CRISPR/Cas9 and emphasised the advantage of 
internally controlled systems that have been used to target the same DNA 
sequence when it is found in two different chromatin conformations within the 
same nuclear environment (Verkuijl and Rots, 2019).  
To date, only two studies have been conducted using such systems. 
The first involved targeting of the p161NK4a locus in HCT116 cells and the 
second focused on targeting maternally-imprinted loci in mESCs (Fujita, Yuno 
and Fujii, 2016; Kallimasioti-Pazi et al., 2018). In both cases the target 
sequences were present in two copies that were characterised by differential 
epigenetic chromatin modifications. In the first case the p161NK4a locus has 
two alleles that are decorated with DNA methylation and H3K9me2 in a 
mutually exclusive manner. Surprisingly, two out of the three employed 
sgRNAs were not affected by the allele-specific chromatin features of the 
target locus (Fujita, Yuno and Fujii, 2016). The findings of the second study 












1.4 Mammalian genomic imprinting  
  
1.4.1 Historical discovery, establishment and function of genomic 
imprinting 
 
 The notion that the two sets of chromosomes all mammals inherit from 
their parents have distinct functions during development was originally 
demonstrated by two different research groups in the early 1980s. Pronuclear 
transplantation was utilised to generate bimaternal and bipaternal mouse 
zygotes, which contain two copies of the maternal and paternal genomes in 
either case, respectively (McGrath and Solter, 1983; Surani and Barton, 1983). 
The resulting embryos were delivered to pseudo-pregnant female mice, 
resulting solely in short pregnancies that were characterised by early 
embryonic lethality shortly after implantation (McGrath and Solter, 1984a; 
Surani, Barton and Norris, 1984). Consecutive studies established that this 
drastic phenotype was owed to the presence of two genomic copies of the 
same parental origin, instead of other cytoplasm-related effects (Mann and 
Lovell-Badge, 1984; McGrath and Solter, 1984b). 
 A few years later, the discovery and characterisation of the first 
imprinted murine genes confirmed earlier speculations that a certain number 
of genes are expressed from only one of the two parental chromosomes 
throughout embryonic development (Cattanach and Kirk, 1985; Barlow et al., 
1991; Bartolomei, Zemel and Tilghman, 1991; DeChiara, Robertson and 
Efstratiadis, 1991; Ferguson-Smith et al., 1991). Examples include the 
reciprocally imprinted insulin-like growth factor 2 (Igf2), which is maternally 
imprinted in mouse and human (DeChiara, Robertson and Efstratiadis, 1991; 
Giannoukakis et al., 1993) and the insulin-like growth factor 2 receptor (Igf2r), 
which is paternally imprinted (Wutz et al., 1997; Birger et al., 1999).  
To date, approximately 200 imprinted genes have been identified within 
the mouse and human genomes (Barlow, 2011; Ferguson-Smith, 2011; 
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Ferguson-Smith and Bourchis, 2018). The striking similarity of all imprinted 
genes is allele-specific DNA methylation, which is established de novo by 
essential DNA methyltransferases and acts as a platform for additional allele-
specific epigenetic marks (Li, Beard and Jaenisch, 1993; Bourc’his et al., 2001; 
Fournier et al., 2002; Kaneda et al., 2004). More specifically, the DNMT3L de 
novo DNA methyltransferase is recruited at regions where H3K4me3 is erased 
from the KDM1B histone demethylase (Ooi et al., 2007; Ciccone et al., 2009). 
 The allele-specific DNA methylation marks found on imprinted genes 
are termed ‘imprints’ and are established during gametogenesis in mammals. 
Meiotically-arrested oocytes acquire ‘imprints’ during oocytes growth (Obata 
et al., 1998) whereas in males ‘imprints’ are laid prior to meiosis during testis 
development (Davis et al., 2000; Ueda et al., 2000). As illustrated in Figure 
1.6, ‘imprints’ are stably maintained after fertilization throughout development, 
with the exception of the germline where they are reset and re-established in 
a gender-specific manner (Reik and Walter, 2001). There, the DNA 
methylation is completely erased and the ‘imprints’ are established de novo in 
a sex-specific manner during gonadal development (Barlow and Bartolomei, 
2014).  
 Imprinting maintenance is achieved through the synergistic action of the 
pre-existing DNA methylation mark and additional factors that are recruited by 
it. The precise locations where the allele-specific DNA methylation is deposited 
near imprinted genes are called imprinting control regions (ICRs), which 
frequently contain repeats of the TGCCGC motif (Weaver et al., 2010). When 
an ICR is methylated, the ZFP57 zinc finger protein associates with this motif 
and in turn recruits the KAP1 complex and DNA methyltransferases, which aid 
in maintenance of the local DNA methylation environment (Li et al., 2008; 
Quenneville et al., 2011). Similarly, PGC7/Stella also has an active role in DNA 
methylation maintenance of two imprinted genes in early embryogenesis 
through a yet undetermined mechanism (Nakamura et al., 2007). Thus, 
‘imprints’ are protected from the genome-wide waves of DNA demethylation 
that occur after fertilization and before embryonic implantation (Reik, Dean and 
Walter, 2001).  
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 Genomic imprinting is essential for mammalian development (McGrath 
and Solter, 1984a; Surani, Barton and Norris, 1984; Cattanach, 1986). 
Embryonic stem cell lines with two copies of the paternal genome have been 
developed and injected to adult mice, where they cluster and form tumours 
(Mann et al., 1990). In addition, it has been demonstrated that chimeric 
embryos that contain cells with two genomic copies from the same parent, 
develop clusters to retain these abnormal cells to the cerebral cortex (Allen et 
al., 1995).  
Most importantly, genomic imprinting is necessary to maintain a 
balance in expression between growth suppressor and growth enhancer 
genes in the placenta and other extraembryonic tissues. Paternally expressed 
genes are responsible for promoting embryonic growth, whereas maternally 
expressed genes suppress embryonic growth to guarantee the survival of the 
mother (Coan, Burton and Ferguson-Smith, 2005). For example, paternally 
expressed Igf2 promotes growth in the fetus (Murphy et al., 2015). Disruption 
of Igf2 leads to growth deficiency in murine embryos (DeChiara, Efstratiadis 
and Robertsen, 1990), whereas knocking out Igf2 further leads to 
disproportionate growth of the placenta (Coan et al., 2008). On the contrary, 
maternally expressed Igf2r binds Igf2, leading to degradation of Igf2 (Okas, 
Rozek and Czech, 1985; Zavorka et al., 2016). Biallelic expression of Igf2r 
leads to a reduction in embryonic growth, which may persist into adult mice 
(Wutz et al., 2001). Additional studies have linked the function of imprinted 
genes with postnatal processes, such as adaptation to feeding and social 
behaviour (Plagge et al., 2004; Garfield et al., 2011). Therefore, the expression 
of imprinted genes must be regulated appropriately for mammals to develop 
properly before and after birth.  






Figure 1.6 The life cycle of imprints in mice.  
Imprint establishment occurs in female and male gametes, followed by maintenance 
throughout the embryonic and extraembryonic tissue. Prior to sex determination, 
imprints are erased from the embryonic gonad, where the germline will develop later. 
A second round of establishment occurs after the sex of the progeny is determined, 
when paternal and maternal imprints are acquired in sperm and eggs, respectively. 
Adapted from Barlow and Bartolomei, 2014.  
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1.4.2 Epigenetic properties and insightful contributions of imprinted 
genes 
 
 Imprinted genes must be expressed either from the maternal or paternal 
allele. With the exception of only a few, imprinted genes are found in clusters 
throughout the murine genome (Zwart et al., 2001). Allele-specific silencing of 
imprinted genes is primarily determined by the ICR, which acquires differential 
DNA methylation during imprinting establishment (Edwards and Ferguson-
Smith, 2007).   
 The expression of imprinted genes is regulated by ‘imprints’ and 
additional layers of epigenetic information. Chromatin immunoprecipitation 
(ChIP) experiments on mouse liver and brain tissue have first reported the 
presence of H3K9me3 on the methylated allele and H3K4me3 on the 
unmethylated allele of imprinted ICRs (Fournier et al., 2002). Furthermore, the 
study of DNMT3L-depleted midgestation embryos that were derived from 
crossing female C57BL/6 and male JF1 mice provided useful insights into the 
link between DNA methylation and histone modifications at ICRs. ChIP for 
H3K9me3 and H4K20me3 revealed a dramatic loss of both of these repressive 
histone modifications at ICRs, which correlated with the absence of ICR 
methylation and biallelic expression of imprinted genes (Henckel et al., 2009). 
This shows that repressive histone modifications require the germline-
deposited CpG methylation mark on ICRs.  
With respect to chromatin modifications, methylated sequences 
resemble repetitive and transposable elements that are naturally silenced in 
mammalian cells. Imprinted alleles and retrotransposons are transcriptionally 
silenced through a mechanism that involves the KAP1 complex recruiting HP1 
(Rowe et al., 2010). Additionally, both of the above are decorated with 
H3K9me3 and H4K20me3 to maintain a compacted status (Martens et al., 
2005; McEwen and Ferguson-Smith, 2010). Imprinted alleles therefore 
resemble constitutive heterochromatin (Regha et al., 2007) (as shown in 




Figure 1.7 Allele-specific epigenetic properties of imprinted loci.  
Representation of the epigenetic characteristic differences between alleles of 
imprinted genes. The ICR or promoter of a transcriptionally-silent imprinted allele is 
methylated and tightly wrapped around deacetylated histones (shown on the left). 
Proteins with Methyl-CpG-binding domains (MBDs) like MeCP2, MBD1 and MBD3 
have been found to associate with hypoacetylated imprinted allelic regions (Fournier 
et al., 2002). In contrast, the transcriptionally-active allele (shown on the right) does 
not undergo nucleosomal condensation due to the presence of acetylated histones. 











A final characteristic that is specific to the promoters of imprinted genes 
is differential accessibility and nucleosomal density. DNase I sensitivity assays 
have demontrated that the promoter of the unmethylated allele is sensitive to 
digestion, whereas the promoter of the methylated imprinted allele is 
inaccesible (Feil et al., 1997).  
To date, the majority of imprinted mammalian genes are controlled by 
maternally-methylated ICRs, where DNA methylation and repressive histone 
modifications work in synergy to silence the allele that is inherited from the 
mother (Ferguson-Smith and Bourchis, 2018). These genes are mostly found 
in large clusters but also, less frequenctly, as individual genes controlled by a 
single ICR (Ferguson-Smith, 2011). It would be preferable to assess the effect 
of chromatin modifications in ICRs from clusters of genes, but also in ICRs that 
regulate individual genes.  
Maternally-imprinted ICRs have a high CG dinuclotide content and are 
highly influential for mammalian development. On the contrary, paternally-
imprinted genes are usually located within intergenic regions, contain fewer 
CG dinucleotides and are more prone to imprinting erasure (Schulz et al., 
2010). The latter is further supported by a large-scale study in human 
pluripotent stem cells that demonstrated higher CG methylation loss at the 
ICRs of paternally-imprinted genes (Bar et al., 2017).Therefore, for the 
purposes of my PhD, I have decided to only focus on maternally imprinted 
ICRs and target only maternally imprinted genes. Despite this decision, both 
types of imprinted genes have been used as model systems that led to 
important discoveries about epigenetic regulatory mechanisms of gene 
expression, like the relationship between DNA methylation and alternative 
polyadenylation on a maternally-imprinted gene (Wood et al., 2008). 
 CTCF, or the CCCTC-binding factor, is a DNA binding protein that is 
highly conserved among vertebrates. This ubiquitous protein defines 
chromosomal domain boundaries and is mostly associated with transcriptional 
repression but also transcriptional activation (Filippova et al., 1996; Vostrov 
and Quitschke, 1997; Bell, West and Felsenfeld, 1999). It was later established 
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that CTCF associates with the maternal unmethylated ICR of the H19 
paternally-imprinted gene, where it regulates the expression of the 
neighbouring Igf2 maternally-imprinted gene by isolating Igf2 from its cis 
regulatory enhancer (Bell and Felsenfeld, 2000; Hark et al., 2000; Szabó et al., 
2000; Engel et al., 2004). This is a case where genomic imprinting was 
repurposed into a system that led to discoveries about protein-mediated 
transcriptional regulation and chromosome topology (Murrell, Heeson and 
Reik, 2004).  
Another major contribution to the understanding of transcriptional 
regulation was made through the elucidation of the role of long non-coding 
RNAs (lncRNAs) in imprinting maintenance. Imprinted gene clusters, such as 
Igf2r and Cdkn1c/Kcnq1, contain long non-coding transcripts that are 
specifically transcribed from the paternal chromosome and aid in 
transcriptional repression of nearby paternally-imprinted genes (Sleutels, 
Zwart and Barlow, 2002; Mancini-Dinardo et al., 2006). Specifically, the Air 
lncRNA has a central role to the recruitment of the G9a H3K9 mono- and di-
methyltransferase to the paternal chromosome (Nagano et al., 2008). 
Similarly, Kcnq1ot1 recruits the DNMT1 maintenance DNA methyltransferase 
(Mohammad et al., 2010, 2012), G9a and PRC2 to block transcription in cis 
(Pandey et al., 2008; Terranova et al., 2008). A recent study even suggested 
a functional role for Kcnq1ot1 that is not related with genomic imprinting, 
highlighting potential for further significant discoveries that can be made by 
repurposing genomic imprinting (Andresini et al., 2019).  
Genomic imprinting is arguably an excellent system to study epigenetic 
regulation of transcription. The presence of differential epigenetic 
modifications on two identical copies of the same underlying DNA sequence 
make imprinted genes a very attractive system for studying the effect of 
chromatin modifications on the efficiency of CRISPR/Cas9, as  well as the 
repair of DSBs in the context of genome editing with an externally-provided 






The central goal of my PhD project was to understand how chromatin 
influences the efficiency of genome editing with the CRISPR/Cas9 
programmable nuclease and identify which DNA DSB repair pathway is 
favoured by different chromatin contexts. The specific aims of my project were:  
 
1) To establish a system using genomic imprinting to study the effect of 
chromatin modifications on genome editing with CRISPR/Cas9.  
2) To investigate how additional factors may influence the effect of 
chromatin on genome editing with CRISPR/Cas9. 
3) To assess how chromatin modifications affect off-target site 
mutagenesis by CRISPR/Cas9. 
4) To determine the effect of chromatin on mutagenic repair outcomes 
















Chapter 2  
 











2.1 Molecular cloning  
2.1.1 Design and preparation of sgRNAs 
  
Target regions near promoters and within imprinted gene bodies were 
selected based on publicly available DHS data in the UCSC Genome Browser. 
SNP information for sgRNA selection was obtained from the National Institute 
of Genetics (NIG) mouse genome database 
(http://molossinus.nig.ac.jp/msmdb/index.jsp). The National Institute of 
Genetics, in Mishima, Shizuoka, Japan, is where the Japanese funky 1 mouse 
(JF1) was first sequenced (Takada et al., 2013). The CRISPR sgRNA designer 
for the Broad Institute (Doench et al., 2014) was used to select sgRNAs 
(http://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design). 
Guides with GGG PAM sequences, high On-Target Efficacy Scores and close 
proximity to a SNP in the murine JF1 genome were selected for cloning.  
 Complementary oligonucleotides, consisting of the 20 nucleotide-long 
protospacer sequence and a 4 nucleotide-long overhang, were ordered from 
Integrated DNA Technologies. After pairwise phosphorylation with T4 
Polynucloetide kinase (NEB, M0201S), the phosphorylated complementary 
oligonucleotide pairs were heated at 95 °C for 5 minutes and allowed to 
gradually cool down and anneal. All sgRNA oligonucleotide sequences are 
listed in Appendix 1.1. 
 
2.1.2 Cloning sgRNAs in mammalian CRISPR vectors 
 
The universally available protocol by Feng Zhang’s lab was used to 
clone all guides in the GFP (px458, Addgene Plasmid #48138) and Puromycin 
resistance (px459v2, Addgene Plasmid #62988) vectors (Ran, Hsu, Wright, et 
al., 2013). In addition, gInpp5f_v2, gImpact1, gKvDMR#1 and gKvDMR#3 
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were also cloned into a vector coding a 3xFLAG-dCas9 (pX330A_dCas9-1x2, 
Addgene Plasmid #63596) for dCas9 ChIP. All vectors were digested with 
FastDigest BpiI (ThermoFisher Scientific, FD1014) and dephosphorylated with 
FastAP (ThermoFisher Scientific, EF0654). Annealed complexes of 
phosphorylated sgRNA oligonucleotides were ligated to all vectors with the T4 
DNA Ligase (NEB, M0202S). 
 
2.1.3 Design of ssODNs 
 
All ssODNs were designed to span the sgRNA target site and contain a 
mutation that abolishes the PAM sequence and generates a restriction enzyme 
site. Detection of HDR events is possible through identification of the pre-
engineered mutation in the NGS reads or by enzymatic digestion. The ssODNs 
used in this study were 150bp long and did not overlap with any SNPs, to avoid 
introducing bias to the overall mutagenesis result. All ssODN sequences were 
ordered as custom single-stranded ultramers from Integrated DNA 
Technologies, a full record is provided in Appendix 1.2. 
 
 
2.2 Cell Culture 
2.2.1 Hybrid mESC culture and maintenance 
 
BxJ and JxB hybrid mESCs were derived as extensively described in 
section 3.2, cultured in ESGRO Complete PLUS Clonal Grade Medium 
(Millipore, SF001-500P) and passaged once every two days. Cells were 
seeded in standard plastic cell culture flasks and plates that were coated with 
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0.2% Gelatin (Sigma, G1393-100ML) solution for 2 minutes immediately 
before seeding.  
 
2.2.2 Transfection and puromycin selection 
  
Cells, with passages ranging from 6 to 12 unless otherwise specified, 
were plated in 6-well plates. The amount of 0.3 million cells was seeded in 
each well of a 6-well plate and transfected with 3ug plasmid DNA and 2 μl of 
10uM ssODN using Lipofectamine 2000 (ThermoFisher Scientific, 11668019). 
Transfections were performed 24 hours after seeding the indicated amount of 
cells. Unless otherwise mentioned, two sgRNAs and ssODNs were transfected 
simultaneously. The effect of co-transfection on editing efficiency is not known. 
Additional details from the dCas9 cross-linked ChIP transfections are 
mentioned in section 2.4.2. For all transfections, lipofectamine-containing 
media was removed five hours post-transfection to avoid cytotoxic effects. 
Twenty-four hours post-transfection cells were subjected to 1.5ug/ml 
Puromycin-containing media (ThermoFisher Scientific, A1113803) for twenty-
four hours. Longer Puromycin selection timings resulted in extensive cell 
death. Recovery after puromycin selection required maintaining the cells in 
culture for 48 hours, leading to cell harvesting after puromycin selection at 4 
days (or 96 hours) after transfection.  
 Due to the limited time of reagent exposure during early time points, 
time course experiments were performed without puromycin selection. In 
addition, the experiments shown in section 4.3 of Chapter 4 were performed 
with slight deviation from the general protocol. At 24 hours after transfection, 
cells were FACS sorted according to GFP fluorescence levels and maintained 
as distinct populations. Half of the cells from each population were immediately 
harvested and genomic DNA was extracted for downstream processing. The 
remaining half was re-seeded and maintained in culture for a further 72 hours. 
Transfection efficiency ranged between 30% and 40%, as determined by GFP 
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fluorescence during the experiments described in section 4.3. Alternatively, 
during experiments with puromycin selection, cell viability was used as a 
quality control measure. Cell density was observed 24 hours after puromycin 
addition, if confluency was below 40% then the experiment was discarded.   
 
2.2.3 Hybrid mESC 2i culture with vitamin C supplement 
 
A vial with BxJ passage 6 cells was thawed and plated in ESGRO. Cells 
were maintained in 1i for 3 passages (always 1:10 split). A day after the third 
passage was seeded, the cells settled down. ESGRO was removed, the cells 
were washed with PBS and supplied with 2i media (PD0325901 and 
CHIR99021 inhibitors for MEK and GSK3, respectively). 2i media was supplied 
daily and the cells were passaged (1:10) every two days until they reached 
passage 20. After the cells settled down 1 day after plating passage 20, the 2i 
media was replaced with 2i with L-Ascorbic acid 2-phosphate 
sesquimagnesium salt hydrate (vitamin C, Sigma, A8960) at a concentration 
of 100ug/ml. 2i media with 100ug/ml vitamin C was also changed daily and 
cells spent 4 days under these conditions. They were passaged twice during 
this time, reaching passage 22. The culture medium was shifted back to 
ESGRO 1 day after plating passage 22 and then the cells were trypsinised and 
plated for transfections in 6 well plates as usual, in ESGRO. Tranfections in 
BxJ passage 23 were performed as previously described with Lipofectamine 
2000. Cells were harvested at 16h and 96h after transfection in the absence 
of Puromycin selection. A complete recipe for the 2i culture medium is provided 







2.2.4 Genomic DNA extraction following transfections 
  
Cells were collected at indicated times after transfection for separate 
experiments. Harvested cells were spun down and resuspended in 200 μl 
PBS. Genomic DNA was isolated with the DNeasy Blood & Tissue kit by 
Qiagen. Samples were quantified on a NanoDrop Spectrophotometer from 
ThermoFisher Scientific.   
 
2.2.5 Fluorescence activated cell sorting (FACS) 
 
Flow cytometric analysis of cells transfected with px458 was conducted 
on a Becton Dickinson FACSAria II instrument by the FACS technicians of the 
MRC HGU, Elisabeth Freyer and Stacey Thomson. Data analysis was 
performed in BD FACSDiva (Becton Dickson, Version 6.1.2) also by Elisabeth 
Freyer and Stacey Thomson. 
 
2.3 Preparation and validation of NGS libraries 
2.3.1 Target locus amplification and labelling 
  
Amplicons for all target regions were designed to cover the sgRNA 
target site and at least one allele-specific SNP. A two-round PCR amplification 
strategy was employed, similar to the ‘16S Metagenomic Sequencing Library 
Preparation Protocol’ by Illumina. Phusion High-Fidelity DNA Polymerase 
(NEB, M0530S) was used instead of the recommended 2x KAPA HiFi HotStart 
ReadyMix. The PCR recipe was adjusted according to the Phusion High-




 Primers were designed to contain adaptor and barcode sequences 
necessary for multiplexed high-throughput amplicon NGS. Initially, 50ng of 
genomic DNA sample was amplified for 25 cycles with region-specific primers 
for every locus. Primers for the first amplification step contained 5´ extensions 
with a random hexamer, binding sites for Illumina sequencing primers, and 
binding sites for the primers of the second round of amplification. First round 
amplicons were purified using AMPure XP beads (Beckman Coulter, A63882) 
as described in the ‘16S Metagenomic Sequencing Library Preparation 
Protocol’ by Illumina and eluted in 50ul. One fifth of the eluate (10ul) was used 
for a second round of amplification for 8 cycles using primers with Illumina 
indices (i5 and i7). Second round amplicons were also purified using AMPure 
XP beads and eluted in 25ul. All first round (region-specific) and second round 
(universal) primer sequences are provided in Appendix 3.1 and Appendix 
3.3, respectively. 
 Concentration, size and sample purity of the generated NGS libraries 
was examined by running 1 μl of each library on an Agilent Bioanalyser High 
Sensitivity chip. Stock dilutions of amplicon libraries passing quality control 
were prepared individually and pooled at equimolar ratio at a final 
concentration of 4nM. NGS was performed on the MiSeq Illumina platform to 
generate 150bp paired-end reads.  
 
2.3.2 Bisulfite library preparation 
  
Genomic DNA samples were converted with the EZ DNA Methylation-
Gold Kit by Zymoresearch. The amount recommended in the protocol (500ng) 
was used per conversion reaction. Region-specific primers for bisulfite 
converted DNA were designed on Methprimer (http://www.urogene.org/cgi-
bin/methprimer/methprimer.cgi). As for non-converted samples, 5´ extensions 
with a random hexamer, binding sites for Illumina sequencing primers, and 
binding sites for the second-round primers were added to the region-specific 
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primers for the first round of amplification. Bisulfite modified genomic DNA 
(100ng) was amplified across regions spanning the sgRNA targeting sites to 
cover 6-10 CpG dinucleotides, as it was not possible to include a SNP for every 
target region. All first round bisulfite primer sequences and the number of 
CpGs for individual amplicons are provided in Appendix 3.2. The first round 
of amplification required 35 cycles and different annealing temperatures for 
different region-specific primer pairs. To obtain a decent amplicon amount, the 
2XGoTaq Green Master Mix (Promega, M7123) was used for both 
amplification rounds. All region-specific primer sequences and annealing 





2.4 Analytical and functional assays 
 
2.4.1 Surveyor assay 
  
Edited genomic DNA samples were subjected to the Surveyor assay to 
assess the presence of NHEJ-related events and derive information about 
overall genome editing efficiency levels prior to NGS. Initially, PCR amplicons 
covering a wide region of 250 nucleotides on either side of the cleavage site, 
were generated using 200ng of each sample. Following 30 cycles of 
amplification, amplicons were purified using the QIAquick PCR Purification Kit 
by Qiagen. Purified amplicons were quantified on a NanoDrop 
Spectrophotometer from ThermoFisher Scientific.   
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 Subsequent steps, such as DNA heteroduplex formation, Surveyor 
nuclease S digestion and visualisation, were performed as in a widely-used 
published protocol (Ran et al., 2013). Digestions reactions were performed 
with the Surveyor Mutation Detection Kit (Integrated DNA Technologies, 
706020) and cleavage products were visualised in a 2% agarose gel stained 
with the sensitive SYBR Gold Nucleic Acid Gel Stain (ThermoFisher Scientific, 
S11494). 
 
2.4.2 DNase I accessibility assay   
  
A published protocol (McArthur, Gerum and Stamatoyannopoulos, 
2001) was modified to fulfil the purposes of our experiments. The amount of 
20 million mESCs from each of the two hybrid lines was harvested and 
resuspended in 5ml of Buffer A. Nuclei were isolated following cell lysis with 
0.5 % (v/v) NP40 and centrifugation at 2000g for 5 minutes and resuspended 
in 1ml of digestion buffer. The amount of 100 μl of nuclei were separately 
digested with 0–60 units of DNase I at 37°C for 5 minutes and discontinued 
after adding 1ml of stop buffer. Protein degradation was performed with 2ug 
Proteinase K treatment at 55°C for 16 hours. Phenol/chloroform extraction and 
ethanol precipitation were performed to recover the DNA, which was 
resuspended in TE buffer. The Qubit high sensitivity assay (ThermoFisher 
Scientific, Q32854) was used to measure the concentration of the resulting 
DNA samples. Regions of interest including one allele-informative SNP were 
amplified from the resulting DNA samples for 30 cycles. AMPure XP beads 
were used to purify amplicons, which were sequenced across the SNP with 
traditional Sanger sequencing. All relevant primer sequences are provided in 
Appendix 4.2. All buffer recipes for this assay are provided in Appendix 5.1. 




2.4.3 Native histone ChIP  
 
The amount of 10 million mESCs from each of the two hybrid lines was 
harvested and resuspended in 10ml chilled PBS. Cells were pelleted at 500g 
for 5 minutes at 4˚C and resuspended in 1ml chilled NBA buffer. Cell lysis was 
performed on ice for 5 minutes with the addition of 1ml of NBB buffer.  Nuclei 
were collected after centrifugation of cell lysates at 1000g for 5 minutes at 4˚C 
and resuspended in 200 μl of NBR buffer. Nuclei were pelleted after a second 
centrifugation step of 5 minutes at 4˚C and resuspended in 600 μl NBR buffer, 
where 10 μl of 10mg/ml PureLink RNaseA (Invitrogen, 12091039) was added 
for 5 minutes for total RNA degradation at room temperature. A total of 40 
Boehringer units of MNAse were used for an incubation at 20˚C for 10 minutes. 
Samples were mixed by pipetting when MNAse was added, as well as 5 
minutes later, during the incubation. Addition of 600 μl MNase stop buffer 
stopped the digestion process and chromatin samples were spun down at 
13,000rpm for 5 minutes at 4˚C.  
In parallel, Protein A Dynabeads (Invitrogen, 10002D) were pre-washed 
in Blocking buffer and mixed and incubated with 2.5ug of antibody (per sample) 
on a rotating wheel for 2 hours at 4˚C. The amount of 40 μl of beads in 
suspension was used for every sample. Antibodies against H3K9me3 (07-442, 
batch 2664282) and H4K20me3 (07-643, batch 2586586) were purchased 
from Millipore. Following conjugation, the beads were washed with 200 μl 
Blocking buffer. At this point, 100 μl of the previously prepared chromatin 
samples was kept separately to be used as 10% Input for later ChIP 
quantification by qPCR. For the immunoprecipitation, 1ml of the previously 
prepared chromatin samples was mixed with the immune-conjugated beads 
and 5 μl of 5mg/ml BSA solution. Chromatin samples and beads were 
incubated on a rotating wheel for 3 hours at 4˚C. 
Immunoprecipitated chromatin and beads were subsequently washed 
thrice with 1ml ChIP-W1 buffer for 10 minutes at 4˚C on a rotating wheel and 
once with TE buffer without nutation. Chromatin was released from the beads 
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following addition of 100 μl Elution buffer, vortexing and an incubation at 37˚C 
for 1 hour at 700rpm. The amount of 7μl of 2M Tris-HCl pH6.8 solution was 
added to adjust the pH value of the samples to 8. A short centrifugation step 
was necessary to discard the beads. The ChIP supernatant was kept and 
subsequently processed along with the 10% Input sample. Histones were 
degraded after a 1 hour treatment with 20ug of Proteinase K treatment at 55°C. 
All ChIP and 10% Input DNA samples were purified with the QIAquick PCR 
Purification Kit by Qiagen. Chromatin modification mapping at the chosen 
imprinted regions in the two hybrid mESC lines was exclusively performed by 
Gillian Taylor. Buffer recipes are provided in Appendix 5.2. 
   
2.4.4 Cross-linked ChIP 
  
Transfections for this experiment were slightly different from the 
procedure described in section 2.2.2. Hybrid mESCs were seeded in 10cm 
dishes and transfected with 24ug of total plasmid DNA with Lipofectamine 
2000. Four plasmids coding a 3XFLAG-dCas9 and four sgRNAs (gImpact1, 
gInpp5f_v2, gKvDMR#1 and gKvDMR#3) were co-transfected without any of 
their corresponding ssODNs. Transfected cells were harvested at the relevant 
time points without any selection, counted and resuspended in 10ml PBS. The 
amount of 10 million cells was subjected to cross-linking with 5ml chilled PBS 
containing 1% formaldehyde (ThermoFisher Scientific, 28906) for 10 minutes 
at room temperature with nutation. The cross-linking process was stopped with 
the addition of 1M glycine solution to a final concentration of 0.125M. Following 
cross-linking, cells were incubated for 5 minutes at room temperature with 
nutation, pelleted at 2000rpm for 5 minutes at 4˚C and washed with 10ml 
chilled PBS.  Cell lysis was performed with 5ml of Farnham lysis buffer and 
nuclei were pelleted at 2000rpm for 5 minutes 4˚C prior to storage at -80˚C. 
After all time points were collected, they were processed in parallel. Once 
thawed, pelleted nuclei were resuspended once more in 5ml Farnham lysis 
buffer. After pelleting again at 2000rpm for 5 minutes 4˚C, nuclei were 
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resuspended in 1ml RIPA buffer. Sonication was then performed by 3 cycles 
of 30s on followed by 30s off on the Soniprep 150 (power = 4 amplitude 
microns) to prevent preferential shearing of the euchromatic allele. Fragment 
size ranged from 1-10kb, with the majority of fragments being around 3-5kb. 
Chromatin samples were spun down at 13,000rpm for 5 minutes at 4˚C and 
kept on ice.  
 In parallel, Protein G Dynabeads (Invitrogen, 10004D) were pre-washed 
in Blocking buffer and mixed and incubated with 5ug of antibody (per sample) 
on a rotating wheel for 2 hours at 4˚C. The amount of 40 μl of beads in 
suspension was used for every sample. A monoclonal antibody against FLAG 
(Sigma, F1804) was used to pull down 3X-FLAG-dCas9. Following 
conjugation, the beads were washed with 200 μl Blocking buffer. At this point, 
100 μl of the previously prepared chromatin samples was kept separately to 
be used as 10% Input for later ChIP quantification by qPCR. For the 
immunoprecipitation, 1ml of the previously prepared chromatin samples was 
mixed with the immune-conjugated beads. Chromatin samples and beads 
were incubated on a rotating wheel for 18 hours at 4˚C. 
 Immunoprecipitated chromatin and beads were subsequently washed 
five times with 1ml LiCl Wash Buffer buffer for 5 minutes at 4˚C on a rotating 
wheel and once with TE buffer without nutation. Chromatin was released from 
the beads following addition of 200 μl Elution buffer, vortexing and an 
incubation at 65˚C for 1 hour at 1,000rpm. A short centrifugation step was 
necessary to discard the beads. The ChIP supernatant was kept and 
subsequently processed along with the 10% Input sample. All samples were 
incubated with 20ug PureLink RNaseA for 30 minutes at 37˚C to degrade total 
RNA. Proteins were degraded after a 5 hour treatment with 40ug of proteinase 
K treatment at 65°C. All ChIP and 10% Input DNA samples were purified with 
the QIAquick PCR Purification Kit by Qiagen. Buffer recipes are provided in 




2.4.5 qPCR and sequencing  
  
Histone occupancy and dCas9 binding patterns were quantified with 
qPCR. Firstly, a standard curve for ChIP samples was generated from serial 
fivefold dilutions of the 10% Input samples of total MNase digested native 
chromatin and total sonicated chromatin. SYBR Select mastermix (Applied 
Biosystems, 4472908) was utilised to conduct reactions in triplicate on a 
LightCycler 480 II (Roche). Total reaction volumes were 20ul, including 0.5 μl 
of neat 10% Input or ChIP DNA. 
 For native histone ChIP, sequencing amplicons containing a SNP were 
prepared with the 2XGoTaq Green Master Mix. AMPure XP beads were used 
to purify amplicons that were subsequently sequenced with traditional Sanger 
sequencing. Alternatively, cross-linked ChIP material was used to generate 
NGS libraries as described in section 2.3.1. All qPCR and sequencing primers 




2.5 Computational methods summary 
2.5.1 Allele-specific data 
MiSeq reads from all samples, including bisulfite-converted, were de-
multiplexed. Duplicate read pairs were removed by FastUniq v1.1 (Xu et al., 
2012), and TrimGalore v0.4.1 was used to trim Illumina adaptor sequences 
(https://www.bioinformatics.babraham.ac.uk/projects/trim galore/).  
BWA v0.7.12 (Li and Durbin, 2010) was used to align processed read 
pairs to the mouse genome (build GRCm38). Information about the targeted 
genomic regions from each experiment allowed mapping read pairs to the 
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relevant genomic regions. Polymorphic SNP information from the National 
Intsitute of Genetics (NIG) mouse genome database 
(http://molossinus.nig.ac.jp/msmdb/index.jsp) was used to assign read pairs to 
the C57BL/6J or JF1 chromosome, to determine allele specificity. To extract 
DSB repair information read pairs were interrogated near the cleavage site of 
every corresponding sgRNA. The presence of InDels within 10 nucleotides of 
the sgRNA cleavage site indicated the presence of an NHEJ event. Notably, 
the presence of pre-engineered mutations from designed ssODNs indicated 
the presence of an HDR event. The absence of InDels and the pre-engineered 
mutation was interpreted to indicate the absence of genome editing on the 
corresponding read pair, as we were unable to rule out ‘scarless’ c-NHEJ upon 
cleavage in our system. The length of insertions and deletions from all NHEJ 
read pairs were quantified with a custom Perl script by Alison Meynert. The 
following link in the University of Edinburgh’s Gitlab contains all of Alison’s 
scripts along with some instructions and examples of parameter files 
(https://git.ecdf.ed.ac.uk/igmmbioinformatics/crispr-allele-specific-effects). 
Analysis of all data was systematically performed by Alison Meynert and Tracy 
Ballinger.   
  
2.5.2 Bisulfite data 
  
Bismark v0.16.3 (Krueger and Andrews, 2011) and Bowtie v2.2.6 
(Langmead and Salzberg, 2012) were used to align processed read pairs to 
the bisulfite conversion of the indexed mouse genome (build GRCm38). Read 
pairs that could not be aligned had to be broken down to single-end reads, 
which could then be aligned from each side of the target region separately. 
After merging the two alignments for single-end reads and the alignment for 
intact read pairs, information about the targeted genomic regions allowed 
mapping read pairs to the relevant genomic regions. A custom Perl script by 
Alison Meynert was used to count the number of methylated CpGs in all reads. 
The following link in the University of Edinburgh’s Gitlab contains all of Alison’s 
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scripts along with some instructions and examples of parameter files 
(https://git.ecdf.ed.ac.uk/igmmbioinformatics/crispr-allele-specific-effects). 
Since most bisulfite amplicons did not cover allele-informative SNPs allele-
specificity information was not determined. Instead, only the total methylation 
level of both alleles is reported. Analysis of all data was systematically 
























Chapter 3  
 
Repurposing genomic imprinting to 
study the effect of chromatin 











Genome editing with CRISPR/Cas9 in mammalian cells is remarkably 
efficient, and is very likely to play an important role in the clinic in the 
foreseeable future. However, the natural function of the CRISPR locus is to 
degrade invading nucleic acids and render prokaryotes immune to 
bacteriophages (Barrangou et al., 2007). The mechanism by which this small 
molecule manages to find its target site within highly compacted eukaryotic 
genomes is still not fully understood and merits further investigation. For 
example, we must improve our understanding of how CRISPR/Cas9 
encounters eukaryotic chromatin before we start using it as a therapeutic tool 
towards treating human disease.  
 In the past, a series of studies have reported that nucleosome 
positioning has a negative impact on CRISPR/Cas9 activity in vitro, especially 
when the PAM site is fully protected by a nucleosome (Hinz, Laughery and 
Wyrick, 2015; Horlbeck et al., 2016; Isaac et al., 2016). It is logical to expect 
though that genome editing experiments in vivo are more likely to provide us 
with evidence of what would happen in a more clinically-relevant scenario.  
In addition to the aforementioned studies, chromatin compaction has 
been shown to reduce the kinetics of Cas9 diffusion within live cells (Knight et 
al., 2015). Several research groups have used a set of different cell-based and 
animal-based systems to demonstrate that chromatin compaction and 
epigenetic modifications reduce CRISPR/Cas9 mutagenesis (Chen et al., 
2016; Fujita, Yuno and Fujii, 2016; Daer et al., 2017; Jensen et al., 2017; X. 
Chen et al., 2017; Uusi-Mäkelä et al., 2018; Yarrington et al., 2018). 
Nevertheless, it is speculated that Cas9 can remodel chromatin (Polstein et 
al., 2015; Barkal et al., 2016). This creates a paradox, and requires systematic 
quantification of genome editing in mammalian cells in a natural system, with 
minimal perturbations compared to previously used systems, where accessible 
and inaccessible chromatin states can be compared with higher fidelity.  
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In this chapter, I will describe how we repurposed genomic imprinting 
as a natural system to study the effect of chromatin modifications on 
CRISPR/Cas9 mutagenesis. This system was selected due to the advantage 
it provides by allowing us to assess genome editing efficiency when target sites 
of the same underlying DNA sequence are present within two different 
conformations within the same nuclear environment.  
The work reported in this chapter was performed in collaboration with a 
number of different people. The hybrid mESCs used in this study were derived 
and provided to the Wood lab by Robert Feil’s group. Gillian Taylor and Keerthi 
Chathoth and I characterised the epigenetic landscape of the intended target 
sites within endogenous imprinted loci, in an allele-specific manner. Alison 
Meynert set up the computational pipeline for using the Next generation 
sequencing data that I generated to quantify mutagenesis frequencies in an 




3.2 Deriving the reciprocal hybrid mouse embryonic 
stem cell lines 
 
 Our goal was to compare CRISPR mutagenesis on the same DNA 
sequence in two different chromatin conformations within the same nucleus. 
We therefore decided to target maternally-imprinted loci. As described in 
Chapter 1.4, we would expect the maternal allele of these loci to be 
transcriptionally silent and compacted into heterochromatin. In addition, we 
would also expect the paternal allele to be transcriptionally active and 
euchromatic (Fitzpatrick, Soloway and Higgins, 2002).  
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Mouse embryonic stem cells have been used extensively for performing 
gene targeting (Capecchi, 2005).  Some of the most important features of 
mESCs are their pluripotency, but also that they can be easily transfected and 
have a high uptake of exogenous repair templates due to efficient HDR 
(Glaser, Anastassiadis and Stewart, 2005).  
In the past, Ildem Sanli and Sébastien Lalevée from Robert Feil’s group 
had derived two male hybrid mouse cell lines by crossing Mus musculus 
C57BL/6J (B) and Mus musculus molossimus JF1 (J) mice in a reciprocal 
manner (Sanli et al., 2018) as shown and described in Figure 3.1. Notably, the 
BxJ line was generated by crossing a female B6 mouse with a male JF1 
mouse. In addition, the JxB line was generated by crossing a JF1 female 
mouse with a male B6 mouse. Both lines were derived under serum-free 
conditions, specifically 1i culture media with only GSK3 inhibitor (Figure 3.1), 
to maintain pluripotency and methylation imprints (Wray et al., 2011; Leitch et 
al., 2013; Kota et al., 2014) and subsequently karyotyped (Nagy et al., 2008). 
The 1i culture media was chosen over 2i culture media (with MEK and GSK3 
inhibitors) since the latter has been shown to affect the maintenance of CpG 
methylation by impairing the function of DNMT1 (Choi et al., 2017; Yagi et al., 
2017). Male lines were selected over female ones, due to the genome-wide 
reduction of DNA methylation observed in female mouse ES cells (Zvetkova 
et al., 2005). This is owed to the presence of two active X chromosomes and 
can be restored by eviction of one of the two active X chromosomes, leading 
to chromosomal instability in female mouse ES cell lines (George et al., 2007). 
The reason why we opted for using hybrid lines was the presence of single-
nucleotide polymorphisms (SNPs), meaning that some nucleotides will be 
distinct between the B and J genomes (Takada et al., 2013). This would allow 
us to distinguish between the two imprinted alleles in our system and quantify 
mutagenesis by CRISPR/Cas9 in the two different localised chromatin 
environments.  
Targeting experiments were performed in parallel for both reciprocal 
hybrid lines. This would be necessary to demonstrate that any allele-specific 
editing preference we observe is owed to the allele-specific epigenetic 
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chromatin modifications instead of the genetic background of the parental 
mouse strains. Before I began using CRISPR/Cas9 to target maternally 
imprinted loci, Gillian Taylor and Keerthi Chathoth selected and validated 3 
endogenous maternally-imprinted loci. The data presented in the following 
section was generated by Gillian and Keerthi, who characterised the allele-
specific chromatin states of the intended target loci and confirmed the 












Figure 3.1 Hybrid mESC derivation process.  
C57BL/6J (B) and JF1 (J) mice were crossed as described in the text. The initial of 
maternal genome of origin preceded the paternal initial in the given name of both 
reciprocal lines. ES cells were isolated from the inner-cell mass of blastocysts in 2i 
culture medium supplemented with LIF and in the absence of serum (Sanli et al., 
2018). The 2i culture medium contained inhibitors for MEK (PD0325901) and GSK3 
(CHIR99021). After derivation, the cells were maintained in 1i culture medium. Unless 
otherwise stated, both hybrid mESC lines were cultured in the same 1i culture medium 








3.3 Epigenetic characterisation of target loci  
  
The first selected locus was KvDMR1, which is a CpG island that is 
methylated only on the maternal chromosome 7 in mice (Smilinich et al., 1999). 
KvDMR1 is part of a large well-studied cluster of maternally imprinted genes 
and will be the locus that is used as an example of a cluster, as previously 
mentioned in Chapter 1.4.2. To avoid confusion with the allocated sgRNA 
names, the targeted region will be referred to as KvDMR. Keerthi Chathoth 
initially designed sgKvDMR#1 to target the ICR of the locus. Consequently, I 
designed sgKvDMR#2 and sgKvDMR#3 to target the promoter of the KvDMR 
region as described in Chapter 2.1.1. The exact position of each of the three 
sgRNA binding sites is shown in Figure 3.2.A, along with data for H3K9me3 
ChIP and DNase I–seq in mESCs from the ENCODE project that were 
obtained through the UCSC genome browser.  
 We were initially interested to confirm whether the hybrid mESCs had 
allele-specific differences in chromatin accessibility at the KvDMR region, as 
previously reported (Feil et al., 1997). A series of digestions with increasing 
units DNase I on whole nuclei at 37 °C for 5 minutes were performed by Gillian 
Taylor. The digested material was used to prepare PCR amplicons that were 
subjected to Sanger sequencing. The positions of the corresponding Sanger 
amplicons are shown in Figure 3.2.A. In Figure 3.2.B we focused on SNPs 
for either target site and observed two peaks on the chromatogram for zero 
units of DNase I. However, as the concentration of DNase I increases, we 
observe that the SNP from the paternal allele disappears while the SNP from 
maternal allele persists. The effect is more profound at the promoter region 
(sgKvDR#2&3), where the paternal SNP is lost with as little as 100 units of 
DNase I. We thus concluded that the paternal allele of the KvDMR region is 




Figure 3.2 Allele-specific epigenetic characteristics at the maternally imprinted 
KvDMR locus. A: View of the KvDMR region including the sgRNA positions, Sanger 
and MiSeq amplicons. B: Allele-specific Sanger sequencing data after PCR 
amplification from digested nuclei. Primer locations for this Sanger PCR amplicon are 
indicated in panel A. C: Native histone ChIP data for H3K9me3 and H4K20me3 
histone modifications for the KvDMR region. Error bars represent the Standard 
Deviation of three technical replicates. Intracisternal A particle (IAP) retrotransposons’ 
qPCR primers were used as a positive control, Actb qPCR primers were used as a 
negative control. D: Allele-specific enrichment of H3K9me3 and H4K20me3 on the 
promoter of Kcnq1ot1. The gDNA feature indicates the specific SNPs associated with 




In addition, Gillian performed native histone ChIP for repressive histone 
modifications associated with imprinting. She demonstrated that there is an 
enrichment for H3K9me3 and H4K20me3 at the ICR and promoter within the 
KvDMR region, compared to the promoter of the mouse beta actin gene (Actb) 
as shown in Figure 3.2.C. PCR amplification and Sanger sequencing of the 
Input and IP material, revealed that the repressive histone modifications were 
enriched on the maternal allele (Figure 3.2.D). This assured us that imprinting 
on the KvDMR region was maintained in the two hybrid mESC lines we 
intended to use and defined the experimental setting for subsequent editing 
experiments.  
The second selected locus was Impact, which is not found in a cluster, 
but is an individual maternally imprinted gene. Impact is one of the most highly 
expressed maternally-imprinted loci in the murine genome and is situated on 
chromosome 18 (Maupetit-Méhouas et al., 2016), though its expression level 
has not been quantitatively assessed in the two hybrid mESC lines by myself. 
At the start of my PhD I designed an sgRNA that targets the promoter of Impact 
(sgImpact), in a site characterised by high sensitivity to DNase I. As for the 
KvDMR region, the position of sgImpact and the H3K9me3 ChIP and DNase I 
–seq ENCODE data from mESCs were obtained through the UCSC genome 
browser and shown in Figure 3.3.A. 
As previously done for the KvDMR region, the same DNase I digestion 
assay was performed. The position of the corresponding Sanger sequencing 
amplicon is shown in Figure 3.3.A. The SNP from the paternal allele is 
preferentially digested and the SNP from maternal allele remains intact 
(Figure 3.3.B). This time the effect was not as profound as for the other two 
target sites from above, since 600 units of DNase I resulted in complete 
digestion in the BxJ line. In the JxB line traces of the paternal SNP remain 
even with 600 units of DNase I. This could be owed to partial loss of imprinting 
for this locus in the JxB line. Overall, we concluded that the paternal allele of 




Figure 3.3 Allele-specific epigenetic characteristics at the maternally imprinted 
Impact locus. A: View of the Impact promoter and the position of the sgRNA target 
site, Sanger and MiSeq amplicons. B: Allele-specific Sanger sequencing data 
following PCR amplification from digested nuclei. Primer locations for this Sanger 
PCR amplicon are indicated in panel A. C: Native histone ChIP data for H3K9me3 
and H4K20me3 histone modifications for the chosen target site. Enrichments were 
determined as for Figure 3.2.C. D: Allele-specific enrichment of H3K9me3 and 
H4K20me3 on the Impact promoter, as determined by Sanger sequencing of PCR 
amplicons from Input and ChIP materials. The gDNA feature indicates the specific 
SNPs associated with each parental mouse strain.  
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Native histone ChIP for H3K9me3 and H4K20me3 modifications 
showed that there is an enrichment for both histone modifications at the 
promoter of Impact compared to the Actb promoter, as shown in Figure 3.3.C. 
Following PCR amplification and Sanger sequencing of the Input and IP 
material amplicons, we demonstrated that H3K9me3 and H4K20me3 would 
only associate with the maternal allele (Figure 3.3.D). However, the DNase I 
profiles shown in Figure 3.3.D show that some of the paternal allele remains 
in heterochromatin-associated ChIP fractions from the JxB line. This raises the 
possibility of a partial loss of imprinting of Impact in this line only. Overall, it 
confirmed that the imprinting was maintained for this locus in the BxJ hybrid 
mESC line.  
The third selected maternally-imprinted region in our study was the CpG 
island located upstream of Inpp5f_v2, which is a variant of the non-imprinted 
Inpp5f gene on chromosome 7 in mice characterised by differential allele-
specific CG dinucleotide methylation (Choi et al., 2005). Like Impact, 
Inpp5f_v2 is not found in a cluster, but its level of expression is low, though it 
has not been quantitatively assessed in the two hybrid mESC lines by myself. 
Keerthi Chathoth designed sgInpp5fv2 within DNase I hypersensitive site, as 
shown in Figure 3.4.A along with data for H3K9me3 ChIP in mESCs from the 
ENCODE project in a similar manner as for the two previous imprinted targets. 
In a similar manner to the other two loci, Gillian demonstrated that the 
SNP of the paternal allele is preferentially digested by increasing units of 
DNase I in Figure 3.4.B. In the BxJ line, traces of the paternal SNP can be 
detected even for 200 units of DNase I. This could also be due to partial loss 
of imprinting for Inpp5f_v2 in the BxJ line, as discovered by subsequent 
findings (Figure 3.9). Thus, we were motivated to create an additional control 
to measure imprinting maintenance, which I will describe in detail in the next 
section. Since it was not possible to amplify from the amplicon material after 
digestion with 600 units of DNase I, the data is not available for this locus. 
However, there was an evident enrichment for H3K9me3 and H4K20me3 in 
the promoter of Inpp5f_v2 (Figure 3.4.C).  
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In contrast to the two previously validated loci, the allele-specific 
association of the two repressive histone modifications was determined 
through restriction fragment length polymorphism (RFLP) analysis of ChIP 
amplicons performed by Gillian Taylor. Figure 3.4.D shows the digestion 
patterns of the two amplicons from the distinct parental genomes and input 
samples from each hybrid line (on the right hand side). To the left, the digested 
amplicons from IP samples from each histone ChIP are shown for BxJ and 
JxB. Every histone ChIP digestion pattern matches the pattern that 
corresponds to the maternal allele for either the BxJ or JxB line. Therefore, we 
concluded that the maternal allele is decorated with these repressive histones 
and the Inpp5f_v2 region was also maternally-imprinted in the hybrid mESC 
lines. 
In the upcoming section I will describe the strategy that was used to 
target the three regions that were validated in this section. The experimental 
process begins with targeting experiments in the hybrid mESC lines and ends 
with quantification of allele-specific genome editing outcomes with the aid of a 
custom computational pipeline.  
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Figure 3.4 Allele-specific epigenetic characteristics at the maternally imprinted 
Inpp5f_v2 locus. A: View of the Inpp5f_v2 promoter and the position of the sgRNA 
target site, Sanger and MiSeq amplicons. B: Allele-specific Sanger sequencing data 
following PCR amplification from digested nuclei. Primer locations for this Sanger 
PCR amplicon are indicated in panel A. C: Native histone ChIP data for H3K9me3 
and H4K20me3 histone modifications for the chosen target site. Enrichments were 
determined as for Figure 3.2.C. D: Allele-specific enrichment of H3K9me3 and 
H4K20me3 on the Inpp5f_v2 promoter was determined by RFLP analysis of PCR 
amplicons generated from the Input and ChIP materials. The first initial of each hybrid 
line corresponds to the maternal mouse strain. The gDNA samples on the left hand 





3.4 Setting up the allele-specific mutagenesis system  
  
After validating the presence of imprinting on the 3 maternally-imprinted 
loci we intended to target, Keerthi Chathoth and I began performing targeting 
experiments in the reciprocal hybrid mESC lines.  
I have been transfecting both hybrid lines in parallel with plasmid 
px459v2 (Addgene #62988) following cloning of the sgRNAs mentioned in the 
previous section. The px459v2 plasmid allowed the simultaneous expression 
of Cas9 and a sgRNA, along with Puromycin N-acetyltransferase (Pérez-
González, Vara and Jiménez, 1983), which conferred Puromycin resistance to 
successfully transfected cells. In addition, I also included a carefully designed 
repair template per transfection mixture that would allow me to measure the 
efficiency of HDR in our system and compare its uptake frequency in the two 
different chromatin contexts. This was typically a single-stranded 
oligodeoxynucleotide (ssODN) containing a signature mutation that would 
abolish the PAM site upon incorporation and prevent consecutive rounds of 
cleavage by Cas9. Puromycin selection was performed to isolate successfully 
transfected cells, and genomic DNA samples were collected typically 4 days 
after transfection.  
Following DNA quantification, amplicon sequencing libraries for the 
Illumina MiSeq platform were prepared for individual samples. This process 
would help us to accurately quantify genome editing outcomes in an allele-
specific manner. After the sequencing reads were made available, we received 
invaluable help for the bioinformatic analysis from Alison Meynert of the 
Bioinformatics core of our Institute. Alison developed a custom computational 
pipeline to use the SNP information from the JF1 murine genome to determine 
the parental strain of origin for all reads. Subsequently, she detected the 
presence of the corresponding pre-engineered mutation from the relevant 
ssODNs I used from each target site or of small insertions and deletions 
(InDels) on the location of the cleavage site. These would be considered to be 
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HDR and NHEJ events, respectively. The total CRISPR/Cas9 mutagenesis 
frequency was calculated as the sum of the reads with evidence of HDR, NHEJ 
or both at the same time. A complete schematic of the experimental strategy 
and computational pipeline is provided in Figure 3.5. 
Being aware that prolonged maintenance of mESCs in culture may lead 
to hypomethylation at a genome-wide level, I introduced an additional control 
to my targeting experiments. Imprints are specifically prone to erosion in 
female mESC lines, thus the BxJ and JxB lines we used were both male. 
However, when cultured in 2i conditions under simultaneous inhibition of MEK 
and GSK3, even male mESCs may become hypomethylated (Choi et al., 
2017). In the previous section we demonstrated that partial loss of imprinting 
might have occurred for Impact in the JxB line and for Inpp5f_v2 in the BxJ 
line. Therefore, I developed a simple method to monitor DNA methylation near 
the target sites of interest. 
Mock transfections with the px458 vector (Addgene # 48138) were 
performed in populations of both hybrid lines that were cultured in parallel to 
the cells used for targeting experiments with the CRISPR/Cas9 reagents. The 
imprinted target sites were not edited, due to the absence of a cloned 
protospacer in the sgRNA of the px458 vector. After the edited and mock-
transfected cells were harvested, genomic DNA material from the mock-
transfected cells would undergo bisulfite conversion with a commercially 
available kit. As a result, unmethylated cytosine residues would be changed to 
uracil residues whereas methylated cytosine residues would continue as such. 
A subsequent PCR amplification step converts uracil residues to thymines, 
which signal the presence of an unmethylated cytosine residue after 
sequencing of the end product (Frommer et al., 1992).   
Amplicon libraries for the Illumina MiSeq platform were prepared from 
the resulting converted DNA samples, in a similar manner to the non-converted 
samples from the targeting experiments. A full account for the differences in 
preparation of both types of Illumina amplicons is available in Chapter 2.3.  
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Once more, Alison Meynert helped me with the bioinformatic analysis 
of the generated MiSeq reads. She developed a special computational pipeline 
that would allow us to quantify the level of methylation across each template 
strand. After counting the number of methylated and unmethylated cytosine 
residues per read, Alison sorted the reads into three categories as shown in 
Figure 3.6. Therefore, we managed to record the numbers of unmethylated, 
partially and fully methylated reads to derive information about the DNA 
methylation levels, and consequently the degree of imprinting maintenance for 





       
Figure 3.5 Schematic outlining the experimental strategy. Simultaneous targeting 
of maternally-imprinted loci was achieved by co-transfection of CRISPR plasmids and 
ssODNs. The pre-engineered special mutation is depicted in orange. The lightning 
bolt represents the Cas9 cut site. Illumina amplicons were generated by two 
consecutive rounds of PCR amplification to include adapter sequences (shown in 
purple) and barcode sequences (shown in blue). The target site for each sgRNA is 
conveniently positioned near a JF1 SNP within the differentially methylated target 





Figure 3.6 Schematic outlining the strategy for monitoring imprinting 
maintenance. Mock transfections without sgRNAs and ssODNs were performed and 
isolated gDNA material was subjected to bisulfite conversion. In theory, the maternal 
imprinted allele should be fully methylated while the paternal allele should be 
unmethylated. In practice though, the presence of partially methylated reads was also 
recorded. Similar to the targeting libraries, adapter and barcode sequences were 
assigned to bisulfite-converted amplicon libraries through a dual-round PCR 
procedure. The reads with 0-20%, 20-80% and 80-100% methylated CGs were 




3.5 Subtle chromatin-related effects after 4 days of 
targeting 
  
After outlining our experimental strategy, I would like to introduce some 
of the early experimental results that were generated with the aforementioned 
methodologies. I began by transfecting both hybrid mESC lines in parallel, with 
the sgRNAs introduced in Chapter 3.3.  
Being aware of the possibility that the imprinting modifications might be 
erased, as a consequence of maintaining the mESCs in culture (Choi et al., 
2017), all targeting experiments were conducted in hybrid  mESCs that did not 
exceed passage number 12. The Puromycin selection process required 2 
days, followed by an additional period of 2 days, which was necessary to allow 
the number of successfully transfected cells to increase. This was crucial for 
harvesting sufficient genomic DNA material for downstream preparation of 
amplicon sequencing libraries.  
 By analysing the corresponding MiSeq data, we were able to make the 
following observations. Using the SNPs to distinguish maternal from paternal 
reads, we calculated mutation frequencies separately for maternal versus 
paternal alleles. We then expressed them as a ratio of paternal / maternal to 
determine the allele-specific bias. Firstly, it was evident that the non-silenced 
paternal (shown in blue) allele was gaining mutations by CRISPR/Cas9 at a 
higher frequency than the inaccessible maternal allele (shown in red). Figure 
3.7 indicates that all 3 sgRNAs destined for the KvDMR region yielded 
significant differences in editing efficiencies between the two alleles, most 
notably in the BxJ hybrid line. This could be owed to the fact that imprinting 
was maintained at a higher degree for the KvDMR region in the BxJ line than 
in the JxB line (Figure 3.9.A). However, the observed allelic bias was quite 
subtle.  
 Secondly, this subtle effect was not always observed for these long 
targeting experiments, as pointed out in Figure 3.8.A. We were initially 
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surprised to discover a lack of allele-specific editing preferences on the 
promoter region of Impact. Upon closer investigation of the MiSeq bisulfite 
amplicon sequencing data we noted a large drop in sequencing reads with fully 
methylated CG dinucleotides and concluded that this target locus had 
undergone partial loss of imprinting (Figure 3.9.B). This could account for the 
lack of observed allelic bias in this case and explain the observed loss of allele-
specific accessibility observed in Figure 3.3.B.  
 Interrogation of the DNA methylation levels on the promoter of 
Inpp5f_v2 revealed a larger hypomethylation on this locus (Figure 3.9.C) 
compared to Impact. The level of loss is greater for the BxJ line this time, and 
may provide an explanation for the persistence of the paternal allele on this 
line in the DNase I assay in BxJ shown in Figure 3.4.B. The targeting data for 
Inpp5f_v2 is therefore not shown.  
Finally, we also revealed the absence of allele-specific bias in editing 
efficiency for a non-imprinted target locus. We selected to target the N-
terminus of Ncaph, which is not known to undergo imprinting and for which a 
previously validated sgRNA was available. In Figure 3.8.B we demonstrate 
that in contrast to the maternally-imprinted target sites, there is no allele-
specific editing preference for Ncaph in both hybrid mESC lines.  
To further confirm that epigenetic chromatin modifications are solely 
responsible for the observed allelic bias, we attempted to remove DNA 
methylation at a global level in the two hybrid mESC lines. As I will describe in 
the following section, we were keen to induce loss of imprinting at our selected 
target sites and observe if this would affect the allelic bias in our allele-specific 




Figure 3.7 Higher editing frequencies on the accessible paternal allele after a 4 
day-long exposure to CRISPR/Cas9. A: Allele-specific editing frequencies for 
sgKvDMR#1, sgKvDMR#2 and sgKvDMR#3. Error bars represent the Standard 
Deviation of three experimental replicates. Asterisks correspond to p-values derived 
from paired two sample t tests for the difference in editing efficiencies on the maternal 
and paternal allele. *p < 0.05, **p < 0.01, ***p < 0.001. The percentage of reads with 
fully methylated CG dinucleotides is shown above every histogram to show the degree 




Figure 3.8 Loss of imprinting results in lower allelic bias and resembles a non-
imprinted target site. A: Allele-specific editing frequencies for sgImpact. Error bars 
represent the Standard Deviation of three experimental replicates. Paired two sample 
t tests for the difference in editing efficiencies on the maternal and paternal allele 
showed the absence of a statistically significant difference.  The percentage of reads 
with fully methylated CG dinucleotides is shown above every histogram to show the 
degree of imprinting maintenance during each targeting experiment. B: Allele-specific 





Figure 3.9 Imprinting is maintained at different degrees across different target 
loci. A: CG dinucleotide methylation levels at the KvDMR region in both hybrid mESC 
lines after a mock transfection with px458. This locus had the greatest level of 
imprinting retention, especially in the BxJ line. The amplicon contains 10 CG 
dinucleotides. B: CG dinucleotide methylation levels at the promoter region of Impact 
in both hybrid mESC lines after a mock transfection with px458. A partial loss of 
imprinting is evident in both hybrid lines. The amplicon contains 7 CG dinucleotides. 
C: CG dinucleotide methylation levels at the promoter of Inpp5f_v2 in both hybrid 
mESC lines after a mock transfection with px458. With very few methylated reads 
obtained from BxJ, this is the region where we discovered the most detrimental 









3.6 Epigenetic modifications influence the levels of 
allelic bias 
  
Following the observation of a subtle yet reproducible preference for 
editing on the accessible, euchromatic paternal allele, it was necessary to 
demonstrate that this preference was owed to the allele-specific epigenetic 
modifications.  
 To achieve this, I tried to induce loss of imprinting by culturing mESCs 
in 2i media supplemented with vitamin C. The aforementioned culture 
conditions have been reported to induce a global loss of DNA methylation in 
cultured E14 mESCs after a continuous treatment of 6 days by promoting the 
activity of Tet enzymes (Blaschke et al., 2013; Walter et al., 2016). I began 
with a low passage BxJ hybrid line, cultured it for several days in the standard 
1i culture medium to increase the passage number, and then I switched the 
culture medium to 2i. I continued increasing the passage number under these 
culture conditions to begin removing some of the DNA methylation (Choi et al., 
2017). Once passage 20 was reached, I also added an appropriate 
concentration of vitamin C in the 2i culture medium and continued culturing the 
cells for an additional period of 6 days. Thus, I generated a high passage BxJ 
cell line that would be hypomethylated as a consequence of the 2i/vitamin C 
culture treatment.   
 As shown in Figure 3.10.A, I also targeted the same BxJ hybrid line, 
while it was at a low passage and had not been treated like the high passage 
BxJ hybrid line. Interrogation of the Illumina bisulfite amplicon sequencing data 
revealed a trend towards loss of methylation at all 3 loci, but to very different 
degrees. The reason for this locus specificity is not clear. Figure 3.10.B shows 
that DNA methylation was largely maintained in the KvDMR region, where the 
allelic bias in the CRISPR mutagenesis was also maintained. Similarly, the 
allelic bias was also present on Impact, where only partial loss of DNA 
methylation was detected. Finally, DNA methylation was almost completely 
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erased from the Inpp5f_v2 promoter region. This resulted in equal frequencies 
of CRISPR mutagenesis between the two alleles of Inpp5f_v2, and the loss of 
allelic bias (Figure 3.11).  
Thus, we concluded that the previously observed allelic bias was owed 
to the allele-specific epigenetic modifications that can be found in the targeted 
maternally-imprinted loci. The effect is also reversible, since allelic bias can be 










Figure 3.10 Inducing loss of imprinting in BxJ mESCs. A: Outline of the DNA 
hypomethylation treatment that was used to generate the high passage BxJ line. The 
low passage line was untreated and both lines were targeted in parallel. B: CG 
dinucleotide methylation levels at three target loci in the high and low passage BxJ 
lines after a mock transfection with px458. There are less methylated CGs in the high 





Figure 3.11 Allele-specific editing bias is owed to allele-specific epigenetic 
modifications. Allele-specific editing frequencies for sgKvDMR#1, sgImpact and 
sgInpp5f_v2 in both BxJ hybrid lines. Error bars represent the Standard Deviation of 
three experimental replicates. Asterisks correspond to p-values derived from unpaired 
t tests on the fold-difference between mutation frequencies on maternal and paternal 
alleles in low- compared to high-passage cells. ***p < 0.001. Due to the absence of 
Puromycin selection the editing efficiency appears lower than for Figures 3.7&8. 
Maintenance of the high passage BxJ line in 2i culture conditions resulted in a smaller 





Despite the fact that genome editing with CRISPR/Cas9 is nowadays 
used to introduce genetic modifications in a plethora of organisms ranging from 
plant (Char et al., 2017) to mammalian species (Nelson et al., 2019), little is 
known about how eukaryotic chromatin compaction affect the most widely-
used genome editing tool.  
 In this chapter I have explained how we successfully repurposed a 
naturally occurring epigenetic mechanism into a system that would allow us to 
assess the effect of chromatin modifications on targeted mutagenesis. In the 
past, genomic imprinting has provided insights into numerous epigenetic 
phenomena, including the function of long non-coding RNAs in chromatin 
modification (Filson et al., 1993; Wutz et al., 1997, 2001) and the role of CTCF 
binding as an insulator element (Bell and Felsenfeld, 2000; Hark et al., 2000; 
Yusufzai et al., 2004). Our study represents the first use of this system, to our 
knowledge, to study the effects of different chromatin states on mutagenic 
processes. It is therefore evident that it is a very attractive, natural and timeless 
system that may play a key role in other great discoveries in the future.  
 Prior to the commencement of my PhD project other research groups 
have published evidence that chromatin impedes mutagenesis by 
CRISPR/Cas9. The position of the PAM site relative to individual nucleosomes 
seems to be the factor that determines if the Cas9 endonuclease will generate 
a double-strand break (Hinz, Laughery and Wyrick, 2015; Horlbeck et al., 
2016; Isaac et al., 2016). Nevertheless, these findings were established from 
in vitro studies assessing one nucleosome at a time. It is of paramount 
importance to investigate what is happening in living mammalian cells, where 
the genome is folded into higher order structures in three dimensional space.   
 Notably, evidence for the inhibitory effect of chromatin compaction on 
CRISPR/Cas9 mutagenesis have also emerged from studies that used cell-
based systems (Chen et al., 2016; Daer et al., 2017). However, both of these 
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studies relied on exogenous reporter constructs and chemical induction for 
compaction and de-compaction of the wider regions where the reporters were 
situated. As a consequence, euchromatic and heterochromatic conditions 
were interrogated in distinct populations of cells, which creates a big caveat.  
In contrast to the subtle results we obtained from our initial prolonged 
targeting experiments, where allelic bias would not exceed 1.6-fold, Chen et 
al. (2016) reported that the magnitude of  effect they observed was up to 2.7-
fold. CRISPR/Cas9 was also found to associate and edit the euchromatic state 
of the luciferase construct that was employed by Daer et al. (2017) by up to 5-
fold. One possible explanation for this inconsistency is that our experimental 
system allows editing of both open and closed chromatin regions in the same 
cell population, instead of assessing the same sequence before and after 
perturbing chromatin in separate cell populations. This quality of our system 
abolishes any type of bias from transfecting separate cell populations, such as 
differences in the uptake efficiency of the introduced reagents. It also provides 
a convenient internal control that eliminates potentially confounding factors 
such as cell cycle stage and availability of trans-regulator molecules.  
 The caveat of our system is the attrition of the imprinting marks from the 
selected maternally-imprinted loci. We have already witnessed this effect in 
different degrees among different target loci, despite performing our 
experiments in cells that never exceeded passage 12 in culture. To minimise 
this as much as possible, we used male BxJ and JxB reciprocal hybrid mESC 
lines that we cultured in the absence of serum under inhibition of GSK3 alone. 
We also developed a method to monitor the degree of imprinting maintenance 
in every individual targeting experiment, by interrogating the DNA methylation 
status of a certain number of CG dinucleotides in close proximity to the target 
site. This assured us that we can reliably report on the effect that different 
epigenetic states exert on CRISPR mutagenesis in vivo, in a sensitive and 
quantitative manner.  
 A similar system has recently emerged, where a number of endogenous 
target sites were selected in human HeLa and HEK293 cells (Kim and Kim, 
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2018). These random sites were selected after extensive analysis of publicly 
available DNase Hypersensitivity data from the ENCODE project. Their key 
feature was that they were present in two copies in the human genome, one 
of which was accessible and the other inaccessible. Contrary to what has been 
reported so far, Kim and Kim (2018) argued that chromatin does not affect 
genome editing with CRISPR/Cas9 when the sgRNA is perfectly 
complementary to the assessed target site. It is worth mentioning though that 
the timeframe of those targeting experiments was not clearly specified. In 
addition, the wider chromatin context where the selected target sequences 
were embedded was not reported, or the extent of the regions that were 
accessible/inaccessible for each copy of the different target sites they picked.    
 All of the above inspired us to continue investigating and work towards 
gaining mechanistic insights of the inhibitory effect we observed. Daer et al 
(2017) suggested that the degree of inhibition may be regulated by additional 
factors that were not assessed at the time. Thus, we decided to use our system 
to discover what other factors may affect the way chromatin modifications 
regulate CRISPR mutagenesis. In the next chapter I will investigate how the 
time of exposure to the genome editing reagents and the concentration of the 
Cas9 endonuclease may lead to higher allelic bias ratios and a higher editing 














Study of the additional parameters that 












The effects we have observed during a 4-day exposure to 
CRISPR/Cas9 (Figure 3.7 and Figure3.8) were subtle. As mentioned earlier 
in Chapter 1.3.3, it is possible that certain experimental conditions may 
influence the way chromatin modifications affect the action of CRISPR/Cas9. 
For example, Knight et al. have demonstrated that the kinetics of Cas9 
diffusion are slower within heterochromatic regions (Knight et al., 2015). Our 
previous targeting experiments focused on a single time point: 4 days after 
lipofection. Therefore, we decided to quantify and compare CRISPR/Cas9 
activity at maternally-imprinted regions for shorter periods of exposure. 
Another important factor to consider is the concentration of the Cas9 
endonuclease, which may have been different between the separate editing 
experiments described in the previous chapter.   
 In addition, evidence from a more recent in vitro study by Hinz, 
Laughery and Wyrick (2016) suggested that nucleosome positioning is key to 
reducing off-target site mutagenesis by CRISPR/Cas9. By changing individual 
nucleotides in the protospacer region, and thus reducing complementarity 
between the sgRNA molecule and the target site, the authors simulated off-
target recognition using naked DNA and nucleosome substrates. It was 
established that single nucleotide PAM-proximal mismatches were only 
reducing Cas9 activity on nucleosome substrates. This inspired us to 
investigate the effect of chromatin modifications on off-target mutagenesis by 
making use of the system we previously established. We also decided to 
examine different combinations of more than one mismatches in the 
protospacer. By determining the key players for achieving target-specific 
editing at high frequency, we aim to improve our understanding of the 
mechanism of action of CRISPR/Cas9 within mammalian cells and contribute 
towards promoting the use of genome editing in the clinic. 
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 The work presented in this chapter was primarily my own, except for the 
following notable contributions. Elizabeth Freyer helped me with flow 
cytometry. Gillian Taylor contributed by cloning the plasmid constructs for the 
dCas9 ChIP. Andrew Wood harvested some critical time points in the middle 
of the night during the initial Impact promoter and dCas9 ChIP time course 
experiments. As mentioned before, Alison Meynert conducted the 
bioinformatics analysis for the NGS data.  
 
 
4.2 Brief exposure to CRISPR/Cas9 elevates allelic 
bias 
  
To test if chromatin modifications delay CRISPR mutagenesis in our 
previously described and validated system based on genomic imprinting, I 
performed a time course experiment in the BxJ hybrid mESC line. Initially, I 
targeted the promoter region of Impact because this was the locus where we 
previously observed the lowest allelic bias following 4 days of exposure to 
CRISPR/Cas9 (Figure 3.8.A).  
 Selection of the precise time points for this experiment was of 
paramount importance. In a former study Kim et al. (2014) compared the 
kinetics of mutation frequency for two different types of genome editing reagent 
delivery in K562 cells. Namely, the reagents were Ribonuclear Particles 
(RNPs) and plasmids. It was established that the use of plasmid DNA resulted 
in a slower accumulation of InDels than purified Cas9 protein. As shown by 
Kim et al., 2014, when Cas9 is expressed from a plasmid the expressed protein 
appears at 6 hours after transfection and continues to accumulate for up to 24 
hours (Kim et al., 2014). At 48 hours after transfection the level of Cas9 protein 
is reduced. We were therefore interested to quantify allele-specific 
mutagenesis during this period.  
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As shown in Figure 4.1.A, six experimental sets of triplicates were 
simultaneously transfected with sgImpact in the px459v2 puromycin vector. 
Each set was harvested at the indicated time points after transfection. In 
contrast to the experiments described in the previous chapter, Puromycin 
selection was not performed in this case, due to the absence of enough time 
to complete the selection process. Consequently, the overall mutagenesis 
frequency was reduced due to the higher frequency of reads originating from 
untransfected cells.  
Upon averaging the mutagenesis information for the two assessed 
alleles we could clearly see that there was an increase in mutagenesis 
frequency. This is shown in Figure 4.1.C in the right-hand side y-axis of the 
graph. Allele-specific quantification of mutations revealed higher editing 
frequencies on the paternal allele throughout the assessed period of time 
(Figure 4.1.B). However, we observed a trend where mutagenesis on the 
maternal allele would also increase steadily during the time course experiment. 
This demonstrates that repressive chromatin modifications do not completely 
abolish CRISPR/Cas9 mutagenesis. The data plotted on the right-hand axis of 
the graph in Figure 4.1.C suggest that the allelic bias of CRISPR/Cas9 
mutagenesis decreases with time. One-way Analysis of Variance (ANOVA) 
followed by Tukey’s HSD test were performed to assess if there are significant 
differences in allelic bias from individual replicates between time points. The 
only statistically significant difference that emerged was between 16 hours and 
48 hours after transfection. What was also striking from Figure 4.1.C was that 
the highest allelic bias was observed at 16 hours after transfection. This 
inspired me to inspect if this phenomenon is also true for more genomic sites. 
As for the promoter region of Impact, I used sgKvDMR#1 and sgInpp5f_v2 to 
target two other maternally imprinted regions. Separate sets of triplicates were 
harvested at 16 hours and 4 days after lipofection in the absence of puromycin 
selection. The results are shown in Figure 4.2.A and Figure 4.2.B for 
sgKvDMR#1 and sgInpp5f_v2, respectively.   
Consistent with our previous findings for sgImpact, at 16 hours after 
transfection the paternal non-imprinted gene was edited at a higher frequency 
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than the maternal allele. The magnitude of effect was larger at 16 hours after 
transfection and was greatly reduced at 4 days after transfection, as shown in 
Figure 4.2.C for sgKvDMR#1. There was one occasion where the difference 
observed between the 16-hour and 4-day timepoint did not reach statistical 
significance, in the condition with sgInpp5f_v2 in the BxJ line (Figure 4.2.D). 
This could be owed to the drastic reduction in CpG methylation that we also 
observed for the promoter region of Inpp5f_v2 in the BxJ line that was used for 
this experiment, as shown on the top right-hand side of Figure 4.2.B.  
Overall, the data from three independent target loci suggest that allelic 
bias is higher for short periods following transfection. We therefore concluded 
that the frequency of CRISPR/Cas9 mutagenesis is impeded in less accessible 
chromatin regions in a time-dependent manner. If expression of Cas9 from a 
plasmid vector requires time for Cas9 protein levels to increase within the cell, 
it is possible that the concentration of Cas9 may have a contribution to the 













Figure 4.1 Chromatin modifications impair the kinetics of CRISPR/Cas9 
mutagenesis on the promoter of Impact. A: Schematic of the experimental time 
frame for the time course experiment. BxJ cells were transfected px459v2 containing 
sgImpact and a ssODN. Cells were harvested at the indicated 4-hour intervals and 
genomic DNA was isolated for targeted amplicon NGS and allele-specific 
quantification of Cas9 mutagenesis. B: Allele-specific mutagenesis frequencies 
plotted against time. The paternal accessible allele is shown in blue and the maternal 
inaccessible allele is shown in red. Editing is more frequent on the paternal allele, but 
both alleles demonstrate a similar trend of increase in mutation frequency over time. 
The percentage fully methylated reads shown above implies the degree of imprinting 
maintenance during this experiment. C: Comparison of the overall mutation frequency 
and allelic bias. While mutagenesis (green) increases with time, allelic bias (purple) 





Figure 4.2 Chromatin modifications also impair the kinetics of CRISPR/Cas9 
mutagenesis on KvDMR and Inpp5f_v2. A: Allele-specific editing frequencies for 
sgKvDMR#1 for 16 hours and 4 days after lipofection. Error bars represent the 
Standard Deviation of three experimental replicates. The percentage of reads with 
fully methylated CG dinucleotides is shown above every histogram to show the degree 
of imprinting maintenance. All the experiments in this figure were performed in the 
absence of selection for successfully transfected cells. B: Allele-specific editing 
frequencies for sgInpp5f_v2 for 16 hours and 4 days after lipofection. As for 
sgKvDMR#1 in A. C: Stacked histograms demonstrate the allelic mutation bias for 
sgKvDMR#1. Asterisks correspond to p-values for unpaired t tests on the fold-
difference between maternal (red) and paternal (blue) editing frequencies for brief (16-
hour) and long (4-day) exposure. D: Stacked histograms demonstrate the allelic 
mutation bias for sgInpp5f_v2. The statistics are as for sgKvDMR#1 in C. 
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4.3 Limiting Cas9 concentration results in higher 
allelic bias  
 
Prolonged exposure to CRISPR/Cas9 was formerly shown to lead to 
similar levels mutagenesis between the two alleles in our system. To test if the 
concentration of Cas9 is crucial to achieve allele-specific mutagenesis I 
designed the following experiment. Lipofection is the preferred method to 
deliver the genome editing reagents in the hybrid mESCs that I am using. 
However, it is possible that individual cells receive different numbers of copies 
of the introduced plasmid, resulting in a heterogeneous population of 
transfected cells with variable Cas9 concentrations. In order to categorise 
transfected cells based on the concentration of Cas9 I used a different plasmid 
construct (px458, Addgene #48138, as mentioned in Chapter 2.1.2), where 
Cas9 is coupled to eGFP via a self-cleaving 2A peptide. The 2A peptide allows 
two proteins to be produced in a 1:1 ratio. A promoter mediates transcription 
of a single mRNA encoding two polypeptides, linked by the 2A sequence. As 
the 2A peptide emerges from the ribosome it is cleaved, liberating the first 
polypeptide and leaving the second polypeptide to be translated independently 
(De Felipe et al., 2006). 
Triplicate sets of both BxJ and JxB were transfected with the px458 
construct including sgKvDMR#3 and the relevant ssODN. Since eGFP 
concentration reflects the concentration of Cas9, fluorescence activated cell 
sorting (FACS) was performed to sort the cells into three distinct populations 
according to eGFP fluorescence. The sorting was conducted at 24 hours after 
transfection, to allow enough expression of the eGFP fluorescent reporter, as 
shown for BxJ cells in Figure 4.3.A.  
Half of the harvested cells from each population were used to isolate 
genomic DNA immediately after the sorting, whereas the remaining cells were 
maintained in culture for an additional 3 days (Figure 4.3.B). Therefore, data 
was collected for both a short and a long time of exposure to differing 
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concentrations of the genome editing reagents. The different populations that 
emerged from the sorting were maintained and analysed separately with the 
previously described experimental pipeline.  
As shown in Figure 4.3.C, at low limiting Cas9 concentration the allelic 
bias was elevated than previously obtained values. In addition, a shorter 
exposure time to the genome editing reagents led to an evident increase in 
allelic bias, especially when the concentration of Cas9 was low. On the 
contrary, prolonged exposure to the genome editing reagents resulted in allelic 
bias values similar to the ones that were observed in previous experiments 
(Figure 4.3.D). This is true especially for the population of cells where Cas9 
was abundant. In the populations with low and intermediate Cas9 levels the 
allelic bias was persistently higher than previously observed values, even after 
4 days of exposure (Figure 4.3.D).  One-way ANOVA followed by Tukey’s 
HSD test were performed to assess if there are significant differences in allelic 
bias from individual replicates between the different cell populations with Low, 
Intermediate and High eGFP and Cas9 expression. Statistically significant 
differences are shown at the bottom panels of Figures 4.3.B&C.  
The same experiment was also performed in parallel for the JxB hybrid 
line. As illustrated in Figure 4.4.A the experimental strategy was the same as 
for the BxJ hybrid line. The gating profile for JxB is shown in Figure 4.4.B, 
where cells were split and harvested once more at 24 hours and 4 days after 
transfection. In contrast to the BxJ line, the percentage of fully methylated 
reads was reduced, as assessed by illumina sequencing of bisulfite-modified 
DNA. This means that the mutagenesis results should be interpreted bearing 
in mind that there has been partial loss of imprinting for the KvDMR region in 
this hybrid mESC line. Accordingly, as shown in Figures 4.4.C and 4.4.D, the 
allelic bias is greatly reduced compared to the previously observed bias in the 
BxJ line.  
Nonetheless, although the magnitude of effect was smaller, the same 
general trends were observed in the JxB line. Prolonged exposure leads to 
lower allelic bias values (Figure 4.4.D). Similar to the BxJ line, the highest 
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allelic bias value among the three different populations at 4 days after 
transfection is observed at the condition where the concentration of Cas9 is 
low. In contrast, for a shorter 24-hour period of exposure we observe a lack of 
allelic bias for low limiting Cas9 concentration, as shown on the left-hand site 
of Figure 4.4.C. This does not agree with our previous observations but could 
be a consequence of the aforementioned partial loss of imprinting that 
characterises the KvDMR region in the JxB line. Nevertheless, the allelic bias 
observed when Cas9 was abundant was lower than the equivalent value in the 
population with intermediate Cas9 expression, which agrees with our previous 
findings.  
Overall, the data suggests that chromatin modifications influence the 
way chromatin regulates mutagenesis by CRISPR/Cas9 in a manner that 
relies both on the concentration of Cas9 and the time of exposure. The 
combination of prolonged exposure to the reagents and a high expression level 
of Cas9 leads to the mutagenesis reaction proceeding to completion quicker. 
Conversely, when Cas9 is not abundant the difference in mutagenesis 




Figure 4.3 Chromatin modifications influence genome editing in a Cas9-
concentration–dependent manner in BxJ hybrid mESCs. A: Schematic showing 
the experimental strategy for the Cas9-eGFP sorting experiment. B: Flow cytometry 
profiles demonstrating the heterogeneity in Cas9-2A-eGFP expression for the BxJ 
line. Data shown for sgKvDMR#3 for the promoter of KvDMR (position shown in 
Figure 3.2.A). C: Analysis at 24 hours after transfection. The percentage of 
methylated reads from mock-transfected cells without selection for Cas9 expression 
is shown at the top. Imprinting was highly maintained in this line. Error bars represent 
the Standard Deviation of three experimental replicates. Stacked histograms at the 
bottom illustrate the allele-specific mutation bias in each population. Asterisks for 
Tukey’s HSD test p-values per pairwise comparisons *p < 0.05, **p < 0.01. D: Analysis 
at 4 days after transfection, as described above for 24 hours after transfection. 
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Figure 4.4 Chromatin modifications influence genome editing in a Cas9-
concentration–dependent manner in JxB hybrid mESCs. A: Schematic showing 
the experimental strategy for the Cas9-eGFP sorting experiment. B: Flow cytometry 
profiles demonstrating the heterogeneity in Cas9-2A-eGFP expression for the JxB 
line, which was similar to the BxJ line. Data shown for sgKvDMR#3 for the promoter 
of KvDMR (position shown in Figure 3.2.A). C: Analysis at 24 hours after transfection. 
The percentage of methylated reads was lower compared to BxJ, indicating partial 
loss of imprinting. Error bars represent the Standard Deviation of three experimental 
replicates. Stacked histograms at the bottom illustrate the allele-specific mutation bias 
per population. Asterisks for Tukey’s HSD test p-values per pairwise comparisons *p 
< 0.05, **p < 0.01. D: Analysis at 4 days after transfection, as described above for 24 
hours after transfection.  
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4.4 Accessible chromatin allows higher levels of 
dCas9 occupancy   
  
Having identified two factors that regulate the effect repressive 
chromatin modifications exert on targeted mutagenesis with CRISPR/Cas9, 
we then decided to gain further insights into the inhibition mechanism. 
Previous reports have shown that catalytically dead Cas9 (dCas9) is able to 
associate with many off-target sites, the majority of which is found in open 
chromatin regions. These findings have emerged from genome-wide 
chromatin immunoprecipitation and sequencing (ChIP-Seq) studies in mESCs 
(Wu et al., 2014) and HEK293 cells (Kuscu et al., 2014). In order to ascertain 
at which stage of the CRISPR/Cas9 mutagenesis procedure chromatin exerts 
an effect we adapted a similar approach to assess the binding specificity of 
dCas9 in our previously established system in the hybrid mESCs in a time-
dependent manner.    
 In general, SpCas9 must first associate with the sgRNA molecule in 
order to begin searching for its target site in the genome (Jiang et al., 2015). 
Upon recognition of an NGG protospacer-adjacent motif (PAM) nucleotide 
triplet, SpCas9 stops and interrogates the adjacent sequence. Then, if the 
latter is complementary to the protospacer on the sgRNA molecule then it is 
identified as the appropriate target site (Sternberg et al., 2014). Evidence from 
a recent study suggests that the complex diffuses in a lateral manner on the 
DNA while searching for PAM triplets (Globyte et al., 2019). Nevertheless, all 
the above conclusions have been drawn through the use of in vitro systems 
and fail to consider the effect of chromatin modifications on the association 
rate of the assembled Cas9-sgRNA complex on mammalian genomes in vivo. 
 To investigate this, I performed a time course experiment to assess the 
degree of binding of catalytically dead Cas9 (dCas9) in an allele-specific 
manner. After harvesting at different timepoints following transfection, cells 
were crosslinked with formaldehyde and ChIP was performed followed by 
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qPCR and targeted amplicon NGS. As illustrated in the diagram in Figure 
4.5.A cells were transfected with plasmid constructs encoding the relevant 
sgRNAs and dCas9 with a triple flag tag (3xFLAG-dCas9). After crosslinking 
and sonication was performed, sheared chromatin was incubated with an anti-
flag antibody to enrich for genomic regions bound to dCas9.  
Enrichment analysis by qPCR revealed that the highest level of dCas9 
association on the KvDMR and promoter region of Impact was at 16 hours 
following lipofection, as shown in Figure 4.5.B and Figure 4.5.C, respectively. 
Target amplicon sequencing and allele-specific read analysis revealed that 
dCas9 shows approximately two-fold greater occupancy on the accessible 








Figure 4.5 Enhanced Cas9 occupancy in accessible compared to inaccessible 
chromatin. A: Schematic showing the experimental strategy for the dCas9 time 
course ChIP experiment. This was only performed once and only in the BxJ line. B: 
Stacked histograms showing allele-specific enrichment of dCas9 on the KvDMR 
region, expressed relative to Input DNA. Error bars represent the Standard Deviation 
of three technical qPCR replicates. Allelic bias was calculated from subsequent 
targeted PCR amplicon sequencing. C: Stacked histograms showing allele-specific 
enrichment of dCas9 on the promoter region of Impact, expressed relative to Input 
DNA. Error bars represent the Standard Deviation of three technical qPCR replicates. 
Allelic bias was calculated from targeted PCR amplicon sequencing. 
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4.5 Studying the effect of repressive chromatin 
modifications during off-target mutagenesis by 
CRISPR/Cas9 
 
In general, off-target mutagenesis is a major problem during genome 
editing with CRISPR/Cas9 but may be subject to different constraints relative 
to on-target due to the presence of mismatches between guide and target. 
Emerging evidence from another in vitro study suggests that off-target 
mutagenesis by CRISPR/Cas9 is inhibited by nucleosome positioning, even if 
the target site is at nucleosome exit site (Hinz, Laughery and Wyrick, 2016). It 
was also suggested that the position of the mismatch is critical for the degree 
of inhibition. This study showed that if the mismatch located within positions 1-
10 out of 20 in the protospacer, which is proximal to the PAM site, then the 
effect was reported to be greater.  Similar conclusions about the position of the 
mismatch have been drawn during a study in HEK293 cells (Hsu et al., 2013), 
which did not assess how chromatin may further affect mismatch tolerance 
during off-target site recognition. 
To experimentally measure this effect using the internally controlled 
system that we established, we modified the sgRNAs that were previously 
used on maternally-imprinted loci to contain mismatches on certain positions 
within the protospacer sequence. This would perturb full complementarity 
between the protospacer and the target site for two of the maternally imprinted 
regions we have previously characterised and targeted with perfectly-matching 
sgRNAs. I focused on the KvDMR region and the promoter region of Impact, 
due to the frequent loss of imprinting that I previously observed on the 
promoter region of Inpp5fv2 (Figure 3.9 and Figure 3.10.B). Finally, I also 
decided to compare the effect of different combinations of mismatches within 
the protospacer sequence of the sgRNA.  
All the experiments with mismatch-containing sgRNAs were performed 
in a 4-day timeframe with puromycin selection, similar to the very first editing 
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experiments shown in Figure 3.7 and Figure 3.8. Since the corresponding 
perfect-match sgRNAs were not used to edit separate cell populations in 
parallel with the mismatch-containing sgRNA editing experiments, the data 
shown in Figures 4.7-4.12 is missing an optimal control to compare the effect 
exerted by repressive chromatin modifications for on-target versus off-target 
mutagenesis. Therefore, throughout sections 4.5.1, 4.5.2 and 4.5.3 the data 
from Figure 3.7.A and Figure 3.8.A is used as a suboptimal control for on-




4.5.1 Single mismatches and positioning within the 
protospacer 
  
Firstly, I assessed the effect of single nucleotide mismatches within the 
protospacer. Hinz, Laughery and Wyrick (2016) reported that the closer the 
mismatch is located to the PAM site, the more likely it is to affect the cleavage 
efficiency of Cas9. This effect was specific to mismatches on positions 1 to 10 
on the protospacer. Therefore, I compared the effect of a single mismatch 
when it is found either within or outside of this region of the protospacer. In 
addition, a single mismatch at position 14 led to an overall decrease in the 
cleavage potency of the sgRNA. Therefore, I used sgRNAs that bear a single 
nucleotide substitution on position 1 or position 14. The results for sgKvDMR#1 
and sgImpact are shown in Figure 4.7 and Figure 4.8, respectively.  
 As for previous targeting experiments, I transfected the BxJ and JxB 
hybrid mESC lines with mismatch-bearing sgRNAs in the px459v2 vector. The 
time of exposure for all experiments with sgRNAs that contain mismatches was 
4 days, to include puromycin selection of successfully transfected cells. When 
the first position of the sgKvDMR#1 protospacer was substituted (Figure 
4.7.A) the overall potency of sgKvDMR#1 dropped below 10% (Figure 4.7.B), 
102 
 
compared to 80% for sgKvDMR match (Figure 3.7.A). In contrast, when the 
same position was mutated in the protospacer of sgImpact (Figure 4.8.A) the 
overall editing efficiency of sgImpact mm1, shown in Figure 4.8.B, was similar 
to that of the perfect sgImpact match (Figure 3.8.A). The same was true for 
both sgKvDMR#1 and sgImpact when the nucleotide on position 14 of the 
protospacer was mutated (Figure 4.7.C and Figure 4.8.C).  
An increase in allelic bias, compared to the perfect match sgRNAs, was 
observed for sgKvDMR#1 mm1 and sgImpact mm1 in BxJ, where imprinting 
was better maintained and there was an overall reduction in editing by a 
mismatch-containing sgRNA, relative to the perfect match sgRNA (Figure 
4.7.B). In this case, the paternal non-imprinted allele is edited more frequently 
than the maternal allele. In contrast, sgKvDMR#1 mm14 (Figure 4.7.C) and 
sgImpact mm14 (Figure 4.8.C) did not yield any increase in allelic bias 
compared to the equivalent perfectly matching sgRNAs for both target loci. 
This raises the possibility that when the overall editing potency of the sgRNA 
decreases allelic bias increases, implying that there is a chromatin-related 
effect.  
It is possible that chromatin modifications do not influence off-target site 
recognition when there are only single mismatches within the protospacer. A 
profound effect is only observed for sgKvDMR#1 mm1, where the first position 
next to the PAM site is mutated and the overall editing efficiency of the 
mismatch containing sgRNA is reduced. However, as shown in Figure 4.8.B 
the effect is more subtle for sgImpact mm1. This could be either owed to 
sequence-specific properties of the two different sgRNAs or due to the different 
degrees of imprinting maintenance that were observed from the percentage of 
methylated reads for each target locus at the time the experiment was 
performed. Additionally, a distal single nucleotide mutation at position 14 was 
not sufficient to increase the allelic bias in either of the two target loci. 
Therefore, it is possible that the overall mutation efficiency and position of the 
single mismatch within the protospacer affect the inhibition of off-target site 








Figure 4.6 A PAM-proximal single mismatch influences target site recognition 
for sgKvDMR#1. A: Schematic of the sequences for the perfect match sgKvDMR#1 
and the two single mismatch-containing sgRNAs. The single nucleotide substitutions 
are shown in light blue in relation to the PAM site, shown in red. mm = mismatch B: 
Allele-specific editing frequencies for sgKvDMR#1 mm1. Error bars represent the 
Standard Deviation of three experimental replicates. The percentage of reads with 
fully methylated CG dinucleotides is shown above every histogram to show the degree 
of imprinting maintenance during each targeting experiment. Stacked histograms that 
demonstrate the allelic mutation bias are shown at the bottom. C: Allele-specific 
editing frequencies for sgKvDMR#1 mm14. As usual, error bars represent the 
Standard Deviation of three experimental replicates. The percentage of reads with 
fully methylated CG dinucleotides is shown above the histogram. Stacked histograms 





Figure 4.7 Single nucleotide mismatches do not influence target site 
recognition for sgImpact. 
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Figure 4.7 Single nucleotide mismatches do not influence target site 
recognition for sgImpact. A: Schematic of the sequences for the perfect match 
sgImpact and the two single mismatch-containing sgRNAs. The single nucleotide 
substitutions are shown in light blue in relation to the PAM site, shown in red. mm = 
mismatch B: Allele-specific editing frequencies for sgImpact mm1. Error bars 
represent the Standard Deviation of three experimental replicates. The percentage of 
reads with fully methylated CG dinucleotides shown at the top of the histogram shows 
the degree of imprinting maintenance during this targeting experiment. Stacked 
histograms that demonstrate the allelic mutation bias are shown at the bottom. C: 
Allele-specific editing frequencies for sgImpact mm14. Error bars represent the 
Standard Deviation of three experimental replicates. The percentage of reads with 
fully methylated CG dinucleotides is shown above the histogram. Stacked histograms 
















4.5.2 Two mismatches and positioning within the protospacer 
  
The single mismatch experiments from the previous section suggested 
that chromatin disproportionately affects mutagenesis in the presence of 
mismatches, but the effect is only observed when there is an overall reduction 
in mutagenesis. To explore this further, we introduced two mismatches to 
increase the likelihood that the overall mutation frequency would decrease. As 
for single mismatches, I compared the effect of two PAM-proximal or PAM-
distal mismatches. This time I introduced mismatches in positions 1 and 10, 
which are proximal to the PAM site, and positions 11 and 12, which are distal. 
The nucleotide substitutions are illustrated in Figure 4.9.A for sgKvDMR#1 
and in Figure 4.10.A for sgImpact.  
 A reduction in the overall editing potency of both sgKvDMR#1 and 
sgImpact is evident after the introduction of two mismatches in the 
protospacer. The reduction is disproportionate and related to the maternal 
inaccessible allele. The effect is more profound for sgKvDMR#1 mm1+10, 
where the highest allelic bias is observed (Figure 4.9.B). Distal mismatches 
on positions 11 and 12 also raised the allelic bias (Figure 4.9.C), though not 
as much as the combination of two proximal mismatches in positions 1 and 10.  
 A similar trend is also present for sgImpact. This is only observed in 
BxJ, since a great reduction in DNA methylation was observed at the promoter 
region of Impact in JxB during this set of experiments. The combination of 
mismatches 1 and 10 increased the bias between off-target site recognition 
towards the accessible paternal allele. It is also striking that this double 
mismatch combination also reduced the overall potency of sgImpact to levels 
below 10% for both alleles (Figure 4.10.B). As shown in Figure 4.10.C, the 
overall potency of sgImpact mm11+12 was not reduced as drastically as of 
sgImpact mm1+10 and the observed rise in allelic bias of sgImpact mm11+12 
was not as profound as for sgImpact mm1+10.   
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 Overall, the presence of two mismatches within the protospacer results 
in elevated inhibition of mutagenesis on the maternal allele compared to a 
single mismatch. The position of the mismatches is also critical, since the 




Figure 4.8 Two mismatches in sgKvDMR#1 disproportionately reduce target 
site recognition on the paternal allele. 
110 
 
Figure 4.8 Two mismatches in sgKvDMR#1 disproportionately reduce target 
site recognition on the paternal allele. A: Schematic of the sequences for the 
perfect match sgKvDMR#1 and the two combinations of double mismatches in 
sgKvDMR#1. The individual nucleotide substitutions for each position are shown in 
light blue in relation to the PAM site, shown in red. B: Allele-specific editing 
frequencies for sgKvDMR#1 mm1+10. Error bars represent the Standard Deviation 
of three experimental replicates. The percentage of reads with fully methylated CG 
dinucleotides is shown above every histogram to show the degree of imprinting 
maintenance during this experiment. Stacked histograms demonstrating the allelic 
mutation bias are shown at the bottom. C: Allele-specific editing frequencies for 
sgKvDMR#1 mm11+12. As for above, error bars represent the Standard Deviation of 
three experimental replicates. The percentage of reads with fully methylated CG 
dinucleotides is shown above the histogram. Stacked histograms demonstrating the 




Figure 4.9 Subtle reduction of target site recognition on the maternal allele 
when sgImpact bears two mismatches. 
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Figure 4.9 Subtle reduction of target site recognition on the maternal allele 
when sgImpact bears two mismatches. Schematic of the sequences for the perfect 
match sgImpact and the two combinations of double mismatches in sgImpact. The 
individual nucleotide substitutions are shown in light blue in relation to the PAM site, 
shown in red. B: Allele-specific editing frequencies for sgImpact mm1+10. Error bars 
represent the Standard Deviation of three experimental replicates. The percentage of 
reads with fully methylated CG dinucleotides shown at the top of the histogram shows 
the degree of imprinting maintenance during this targeting experiment. Stacked 
histograms that demonstrate the allelic mutation bias are shown at the bottom. C: 
Allele-specific editing frequencies for sgImpact mm11+12. Error bars represent the 
Standard Deviation of three experimental replicates. The percentage of reads with 
fully methylated CG dinucleotides is shown above the histogram. Stacked histograms 
















4.5.3 Presence of a third mismatch within the protospacer 
 
In the end, I also investigated the effect of chromatin modifications on off-
target site recognition when more than two nucleotide mismatches are present 
within the protospacer. In order to avoid reducing the overall editing potency 
of the sgRNAs to a drastic extend by introducing three mismatches near the 
PAM site, positions 14, 11 and 8 were selected after examination of a single-
nucleotide specificity matrix that was published for Cas9 (Hsu et al., 2013). 
Therefore, two out of three of the selected mismatches were introduced on the 
second half of the protospacer. I also assessed the combined effect of these 
two distal mismatches for positions 14 and 11 in comparison to the triple 
mismatch-containing sgRNAs for both sgKvDMR#1 and sgImpact. 
Interestingly, these mismatch combinations led to extreme reductions to 
the potency of the sgRNAs as shown in the histograms throughout Figure 4.11 
and Figure 4.12. Notably the overall mutation frequency on the imprinted 
target sites was around 1% or lower, which was the lowest of all the different 
combinations of mismatches that were tested previously.  
Despite the greatly reduced overall mutation frequency resulting from these 
nucleotide mismatches, a reduction was observed on the maternal imprinted 
allele. More specifically, Figure 4.11.B demonstrates that the majority of 
sgKvDMR#1 mm14+11 edits occurred on the paternal allele. This trend is also 
true for sgKvDMR#1 mm14+11+8, thought the effect is more subtle due to the 
presence of the third mismatch at position 8 (Figure 4.11.C).  
The results for sgRNA targeting the promoter region of Impact are once 
more similar. Figure 4.12.B shows that sgImpact mm14+11 mostly generated 
mutations on the paternal allele, though it is evident from the allelic bias value 
that the effect is more subtle compared to sgKvDMR#1 mm14+11 from Figure 
4.11.B. In contrast, introducing a third mismatch on position 8 of sgImpact did 
not reduce the mutation frequency on the maternal allele for this target locus 
(Figure 4.12.C).  
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Overall, the low mutation frequencies observed for these combinations of 
mismatches should be interpreted with caution. It is also not clear if the 
differences we observed between the two loci are owed to sequence-specific 
properties of the two different sgRNAs or the presence of a third mismatch 





Figure 4.10 A third mismatch in sgKvDMR#1 does not contribute to the allele-
specific inhibition of off-target mutagenesis. 
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Figure 4.10 A third mismatch in sgKvDMR#1 does not contribute to the allele-
specific inhibition of off-target mutagenesis. A: Schematic of the sequences for 
the perfect match sgKvDMR#1 and the mismatches in positions 14, 11 and 8. The 
individual nucleotide substitutions for each position are shown in light blue in relation 
to the PAM site. B: Allele-specific editing frequencies for sgKvDMR#1 mm14+11. 
Error bars represent the Standard Deviation of three experimental replicates. The 
percentage of reads with fully methylated CG dinucleotides is shown above the 
histogram to illustrate the degree of imprinting maintenance during this experiment. 
Stacked histograms that demonstrate the allelic mutation bias are shown at the 
bottom. C: Allele-specific editing frequencies for sgKvDMR#1 mm14+11+8. As for 
above, error bars represent the Standard Deviation of three experimental replicates. 
The percentage of reads with fully methylated CG dinucleotides is shown above the 






Figure 4.11 A third mismatch in sgImpact does not affect allele-specific 
inhibition of off-target mutagenesis. 
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Figure 4.11 A third mismatch in sgImpact does not affect allele-specific 
inhibition of off-target mutagenesis. Schematic of the sequences for the perfect 
match sgImpact and the mismatches in positions 14, 11 and 8. The individual 
nucleotide substitutions are shown in light blue in relation to the PAM site. B: Allele-
specific editing frequencies for sgImpact mm14+11. Error bars represent the Standard 
Deviation of three experimental replicates. The percentage of reads with fully 
methylated CG dinucleotides shown at the top of the histogram shows the degree of 
imprinting maintenance during this targeting experiment. Stacked histograms that 
demonstrate the allelic mutation bias are shown at the bottom. C: Allele-specific 
editing frequencies for sgImpact mm14+11+8. Error bars represent the Standard 
Deviation of three experimental replicates. The percentage of reads with fully 
methylated CG dinucleotides is shown above the histogram. Stacked histograms 




















In this chapter I described how I identified additional factors that strongly 
influence how chromatin and epigenetic modifications regulate CRISPR/Cas9 
mutagenesis. Assessing allele-specific mutagenesis for different exposure 
times revealed that mutations appear more rapidly on the paternal euchromatic 
allele.  
Prolonged exposure to the genome editing reagents allowed mutations 
on the maternal heterochromatin-associated allele to accumulate over time, 
leading to almost equal mutation frequencies after 4 days of exposure. The 
concentration of Cas9 was also important towards allele-specific genome 
editing. High levels of Cas9 expression led to a faster completion of the 
mutagenesis process during 4 days of targeting. In contrast, the lower the 
concentration of Cas9, the higher the editing bias for the paternal euchromatic 
allele. These findings are novel and will contribute towards improving our 
current understanding about how CRISPR/Cas9 is affected by eukaryotic 
chromatin compaction.  
 The prospect that CRISPR/Cas9 and related genome editing tools will 
be used to treat human disease in the near future looks increasingly likely, but 
should be regarded with care and caution (Baltimore et al., 2015). Recent 
successful examples of the application in human hematopoietic 
stem/progenitor cells (hHSPCs) highlight the potential of using this tool in a 
clinical context (DeWitt et al., 2016; Chung et al., 2019). Additionally, the use 
of improved engineered versions Cas9 on synchronised human hematopoietic 
stem cells (hHSCs) boosts the genome editing efficiency in this primary cell 
line through temporal control of DNA repair (Lomova et al., 2019).  
 In general, it is desirable to have a high on-target editing efficiency with 
as few off-target mutations as possible. Our results suggest a strategy to use 
a priori knowledge of chromatin state to achieve this. When the intended target 
site is within accessible chromatin, but potential off target sites are not, brief 
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exposure to Cas9 in conjunction with maintaining the expression level of Cas9 
low would favour on versus off-target mutagenesis to a greater extent than 
result in the accumulation of edits on the appropriate target site. In addition, 
the chromatin context of predicted off-target sites should also be considered 
before choosing to use a sgRNA. All the experiments performed with 
mismatch-containing sgRNAs (Chapter 4.5) were 4-days long and included 
puromycin treatment selection of successfully-transfected cells. Despite the 
prolonged exposure to CRISPR/Cas9, we demonstrated that off-target 
mutagenesis is reduced within inaccessible heterochromatic regions when the 
overall editing efficiency is also reduced.   
 In the past, DNase hypersensitive regions were deemed more 
permissive for dCas9 to associate with an off-target site (Kuscu et al., 2014). 
A more recent study has proved this is also true for wild-type Cas9 after 
assessing several different combinations of single or double mismatches 
within the protospacer (Kim and Kim, 2018). In contrast to the above, our 
approach does not solely rely on accessibility based on DNase hypersensitivity 
but also on additional repressive epigenetic marks associated with constitutive 
heterochromatin, such as DNA methylation and H3K9me3.  
While performing the experiments that are described in Chapter 4.5, a 
study was published where it was argued that inaccessible chromatin regions 
are less prone to off-target CRISPR/Cas9 mutagenesis (Kim and Kim, 2018). 
This time two sgRNAs were assessed in HEK293 and HeLa cells, in a system 
where mismatch-containing sgRNAs were used to target two sequences that 
were present in two copies in the human genome. However, the two target 
sites were selected based on DNase hypersensitivity alone in the absence of 
other epigenetic modification differences between the two copies of the target 
sequences, such as DNA methylation and histone modifications. This 
encouraged me to continue investigating the effect of repressive chromatin 
modifications on off-target mutagenesis in our system.  
We also demonstrated that different combinations of mismatches within 
the protospacer lead to different degrees of inhibition of off-target mutagenesis 
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within heterochromatic regions, as measured by the allelic bias ratio. Kim and 
Kim (2018) showed that several combinations of double mismatches in the 
protospacer lead to the biggest differences in target site recognition between 
accessible and inaccessible regions, whereas single nucleotide mismatches 
led to more subtle differences. This agrees with our observation that some 
combinations of double mismatches generate higher allelic bias than single 
mismatches. However, great variability was also observed when more than 
one target sites were interrogated, since every detectable effect was more 
subtle for sgImpact compared to sgKvDMR#1. The sequence and secondary 
structure of different sgRNAs determines their overall efficiency (Moreno-
Mateos et al., 2015; Jensen et al., 2017). Therefore, it is likely that the sgRNAs 
we used possess different properties that are determined by the different 
protospacer sequences. This highlights the need for a more systematic 
characterisation and assessment of more mismatch combinations for multiple 
target sites. 
An earlier study on the specificity of CRISPR/Cas9 showed that while 
the sequence context and the position of mismatches is important for on-target 
site recognition, specific DNA modifications like DNA methylation did not affect 
the editing activity of CRISPR/Cas9 using an in vitro system (Hsu et al., 2013). 
A different study using an in vivo system later showed that DNA methylation 
did not affect the initial association of CRISPR/Cas9 with its target site (Fujita, 
Yuno and Fujii, 2016). The data presented in Figure 4.5 in this chapter indicate 
that the presence of repressive epigenetic modifications hinder the initial 
association of CRISPR/dCas9 with its target site. However, these data are 
limited to two sgRNAs.  Given the diverse effect that DNA methylation has on 
the binding of transcription factors to their destined DNA sequence from 
mammals to plants (O’Malley et al., 2016; Yin et al., 2017; Héberlé and Bardet, 
2019), more systematic assessment of the effect of DNA methylation on 
CRISPR/Cas9 binding should be performed through the use of simple in vitro 
systems in the future. 
Genome editing is more permissive in euchromatic regions due to the 
higher level of Cas9 occupancy. In 2013 Wu et al reached a similar conclusion 
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after they performed genome-wide dCas9 ChIP-Seq analysis. Dissecting the 
mechanism through which repressed chromatin disproportionately impairs 
mutagenesis for sgRNAs containing mismatches would help us identify the 
causative chromatin modification and contribute towards building better tools 



















Assessing the effect of pre-existing 
chromatin modifications during repair 











Having shown that chromatin compaction affects the efficiency of 
CRISPR/Cas9 mutagenesis we were interested to investigate how pre-existing 
repressive chromatin modifications of a genomic locus affect the outcome of 
genome editing by CRISPR/Cas9.  
 Double-strand breaks (DSBs) by the Cas9 endonuclease are usually 
repaired through two very different DNA repair mechanisms (Doudna and 
Charpentier, 2014). The first is non-homologous end joining (NHEJ), which is 
favoured throughout the cell cycle (Mladenov et al., 2016) and can create a 
mutational scar at the CRISPR/Cas9 target site due to the generation of 
InDels. The second mechanism is homology-directed repair (HDR), which 
resembles SSA and relies on co-delivery of externally provided repair 
templates (Doudna and Charpentier, 2014). Despite its temporal restriction 
through the cell cycle and lower frequency of occurrence compared to NHEJ 
within mammalian cells, HDR is the coveted DNA repair pathway during 
genome editing with CRISPR/Cas9. 
 The chromatin environment and spatial positioning in the nucleus has 
been reported to affect DNA repair pathway choice of DSBs that are not 
generated by the Cas9 endonuclease in mammalian cells (Lemaître et al., 
2014; Burman et al., 2015; Clouaire and Legube, 2015). Most notably, 
epigenetic modifications, like the H3K36me3 mark, have been reported to play 
a role towards the recruitment of factors involved in HR (Aymard et al., 2014). 
However, very little is known about how pre-existing epigenetic chromatin 
modifications influence HDR frequencies and the InDel spectrum across 
different target sites during genome editing. We therefore decided to use our 
genomic imprinting-based system to gain useful insights in this previously 
uncharacterised area.  
 The experimental work presented in this chapter was primarily my own. 
Alison Meynert and Tracy Ballinger conducted the bioinformatic analysis, as 
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described in Materials and Methods, and additionally recorded the different 




5.2 Repressive chromatin modifications do not affect 
the efficiency of homology-directed repair during 
genome editing 
  
In order to report on the outcome of mutagenic DNA repair in the context 
of genome editing with CRISPR/Cas9, we assessed the mutation outcome for 
the five imprinted target sites we studied so far. An exogenous single-stranded 
oligodeoxynucleotide (ssODN) template was used as a donor, allowing us to 
distinguish HDR events. The ssODN for each target site contains a specific 
sequence signature that differs from the original target site sequence such that 
the PAM motif is abolished. Upon introduction of the information included in 
the donor template through HDR, subsequent rounds of Cas9 cleavage are 
therefore prevented. This allows us to derive the frequency of HDR events, 
relative to mutagenic NHEJ, in an allele-specific manner.  
 As described in the Figure 3.5, the parental origin of all reads is 
determined first by the presence of informative SNPs within the BxJ and JxB 
hybrid mESC lines. Alison Meynert then used a custom script to identify HDR 
reads, which were the reads that contained the sequence change we designed 
to abolish the PAM site from the externally provided ssODN. HDR reads were 
divided over the total number of reads that contained evidence of 
CRISPR/Cas9 mutagenesis, which were reads with evidence of NHEJ (NHEJ 
reads) and HDR reads. This process was performed separately for every 
replicate of each sample. The average of three experimental replicates was 
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calculated and used to report the HDR frequency for each sgRNA in either of 
the two hybrid mESC lines that were used.  
 All results illustrated in Figure 5.1 correspond to edited genomic DNA 
samples collected 4 days post transfection. In general, HDR frequencies are 
very similar between the closed maternal allele and the accessible paternal 
allele for all sgRNAs across the KvDMR region (Figure 5.1.A) and the sgRNAs 
for the promoter regions of Inpp5f_v2 (Figure 5.1.B) and Impact (Figure 
5.1.C). A subtle significant preference for HDR occurrence on the euchromatic 
paternal allele was observed for sgKvDMR#2 in the BxJ hybrid mESC line 
(Figure 5.1.A, centre), but the absence of consistency in the JxB line indicates 
that the effect is an isolated case.  
 Having earlier assessed the effect of time on allele-specific 
CRISPR/Cas9 mutagenesis, the design of the time course experiment for 
Impact (shown in Figure 4.1) also allowed assessing the effect of shorter 
periods of exposure to the allele-specific HDR frequencies. Thought this data 
is only available for one locus, it appears that shorter times of exposure to the 
genome editing reagents do not influence the effect of chromatin modifications 
on allele-specific HDR frequencies. As a reminder, this time course was 
performed with the px459v2 vector (Addgene Plasmid #62988) in the absence 
of puromycin selection due to the reduced time frame. A schematic for the 
harvesting of time points is provided in Figure 5.2.A. HDR frequencies are 
plotted separately for each allele over time in Figure 5.2.B. The fold difference 
of paternal/maternal HDR is also shown across time in Figure 5.2.C. This time 
the frequency of HDR appeared to be subtly elevated for the maternal 
inaccessible allele at early time points, but this difference was not statistically 
significant, as determined by paired two sample t tests performed at each time 
point (Figure 5.2.B). Further statistical analysis with 1-way ANOVA also 
showed that there was no significant difference in the fold difference of allele-
specific HDR frequencies between the different time points, as also implied by 
the standard deviation error bars in place for each time point in Figure 5.2.C. 
These error bars are large, especially for the earliest time points at 8 hours 
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and 12 hours, which could be owed to the very low overall mutagenesis 
frequency (as shown in Figure 4.1.B). 
 Combined, the data from all five sgRNAs, and the time course for 
Impact, suggest that pre-existing chromatin modifications on the target sites 
do not influence the frequency of HDR towards repair of Cas9-induced DSBs. 
HDR frequencies range from 10% to 40% for different target sites. This could 
be owed to the sequence-specific properties of each site and/or donor repair 
template used. Overall, accessibility and repressive chromatin modifications 
have little influence on the prevalence of HDR during genome editing with 










Figure 5.1 Chromatin modifications do not affect the frequency of repair via a 
single-stranded donor template. A: HDR frequencies for three individual sgRNAs 
on the KvDMR region, colour-coded in an allele-specific manner. Statistical analysis 
through paired two sample t tests from three experimental replicates revealed no 
significant difference between the maternal and paternal allele frequency. Bonferroni 
correction was performed to correct for type 1 error among these 10 individual 
experiments. The degree of imprinting maintenance is indicated by the percentage of 
fully methylated reads above each graph. The position of each sgRNA is indicated in 
Figure 3.2. B: HDR frequencies for the sgRNA on the promoter region of Inpp5f_v2, 
as for above.  The position of sgInpp5f_v2 is indicated in Figure 3.4. C: HDR 
frequencies for the sgRNA on the promoter region of Impact, as for above.  The 




Figure 5.2 Chromatin modifications do not affect the frequency of HDR during 
CRISPR/Cas9 mutagenesis across time. A: Schematic of the experimental time 
frame for the time course experiment. BxJ cells were transfected px459v2 containing 
sgImpact and a ssODN. Cells were harvested at the indicated 4-hour intervals and 
genomic DNA was isolated for targeted amplicon NGS as previously described. B: 
Allele-specific HDR frequencies plotted against time. The paternal accessible allele is 
shown in blue and the maternal inaccessible allele is shown in red. HDR is slightly yet 
insignificantly more frequent on the maternal allele, as determined by paired two 
sample t tests per time point. The percentage fully methylated reads shown above 
implies the degree of imprinting maintenance during this experiment. C: Fold 
difference of HDR frequencies plotted against time. The green line connects the 
values per each time point. 1-way ANOVA and Tukey’s HSD test showed the lack of 
a significant difference between every time point. 
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5.3 Homology-directed repair does not occur more 
readily within actively transcribed gene bodies 
 
Having observed a lack of significant difference so far, I decided to 
investigate additional regions that possess epigenetic modifications 
associated with a higher prevalence of traditional HR. Since H3K9me3 and 
H4K20me3 are not constant across imprinted domains (Mikkelsen et al., 
2007), which include IRCs and imprinted genes, we sought to compare the 
effect of different classes of chromatin modification, such as H3K36me3 that 
had previously been implicated in HR efficiency. In 2014 Aymard et al 
established the presence of a link between H3K36me3 and the use of HR to 
repair DSBs that arise within actively transcribed gene bodies.  
I selected to target Impact and Grb10, which are two maternally-imprinted 
loci that are highly expressed in mESCs (Maupetit-Méhouas et al., 2016; 
Bouschet et al., 2017). Our established system would allow us to investigate if 
the frequency of HDR would also be disproportionally elevated at the paternal 
transcribed allele of these two loci, as previously demonstrated for HR 
(Aymard et al., 2014). The sgRNAs for both loci were selected to target 3´ end 
distal introns, to avoid disturbing the expression of the two genes. In addition, 
the positions of the sgRNAs correlated with regions of high enrichment of 
H3K36me3 in mESCs, as shown in Figure 5.3.A for Grb10 and Figure 5.4.A 
for Impact, respectively. The H3K36me3 ChIP-Seq tracks were obtained from 
publicly available ENCODE data through the UCSC genome browser. 
Although these ChIP-Seq data are from E14 mESCs cultured in serum+LIF, 
instead of 1i culture conditions, they are the closest publicly available data I 
could use to predict where H3K36me3 would be enriched in the two hybrid 
mESC lines I used.  
Similar to the experiments described in the previous section for promoter-
proximal regions, the data represented here was obtained at 4 days post 
transfection. It is evident that the HDR frequencies are very similar to the 
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values described previously, and no significant enrichment for HDR on the 
expressed paternal was observed. This is true for both the 3´ end of Grb10 
(Figure 5.3.B) and Impact (Figure 5.4.B) in both mESC lines used throughout 
my project.  
However, these experiments were performed before I developed the 
strategy for monitoring imprinting maintenance that is described in Figure 3.6. 
Therefore, I have not reported on the degree of imprinting maintenance at the 
time and passage of cells were these editing experiments were conducted, as 
also mentioned in the figure legends of Figure 5.3 and Figure 5.4. Moreover, 
native histone ChIP followed by qPCR has not been performed to assess the 
presence of H3K36me3 at the time. Nevertheless, it is possible that HDR is 
not influenced like HR does by H3K36me3, for reasons that will be listed in 
Chapter 6. 
The overall conclusion that is drawn from the data for all seven different 
sites studied within and outwith maternally-imprinted gene bodies is that the 
HDR is employed just as frequently on either allele. Therefore, the pre-existing 
chromatin landscape does not influence the outcome of DSB repair during 










Figure 5.3 HDR frequency is not increased within the gene body of the actively 
transcribed allele of Grb10. A: View of the distal region of Grb10 and the relative 
positions of sgGrb10_3´1. B: HDR frequencies for the sgRNA on the 3´ end distal 
intronic region of Grb10, colour-coded in an allele-specific manner. Statistical analysis 
through paired two sample t tests from three experimental replicates revealed no 
significant difference between the maternal and paternal allele frequencies for either 
hybrid mESC line. Bonferroni correction was performed to correct for type 1 error 
among the 4 individual experiments included in the present and next Figure. The 
degree of imprinting maintenance has not been determined for this locus at the time 





Figure 5.4 HDR frequency is not increased within the gene body of the actively 
transcribed allele of Impact. A: View of the distal region of Impact and the relative 
positions of sgImpact_3´1.  B: HDR frequencies for the sgRNA on the 3´ end distal 
intronic region of Impact, colour-coded in an allele-specific manner. Statistical 
analysis through paired two sample t tests from three experimental replicates 
revealed no significant difference between the maternal and paternal allele frequency 
for only one of the two reciprocal hybrid mESC lines. Bonferroni correction was 
performed to correct for type 1 error among the 4 individual experiments included in 
the present and previous Figure. The degree of imprinting maintenance has not been 




5.4 The InDel spectrum is not affected by chromatin 
during genome editing  
  
In addition to the frequency of HDR, we also characterised the sizes 
and recurrence of different types of InDels produced by NHEJ in an allele-
specific manner.  
 During a DNA repair profiling study the authors demonstrated that the 
repair of DSBs generated by the standard Cas9 endonuclease from 
Streptococcus pyogenes is influenced by the sequence of the protospacer 
instead of the wider genomic context (van Overbeek et al., 2016). With the aid 
of Alison Meynert and Tracy Ballinger we focused on the sequencing reads 
that contained evidence of mutagenic NHEJ and assessed the frequencies of 
specific types of small deletions and single base insertions. All the results 
shown in Figure 5.5 and Figure 5.6 are also from edited genomic DNA 
samples collected 4 days post transfection.  
 Overall, it is evident that a unique pattern of InDels is generated after 
editing with every individual sgRNA. The majority of InDels found across all 
five studied target sites fell into distinct categories according to size. The five 
most frequent InDel classes for the five of the sgRNAs used throughout this 
study are shown in Figure 5.5 and Figure 5.6. These five classes are different 
for each sgRNA. The variance across three experimental replicates is provided 
as standard deviation for each indel category of the sgRNAs in Appendix 6. 
When sorted according to parental origin, the frequency for each InDel 
category was similar between the two alleles across three maternally-imprinted 
loci. This trend is observed for sgKvDMR#1 (Figure 5.5.A), sgKvDMR#2 
(Figure 5.5.B), sgKvDMR#3 (Figure 5.5.C), sgInpp5fv_2 (Figure 5.6.A) and 
sgImpact (Figure 5.6.B). This suggests that the pre-existing chromatin 
modifications do not affect the outcome of mutagenic DNA repair during 
genome editing with CRISPR/Cas9.  
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Figure 5.5 Recurring InDel classes at three sites on the KvDMR region.  
A: Size and frequency of the most common InDels for sgKvDMR#1 for each allele. 
The position of the cleavage site is noted by the vertical line. Results from the BxJ 
and JxB lines are shown on the left side and right side, respectively. The scale above 
each graph illustrates the size of deletions, whereas the only single base insertions 
were detected. The degree of imprinting maintenance is indicated by the percentage 
of fully methylated reads is indicated below each graph. Colour coding is used for all 
graphs, with a key provided at the bottom. B: Size and frequency of the most common 
InDels for sgKvDMR#2 for each allele, as described above for sgKvDMR#1. C: Size 
and frequency of the most common InDels for sgKvDMR#3 for each allele, as 




Figure 5.6 Recurring InDel classes at the sites on the promoter regions of 
Inpp5f_v2 and Impact. A: Size and frequency of the most common InDels for 
sgInpp5f_v2 for each allele. The position of the cleavage site is noted by the vertical 
line. Results from the BxJ and JxB lines are shown on the left side and right side, 
respectively. The scale above each graph illustrates the size of deletions, whereas 
the only single base insertions were detected. The degree of imprinting maintenance 
is indicated by the percentage of fully methylated reads is indicated below each graph. 
Colour coding is used for all graphs, with a key provided at the bottom. B: Size and 
frequency of the most common InDels for sgImpact for each allele, as described 






5.5 Changes in the InDel profile of sgImpact over time 
 
 As previously demonstrated by van Overbeek et al, the relative 
frequency of different InDel classes is influenced over time, provided that Cas9 
expression is continuously expressed (van Overbeek et al., 2016). According 
to Kim et al, we assumed Cas9 expression to be maintained at high levels for 
at least 72 hours from plasmid DNA we used (instead of RNPs) to deliver 
CRISPR/cas9 into mESCs (Kim et al., 2014). While performing the time course 
experiment on the promoter region of Impact (as previously described in 
Chapter 4, Figure 4.1) ssODN was co-delivered with CRISPR/Cas9 for us to 
assess the effect of chromatin on repair of Cas9-induced DSBs over a 48-hour 
timeframe. Alison Meynert performed the necessary analysis to distinguish 
single nucleotide deletions into a class (Δ1). She also grouped 10 nucleotide-
long deletions with deletions that were larger than 10 nucleotides in length into 
a single class (Δ≥10). The frequency of both classes was plotted against time 
and shown separately for the euchromatic and heterochromatic allele in 
Figure 5.7. 
As shown in Figure 5.7.A, the frequency of Δ1 has a tendency to 
decrease over time for either allele. On the contrary, the frequency of class 
Δ≥10 showed an increasing trend over time (Figure 5.7.B). These findings 
agree with published results from van Overbeek et al, and may be explained 
by the fact that small deletions are less likely to perturb the PAM site and 
protospacer sequence than larger deletions. Integrity of the target site may 
result in repeated cycles of Cas9 cleavage and the generation of larger 
deletions, such as Δ≥10.  
Despite observing that the frequency of class Δ≥10 increases in both 
the accessible and imprinted allele for this locus (Figure 5.7.B), we also 
observed that the frequency of class Δ1 was higher on the imprinted maternal 
allele for the first 24 hours (Figure 5.7.A). According to Figure 4.1.B, the 
overall editing frequency is lower for the imprinted allele, compared to the 
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accessible paternal allele, for these early time points. This may suggest that 
repetitive cycles of cleavage by Cas9 do not occur as readily on the 
inaccessible, imprinted maternal allele. Although these findings show a logical 
trend, it would be worth to perform additional time course experiments in the 














Figure 5.7 Larger deletions accumulate over time on the promoter of Impact. 
A: Allele-specific changes in the proportion of reads that contain a single nucleotide 
deletion (Δ1). The frequency of this class of (small) deletion is reduced over time for 
both alleles. The data was collected from the 48-hour time course experiment 
previously shown in Figure 4.1 for sgImpact.  Error bars represent Standard Deviation 
from 3 experimental replicates. B: Allele-specific changes in the proportion of reads 
that contain deletions of 10 nucleotides or more (Δ≥10). The frequency of this class 
of (larger) deletion increases over time for both alleles.  The data was collected from 
the 48-hour time course experiment previously shown in Figure 4.1 for sgImpact.  










Despite evidence that suggests DNA repair is influenced by the 
sequence context and the position of a DSB within the nucleus (Lemaître et 
al., 2014; Aymard et al., 2014; Tsouroula et al., 2016) we discovered that 
differential chromatin modifications between two alleles of three distinct 
maternally-imprinted loci do not have an effect to the selection between NHEJ 
and HDR towards the repair of Cas9-induced DSBs.  
As previously suggested by two different research groups, Cas9 may open 
up compacted chromatin regions (Polstein et al., 2015; Barkal et al., 2016). 
This might explain why pre-existing chromatin modifications do not contribute 
to DNA repair pathway selection during genome editing. Our observations are 
in agreement with a recent study, where DSB repair pathway choice was not 
affected by chromatin compaction in Drosophila melanogaster after DSBs 
were induced with the I-SceI endonuclease (Janssen et al., 2016). 
Regarding the InDel analysis performed for five sgRNAs, we observed that 
the InDel spectrum for every unique sgRNA was different. This became 
evident after recording the five most frequent InDel classes for each sgRNA. 
As mentioned earlier, this agrees with the finding that the sequence of the 
protospacer region is responsible for the produced InDel pattern, published by 
van Overbeek et al. in 2016. Emerging evidence continues to support the idea 
that the DNA sequence context of the target site can be used to predict the 
repair outcome of the Cas9-induced DSB in the absence of a repair donor 
either in vitro (Allen et al., 2018; Shou et al., 2018) or in vivo (Shen et al., 2018). 
However, our findings suggest that differential chromatin modifications do not 
influence the repair outcome of Cas9-induced DSBs when the latter are 
repaired without relying on an externally provided repair donor.  
Our system allows us to quantify mutagenesis by CRISPR/Cas9 by 
measuring the frequency of reads that deviate from the wild-type unedited 
sequence of the murine genome. Therefore, we are only able to detect 
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mutagenic DNA repair and cannot account for the frequency of error-free c-
NHEJ, during which there is no InDel formation. Nevertheless, we report that 
genome edits arising via HDR and NHEJ occur at similar frequencies for DSBs 
generated by Cas9 on transcriptionally silenced and transcriptionally active 
genomic sites. All findings from this chapter will be discussed further in the 



























6.1 General Discussion 
 
The development of the CRISPR/Cas9 genome editing tool is 
undoubtedly one of the greatest recent advances in molecular genetics. 
CRISPR/Cas9 is broadly adaptable and will continue to revolutionise the way 
biological research is conducted in the future. The natural origin of the standard 
version of this tool lies in the Type II CRISPR bacterial immunity system from 
Streptococcus pyogenes, where an RNA-guided endonuclease degrades 
invading DNA molecules following RNA-DNA target hybridisation.  
The genomes of higher eukaryotes are organised into chromatin, a 
higher order structure that compacts genomic DNA to fit into the nucleus. 
Despite being widely used, CRISPR/Cas9 does not naturally recognise 
chromatinised DNA as a substrate. Indeed, several studies have shown that 
nucleosomes protect DNA from cleavage by CRISPR/Cas9 in vitro (Hinz, 
Laughery and Wyrick, 2015; Horlbeck et al., 2016; Isaac et al., 2016). Studies 
using cell-based systems have also shown that chromatin compaction reduces 
the efficiency of CRISPR/Cas9 mutagenesis (Chen et al., 2016; Fujita, Yuno 
and Fujii, 2016; Daer et al., 2017). However, Cas9 can penetrate highly 
compacted heterochromatic regions and has been proposed to remodel 
nucleosomes inside mammalian cells (Knight et al., 2015; Polstein et al., 2015; 
Barkal et al., 2016). This creates a paradoxical situation that merits further 
investigation.  
In the past, the use of genomic imprinting as a model system has led to 
key discoveries about the regulation of gene expression by factors like CTCF 
and lncRNAs, as well as genome organisation (Hark et al., 2000; Murrell, 
Heeson and Reik, 2004; Nagano et al., 2008). Imprinted genes must only be 
expressed from one of the two inherited parental alleles in mammals, in order 
to secure proper prenatal development. This is achieved by the establishment 
of ‘imprints’, which consist of differential deposition of DNA methylation on the 
two alleles. This event is followed by additional deposition of repressive 
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histone modifications, such as H3K9me3 and H4K20me3, on the allele that 
needs to be silenced  and results in the establishment of a small-scale 
heterochromatic environment that is frequently embedded within wider 
euchromatic regions (Regha et al., 2007).  
The presence of the same underlying DNA sequence in two different 
chromatin conformations within the same nuclear environment created an 
excellent opportunity for us to investigate the effect of chromatin on 
CRISPR/Cas9 editing efficiency. By repurposing genomic imprinting, we 
developed a system to quantify mutagenesis in an allele-specific manner after 
co-delivery of CRISPR/Cas9 and an ssODN into two reciprocal hybrid mESC 
lines. The presence of repressive chromatin modifications on one of the two 
parental alleles was verified in both mESC lines and the degree of imprinting 
maintenance was monitored throughout every targeting experiment.  
A major advantage of this system is that a repressed and an accessible 
allele are present at a one-to-one ratio inside each cell nucleus, providing an 
ideal internal control. This was a very big caveat of other cell-based systems 
that have been used so far, which relied on perturbing the chromatin 
environment where a reporter gene was located (Chen et al., 2016; Daer et 
al., 2017). Our system avoids perturbing the natural configuration of chromatin 
within mammalian cells, because genomic imprinting is a natural phenomenon. 
Furthermore, both of the studies mentioned above have been transfecting 
separate cell populations (untreated vs doxycycline-treated) to infer about the 
effect of chromatin on the editing efficiency of CRISPR/Cas9. As we 
demonstrated in Figure 4.3, plasmid transfections lead to a heterogeneous 
cell population, where different Cas9 concentrations affected the impact of 
chromatin on the editing efficiency of CRISPR/Cas9. Neither Chen et al nor 
Daer et al controlled for the concentration of Cas9 between the different 
transfections they were performing on the separate cell populations that were 
untreated or treated with doxycycline. This might explain some of the enigmatic 
higher magnitudes of chromatin-related effects they reported, compared to our 
earliest findings (Figure 3.7).  
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Our earliest editing experiments on three separate maternally-imprinted 
loci proved the presence of a subtle yet reproducible bias for editing on the 
paternal non-imprinted allele following exposure to the genome editing 
reagents for 4 days (Figure 3.7 and Figure 3.8). The puromycin selection that 
was performed during these experiments may enrich for the cells with very 
high Cas9 expression from the introduced plasmid. As shown in Figure 4.3 
and Figure 4.4, high Cas9 expression results in lower allelic bias and provides 
more opportunity for the less frequently accessed allele to be cleaved and 
edited. However, similar subtle allele-specific bias values are also observed in 
the absence of puromycin selection during the 4 day-long exposure 
experiments shown in Figure 4.2. 
Despite observing lower bias levels between the euchromatic and 
heterochromatic regions we assessed, compared to the bias levels observed 
by the studies mentioned above, we were able to vary and test other 
parameters that could influence the way chromatin compaction affects 
CRISPR/Cas9 mutagenesis. This is owed to the natural, internally controlled 
system we employed, where two chromatin states were assessed in parallel 
within the same population of cells. Having observed differences in the 
magnitude of the effect of chromatin between separate transfections, or 
between different loci, western blots could have been performed to report on 
the relevant expression levels of Cas9 within cells following transfection. A 
serious caveat of our system was the partial loss of imprinting we frequently 
experienced as a consequence of maintaining the two reciprocal mESC lines 
in 1i culture conditions (Choi et al., 2017). Constant monitoring of the degree 
of imprinting maintenance via targeted sequencing of bisulfite amplicons 
helped us determine the impact of imprinting loss on each experimental 
dataset. 
While our work was ongoing, a study using a different internally-
controlled system emerged. This study assessed a single locus in the HCT116 
human colon cancer cell line, and primarily focused on the effect of DNA 
methylation on CRISPR/Cas9 editing efficiency (Fujita, Yuno and Fujii, 2016). 
Three different sgRNAs were used to edit the p16INK4a locus, in separate 
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transfections for every sgRNA. The authors concluded that the editing 
efficiency of only one of those three sgRNAs was affected by chromatin 
modification, as inferred from differential DNA methylation. We also used three 
different sgRNAs to target the KvDMR locus. As shown in Figure 3.7, we 
observed that chromatin modifications, including repressive histone 
modifications and DNA methylation, reduced the efficiency of all three sgRNAs 
that were used to target the KvDMR locus. This could be attributed to the fact 
that we used a high-throughput assay involving Next generation sequencing 
to quantify the effect of chromatin on CRISPR/Cas9 mutagenesis instead of 
cloning PCR amplicons from edited genomic DNA samples into plasmids and 
performing Sanger sequencing to obtain a smaller number of reads.  
By reducing the editing timeframe and sampling targeted cells at 4-hour 
intervals, as shown in Figure 4.1, we discovered that the impact of repressive 
chromatin modifications is more profound during short timeframes of exposure 
to the genome editing reagents. This supports previous findings showing that 
heterochromatin delays the search of CRISPR/Cas9 for its target site (Knight 
et al., 2015). In addition, we showed that the lower intracellular concentration 
of eGFP, and therefore Cas9, the higher the ablation of allelic bias towards the 
accessible non-imprinted allele (Figure 4.3). Finally, the presence of designer 
mismatches between the sgRNA and the target site resulted in a 
disproportionate reduction of mutagenesis on the imprinted heterochromatic 
allele, implying that chromatin compaction reduces off-target CRISPR/Cas9 
mutagenesis (Chapter 4.5). This finding is consistent with a recently published 
study where differentially accessible genomic regions were targeted in 
HEK293 and HeLa cells (Kim and Kim, 2018). The system employed by Kim 
and Kim involved using mismatch-containing sgRNAs to target two sequences, 
similar to the two loci we targeted, that were present in two copies in the human 
genome. However, the two target sites were selected based on DNase 
hypersensitivity alone in the absence of other epigenetic modification 
differences between the two copies of the target sequences. Our system is 
based on differential accessibility to DNase I, differential DNA methylation and 
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repressive histone modifications, which are overall more informative on the 
effect of natural chromatin compaction than DNase I accessibility alone.  
Additionally, we showed that dCas9 associates more readily with the 
accessible, non-imprinted allele between 8 and 96 hours after lipofection, 
which agrees with conclusions from previous genome-wide ChIP-seq studies 
for global assessment of dCas9 occupancy (Kuscu et al., 2014; Wu et al., 
2014). Except for the possibility that Cas9 can remodel chromatin, it is also 
likely that Cas9 gains access to genomic sites that are occluded by pre-existing 
repressive chromatin modifications as a result of opportunistic nucleosome 
remodelling. Taken together, our data provide novel insights into how 
chromatin regulates CRISPR/Cas9 mutagenesis and extend the findings of 
previous studies on this subject.  
Looking forward, chromatin compaction should be considered when 
designing genome editing experiments and selecting sgRNAs with as few 
predicted off-target site effects as possible. In general, it is desirable to pick 
sgRNAs that have a high on-target efficiency and a low off-target efficiency. 
By combining these two parameters we can derive the ratio of on-target/off-
target mutagenesis. This ratio will be high if the on-target efficiency is also 
high and the off-target efficiency is low, as is preferable while designing editing 
experiments.  
Our data suggests that while the intracellular concentration of Cas9 is 
low, and Cas9 exposure is brief, chromatin exerts the biggest effect at the on-
target mutagenesis frequency. In this scenario, accessible euchromatic 
regions are edited much more readily than inaccessible heterochromatic 
regions. Regardless of the exposure time and intracellular Cas9 concentration, 
we and others (Kim and Kim, 2018) have observed that off-target mutagenesis 
is greatly reduced in inaccessible heterochromatic regions. Our data is thus 
adequate for us to propose a model for obtaining high on-target/off-target 
mutagenesis ratios while designing editing experiments with CRISPR/Cas9. In 
order to maximise on-target and minimise off-target mutagenesis, researchers 
should select sgRNAs whose target sites are located within euchromatin and 
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predicted off-target sites are located in heterochromatin, in any cell line of 
choice. To further refine the efficiency of on-target mutagenesis, exposure to 
the genome editing reagents should be brief and the intracellular concentration 










Figure 6.1 Model for acquiring a high on-target/off-target mutagenesis ratio.  
Off-target site mutagenesis can be minimised by selecting sgRNAs that have 
predicted off-target sites in heterochromatin (represented by purple letters). In 
addition, on-target efficiency can be maximised by selecting sgRNAs that target 
euchromatic regions (represented by turquoise letters) while limiting the concentration 
of Cas9 during the experiment (as implied by the amount of Cas9 molecules, shown 
in pink). If all of these conditions are met, the on-target/off-target mutagenesis ratio 
is maximised (as shown on the right). If the concentration of Cas9 increases the on-
target efficiency for euchromatic sgRNAs decreases, leading to a lower on-target/off-
target mutagenesis ratio (as shown in the middle). Finally, the lowest possible on-
target/off-target mutagenesis ratio is obtained by combining a high intracellular Cas9 
concentration while using heterochromatic sgRNAs that have predicted off-targets 
within euchromatin (as shown on the left).  
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6.2 Can the effect of heterochromatin be refined in 
non-dividing cells?  
   
 Heterochromatin may generally be less permissive for transcription than 
euchromatin, but DNA replication must still occur during each cell cycle (Craig 
and Bickmore, 1993). The passage of the replication fork requires chromatin 
to be remodelled, which may lead to opportunistic binding of Cas9. It is also 
known that due to their special cell cycle arrangements, which are a very short 
G1 phase and extended S phase (White and Dalton, 2005), mESCs have a 
looser chromatin structure compared to differentiated cells (Meshorer, 2007), 
such as neural progenitors and mature neurons (Bonev et al., 2017). 
Therefore, it is worth investigating what the effect of chromatin on 
CRISPR/Cas9 mutagenesis is by using other cell lines with better-defined 
heterochromatic regions.  
Moving forward, I would like to target maternally-imprinted loci in post-
mitotic cells and determine the effect of chromatin on targeted mutagenesis by 
CRISPR/Cas9 in the absence of DNA replication. If the effect we observe in 
post-mitotic cells is ablated compared to what we have observed in mESCs so 
far, we would suggest that chromatin exerts a larger effect in these cells. To 
explore this idea, we plan to target non-dividing hepatocytes in hybrid mice 
derived from the same reciprocal strain crosses as for our hybrid mESC lines. 
An increasingly popular method for direct delivery of the genome editing 
reagents to liver tissue is direct tail vein injection (Yang et al., 2016), which has 
been recently optimised for delivery of naked plasmid DNA by our collaborator 
Dr Luke Boulter.  
In the future, we would deliver our CRISPR-eGFP px458 constructs via 
tail vein injection to hybrid mice and determine the uptake efficiency of the 
reagents with Immunohistochemistry for eGFP. This approach will allow us to 




6.3 How is off-target site mutagenesis inhibited in 
heterochromatin? 
 
Off-target site recognition is undesirable during genome editing with 
programmable nucleases. Despite the existence of several tools that predict 
off-target mutagenesis sites for sgRNA candidates, many of these tools ignore 
the native chromatin context of mammalian genomic DNA. During my PhD I 
introduced mismatches into the sgRNA, while still targeting the same 
maternally-imprinted loci, in order to mimic an off-target site and maintain the 
advantages of our internally controlled system. The early experiments from two 
different maternally-imprinted loci suggested that the native chromatin context 
impairs off-target site mutagenesis.  
Our main focus for the future, will be to dissect the mechanism by which 
heterochromatin inhibits off-target mutagenesis by CRISPR/Cas9. In order to 
examine if heterochromatin impairs the initial association between the Cas9-
sgRNA complex and its target site, we would like to use sgRNAs with 
mismatches on the protospacer sequence of the sgRNA molecule and perform 
ChIP followed by target amplicon sequencing. Similar to our approach for 
perfectly complementary sgRNAs, we would assess the degree of dCas9 
binding in the absence of complementarity between the protospacer and target 
site in an allele-specific manner.  
Furthermore, we would also like to perform additional experiments to 
identify which feature of heterochromatin is primarily responsible for this effect. 
The first heterochromatic feature in question will be DNA methylation, which 
does not influence the initial association of dCas9 in vitro (Fujita, Yuno and 
Fujii, 2016). To address if DNA methylation inhibits some of the later steps 
involved in CRISPR/Cas9 target recognition, such as R-loop formation, we 
would use an in vitro cleavage assay that compares the efficiency of 
CRISPR/Cas9 when the target DNA is either unmethylated or methylated. A 
diagram explaining the assay is provided in Figure 6.2.A. 
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 The second feature of heterochromatin we are considering is 
nucleosome mobility. During the last months of my PhD I briefly undertook the 
design and cloning of DNA segments containing sgRNA into two separate and 
unique chromatin fibre constructs developed by Professor Nick Gilbert. The 
key difference between the two fibres lies in the affinity for nucleosome 
positioning affinity they possess. While the first fibre construct consists of a low 
affinity nucleosome binding site that is flanked by twelve repeats of the Widom 
601 high affinity sequence, which result in a very well structured and stiff fibre 
(Lowary and Widom, 1998), the second fibre construct consists solely of low 
affinity nucleosome binding sites. An illustration of the nucleosome binding 
sites of the two fibre constructs is provided in Figure 6.2.B. The two constructs 
can be assembled into chromatin fibres with the aid of purified histone 
octamers from chicken erythrocytes (Feng, Scherl and Widom, 1993). Our goal 
is to compare how readily each of the two fibres are digested by purified Cas9 
protein coupled with in vitro-transcribed sgRNA molecules in the presence and 
absence of mismatches on the protospacer. This will provide new insights into 
the effect of nucleosome positioning on off-target site cleavage and help us 
understand if nucleosome mobility, which is typically lower in transcriptionally 
repressed heterochromatin, could contribute to the disproportionate effect of 




Figure 6.2 Schematic of the in vitro cleavage assay and the two chromatin fibre 
constructs. A: In vitro assay to assess and compare cleavage of unmethylated and 
methylated templates. The template sequence contains the PAM and protospacer for 
the previously used sgRNAs. Template methylation is also performed in vitro with 
M.SssI. Cleavage products will be visualised by agarose gel electrophoresis. B: 
Representation of the stiff Widom 601 oligomer fibre (top) and the Recon1 fibre 
(bottom). For the 601 Widom oligomer fibre, twelve high affinity 601 sites, shown in 
purple, are located on each site of a central low affinity nucleosome binding site, 
shown in green. The Recon1 fibre construct consists only of low nucleosome binding 
sites, shown in turquoise, and is less stiff than the 601 oligomer fibre. The PAM will 
be positioned at the centre of each fibre, on the central low affinity binding sites.  
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6.4 Pre-existing chromatin modifications do not 
influence Cas9-induced DSB repair  
 
By leveraging the genomic imprinting-based system we developed, we 
also assessed the effect of chromatin on repair of Cas9-induced DSBs in the 
context of genome editing with CRISPR/Cas9. After assigning the parental 
origin to every generated sequencing read, all reads were broken down to 
three categories for each allele. Reads with small gaps or one extra nucleotide 
(InDels) were assigned to the NHEJ category, whereas reads containing the 
pre-engineered designer mutation from the externally provided single-
stranded repair template were assigned to the HDR category. The reads where 
the sequence was identical the reference C57BL/6J (B) or JF1 (J) genomes 
were assigned to the third category, which was reads without evidence of 
CRISPR/Cas9 mutagenesis.  
Allele-specific analysis of the reads bearing NHEJ-derived InDels 
revealed that every individual target site produced a unique InDel pattern that 
was not substantially influenced by chromatin state. This finding is relatable to 
two InDel profiling studies that did not asses the effect of chromatin and were 
published at different times throughout the course of my PhD (van Overbeek 
et al., 2016; Chen et al., 2019). During another recent study, that largely 
resembled that by van Overbeek et al, InDel profiles were assessed before 
and after treating HepG2 human liver cancer cells with Trichostatin A (TSA), 
which is a histone deacetylase inhibitor (Chakrabarti et al., 2018). By altering 
the natural configuration of chromatin, the authors compared InDel profiles for 
compacted and de-compacted (after TSA treatment) genomic locations, using 
separate cell populations for each condition. The conclusion of this study was 
that the InDel profile of some sites, which do not consistently produce certain 
types of InDels, is affected by chromatin whereas sites that consistently 
produce the same types of InDels are not affected by changes in chromatin 
configuration (Chakrabarti et al., 2018). However, perturbing chromatin with 
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TSA in a cancer cell line is perhaps not the best way to derive conclusions 
about features that are shared across cell types, as suggested by the authors.  
An important caveat of our assay relating to DNA repair is that the 
readout depends on mutation, and thus does not report on error-free c-NHEJ. 
However, it allowed us to fulfil our primary objective: to assess the effect of 
chromatin on genome editing. In the absence of resection or the lack of 1bp 
InDel generation during c-NHEJ, the endpoint after Cas9-induced DSB repair 
will be identical to the original target sequence. It is also possible to receive an 
output that is identical to the starting sequence if HR takes place from a sister 
chromatid, which is likely in mESCs due their unusually longer S-phase and 
shorter G1-phase (White and Dalton, 2005). Since these events would not 
produce a mutational consequence, they would be assigned into the spectrum 
of reads without evidence of mutation through our sequencing analysis 
pipeline. It is not currently possible to estimate what fraction of these ‘non-
mutagenised’ reads corresponds to error-free c-NHEJ, HR from a sister 
chromatid or unedited strands, but our assay still reports on the most common 
outcomes of Cas9-induced DSB repair options (error-prone c-NHEJ, MMEJ, 
HDR). Overall, this caveat is shared between our assay and the other assays 
that have been used to assess the effect of chromatin on the outcome of 
CRISPR/Cas9 mutagenesis (Fujita, Yuno and Fujii, 2016; Daer et al., 2017).  
What remains unclear due to the small-scale range we assess with our 
targeted 150bp paired amplicon sequencing, is the occurrence of larger 
deletions through alt-EJ. Ultimately, we hope to subject the plethora of 
samples we generated during this project to an alternative sequencing method 
and generate longer sequencing reads. These will allow us to discover if there 
is a link between pre-existing chromatin modifications and larger deletions 
during genome editing with CRISPR/Cas9.  
Concerning HDR, we discovered that it occurs at similar frequencies 
regardless of pre-existing chromatin modifications due to lack of statistically 
significant differences between the two alleles of the targeted maternally-
imprinted genes. Additional evidence from a very recent study agrees with our 
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observations about HDR being unaffected by the pre-existing chromatin 
context of the target site (Janssen et al., 2019). Another study assessing repair 
of DSBs induced by the I-SceI meganuclease in Drosophila melanogaster also 
reached a similar conclusion about the effect of chromatin compaction on HR 
occurrence (Janssen et al., 2016). Although at first thought this strengthens 
our findings, it should be noted that instead of traditional HR we are assessing 
HDR through externally provided ssODNs, a mechanism that is still not fully 
characterised.  
Our primary hypothesis was that HDR would more prevalent in the 
accessible euchromatic allele in our genomic imprinting-based system. The 
foundations of this hypothesis lie on a study that showed that HR is 
preferentially utilised to repair DSBs occurring within actively transcribed 
regions of the genome (Aymard et al., 2014). According to Aymard et al, 
LEDGF mediates recruitment of CtIP to DSBs in actively transcribed gene 
bodies through direct association with H3K36me3. Although neither allele of 
imprinted promoters is decorated with H3K36me3, as shown in Figure 5.3 and 
Figure 5.4 the Cas9-induced DSBs we generated within actively transcribed 
imprinted gene bodies were not preferentially repaired via HDR on the non-
imprinted transcriptionally active allele either. Therefore, our primary 
hypothesis was rejected. Nevertheless, there are two possible explanations for 
our observations.  
Firstly, HDR with a single-stranded repair should not be mistaken with 
traditional, Rad51-dependent HR. The mechanism of HDR with ssODNs 
requires Rad52, which is necessary for SSA in prokaryotes and yeast. In 
addition, it has also been proposed that HDR with ssODNs resembles SDSA 
and does not require incorporation of the donor molecule (Kan et al., 2017). A 
link between HDR and the Fanconi Anemia pathway, which is responsible for 
the repair of inter-strand crosslinks, has also recently been established 
(Richardson et al., 2018). This is not surprising, considering that Cas9 has 
been repeatedly reported to remain at DNA ends after having induced a DSB 
(Richardson et al., 2016; Brinkman et al., 2018). It is likely that the lack of 
distinct HDR efficiencies on the imprinted alleles is owed to the fundamentally 
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different DSB repair mechanism that was employed to repair Cas9-induced 
DSBs with the aid of an ssODN.  
Secondly, the repair kinetics of Cas9-induced DSBs are reportedly 
slower than for IR-induced DSBs (Brinkman et al., 2018). It is possible that the 
nature of Cas9-induced and IR-induced breaks is fundamentally different, 
especially since Cas9 may remain bound to DNA ends after cleavage or even 
remodel nucleosomes bearing any pre-existing histone modifications during 
target search by the Cas9-sgRNA complex. This possibility remains open to 
further investigation.  
 Due to reporting that chromatin compaction does not influence the 
choice between NHEJ and HDR during genome editing with CRISPR/Cas9, 
we have not managed to identify a chromatin state that is more permissive for 
repair of Cas9-induced DSBs via HDR. However, a number of different 
approaches have been undertaken to increase HDR frequency and ultimately 
result in higher rates of incorporation of the sequence information from the 
supplied repair templates. The most notable mentions include the use of 
plasmids to ectopically express RAD52 in HEK293 cells (Paulsen et al., 2017) 
and an engineered version of RAD18, a RAD51 paralog, which reportedly 
increases HDR in HEK293 and HeLa cells (Nambiar et al., 2019). Alternatively, 
Cas9 can be fused to short peptides that remodel chromatin (Ding et al., 2019) 
or promote HDR, such as the N-terminal fragment of CtIP (Charpentier et al., 
2018). This research area will be particularly important in the future and will 
most likely shape genome editing with CRISPR/Cas9 into a better still method 
for targeted mutagenesis and introduction of desirable modifications to 







6.5 Concluding remarks 
 
In summary, during my PhD I demonstrated that genomic imprinting can 
be successfully repurposed into an epigenetic system to assess how 
chromatin regulates CRISPR/Cas9 mutagenesis and repair of Cas9-induced 
DSBs with an externally provided single-stranded repair template. The key 
advantage of our approach is the simultaneous assessment of the same DNA 
sequence when it is compacted into two different chromatin states as defined 
by differential accessibility, DNA methylation and histone modifications. Our 
findings suggest that the efficiency of editing with CRISPR/Cas9 on a desirable 
target site can be increased if the site is located within accessible chromatin, 
a low concentration of Cas9 is used for a shortly-timed exposure, and the 
predicted off-target sites are located within inaccessible chromatin. In the 
future, we hope that our findings will be considered to refine tools for CRISPR 
design and pave the way towards the development of new off-target site 
prediction methods and improved strategies for genome editing for treating 
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Appendix 2 - Other media recipes 
 
Custom 2i media recipe for mESCs from Heidi Mjøseng 
 
Serum free ES medium (SFES) - 500 ml   
Substance 
 
Amount   
Neurobasal 
 
250 ml   
DMEM/F12 
 
250 ml   
BSA (7.5%) 
 
3.33 ml   
Pen/Strep 
 
5 ml   
N-2 supplement 
 
2.5 ml   
B27+RA 
 










Complete "2i" medium - 50 ml (max shelf life 3 days) 
Substance 
 
Amount   
SFES (above stock) 
 
50 ml   
PD0325901 [1mM stock] 
 
50 ul [1uM final] 
CHIR99021 [3mM stock] 
 
50 ul [3uM final] 
Glutamine [200mM stock] 
 
500 ul [2mM final] 
LIF [10^6U/ml] 
 
50 ul 1000U/ml 









Appendix 5 - Buffers and solutions 
 
5.1 Buffers for DNase I accessibility assay  
 
Buffer A:  
• 15 mM Tris HCl (pH 7.6)  
• 60 mM KCl, 15 mM NaCl 
• 1 mM EDTA 
• 0.5 mM EGTA 
• 0.5 mM spermidine 
• 0.15 mM spermine 
 
Digestion buffer: buffer A supplemented with  
• 3 mM CaCl2 
• 75 mM NaCl  
 
Stop buffer: 
• 0.1 M NaCl 
• 0.1 % (w/v) SDS 
• 50 mM Tris-HCl (pH 8.0) 
• 100 mM EDTA  
 
TE buffer:  
• 10 mM Tris-HCl (pH 8.0)  




5.2 Buffers for Native histone ChIP 
 
NBA buffer:  
• 85mM NaCl 
• 5.5% sucrose 
• 10mM Tris-HCl pH 7.5 
• 0.2mM EDTA 
• 0.2mM PMSF 
• 1mM DTT 
• protease inhibitors (Merck Millipore, 539131) 
 
NBB buffer: NBA buffer with  
• 0.1% NP-40 
 
NBR buffer:  
• 85mM NaCl 
• 5.5% sucrose 
• 10mM Tris-HCl (pH 7.5) 
• 3mM MgCl2 
• 1.5mM CaCl2 
• 0.2mM PMSF 







MNase stop buffer:  
• 215mM NaCl 
• 10mM TrisHCl pH8 
• 20mM EDTA 
• 5.5% sucrose 
• 2% TritonX100 
• 0.2mM PMSF 
• 1mM DTT 
• 2x PMSF 
 
Blocking buffer: 
• 0.5% BSA in PBS 
 
ChIP-W1 buffer:  
• 150mM NaCl 
• 10mM Tris HCl (pH 8.0) 
• 2mM EDTA 
• 1% NP40# 
• 1% Sodium Deoxycholate 
 
TE buffer:  
• 10 mM Tris-HCl (pH 8.0) 
• 1 mM EDTA) 
 
Elution buffer:  
• 0.1mM NaHCO3 
• 1% SDS 
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• 5.3 Buffers for cross-linked ChIP 
 
Farnham lysis buffer:  
• 5mM PIPES (pH 8.0)  
• 85mM KCl 
• 0.5% NP-40 
• protease inhibitors (Merck Millipore, 539131) 
 
RIPA buffer:  
• 1x PBS  
• 1% NP-40  
• 0.5% sodium deoxycholate  
• 0.1% SDS 
• protease inhibitors (Merck Millipore, 539131) 
 
LiCl Wash Buffer:  
• 100mM Tris (pH 7.5) 
• 500mM LiCl 
• 1%NP-40 
• 0.5% sodium deoxycholate 
 
Elution buffer: 
• 0.1mM NaHCO3  





Appendix 6 – Standard deviation of InDel classes  




BxJ maternal STDEV BxJ paternal  STDEV 
Δ5 
(combined) 
0.029383631 Δ5 (combined) 0.01684022 
Δ1 0.01824212 Δ1 0.010263808 
Δ2 0.016073368 Δ2 0.022510046 
I1 0.003327726 I1 0.013761138 
    
    
JxB maternal  STDEV JxB paternal  STDEV 
Δ5 
(combined) 0.017277037 Δ5 (combined) 0.026910128 
Δ1 0.042613555 Δ1 0.010887627 
Δ2 0.018858367 Δ2 0.030471327 





BxJ maternal STDEV BxJ paternal  STDEV 
Δ5 0.101980135 Δ5  0.01989343 
Δ2 0.056707048 Δ2 0.01268864 
Δ6 0.011177243 I1 0.02075783 
I1 0.013393223 Δ6 0.02384817 
Δ16 0.010965797 Δ1 0.01934358 
    
JxB maternal  STDEV JxB paternal  STDEV 
Δ5 0.080880029 Δ5  0.03324798 
Δ2 0.029249498 Δ2 0.01790599 
Δ6 0.049424894 I1 0.01390138 
I1 0.083117846 Δ6 0.01487232 






BxJ maternal STDEV BxJ paternal  STDEV 
Δ5 0.008172038 Δ5  0.005008938 
Δ1 0.008372349 Δ1 0.015668178 
Δ3 0.010804898 Δ3 0.007720155 
Δ2 0.013545753 Δ6 0.00808854 
Δ21 0.002074258 Δ13 0.031161081 
    
JxB maternal  STDEV JxB paternal  STDEV 
Δ5  0.005898988 Δ5  0.011401644 
Δ1 0.017217324 Δ1 0.006058997 
Δ3 0.016047504 Δ3 0.011046054 
Δ6 0.007282596 Δ2 0.016215758 





BxJ maternal STDEV BxJ paternal  STDEV 
Δ14 0.018372703 Δ14 0.017525019 
Δ5 0.023475713 Δ5 0.007075884 
Δ12 0.032954407 Δ12 0.01102461 
I1 
(combined) 





    
JxB maternal  STDEV JxB paternal  STDEV 
Δ14 0.002270929 Δ5  0.023018881 





Δ12 0.023390484 Δ12 0.03021281 
 
 
